[go: up one dir, main page]

WO2010022148A1 - Methods for the preparation of irciniastatin and analogs thereof - Google Patents

Methods for the preparation of irciniastatin and analogs thereof Download PDF

Info

Publication number
WO2010022148A1
WO2010022148A1 PCT/US2009/054305 US2009054305W WO2010022148A1 WO 2010022148 A1 WO2010022148 A1 WO 2010022148A1 US 2009054305 W US2009054305 W US 2009054305W WO 2010022148 A1 WO2010022148 A1 WO 2010022148A1
Authority
WO
WIPO (PCT)
Prior art keywords
compound
formula
equiv
etoac
reaction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2009/054305
Other languages
French (fr)
Inventor
Amos B. Smith, Iii
Jon A. Jurica
Shawn P. Walsh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Pennsylvania Penn
Original Assignee
University of Pennsylvania Penn
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Pennsylvania Penn filed Critical University of Pennsylvania Penn
Publication of WO2010022148A1 publication Critical patent/WO2010022148A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms

Definitions

  • the present invention is directed to methods for the preparation of irciniastatins, as well as methods for the preparation of analogs thereof.
  • Pettit and coworkers first collected samples containing irciniastatins A and B from the Indo- Pacific marine sponge Ircinia ramosa near Samporna, Borneo in 1991 .
  • the dichloromethane-methanol extracts exhibited strong activity (GI50 - 10 '2 ⁇ g/mL) against the P388 murine lymphocytic leukemia cancer cell line.
  • irciniastatins A and B were isolated as an individual constituent (34.7 mg and 2.2 mg, respectively) from the initial dichloromethane-methanol extracts.
  • Table 1.1 Growth Inhibition of Cancer Cell Lines (GI 5 0, ⁇ g/ml) by Irciniastatin A and B Cancer Cell Line Irciniastatin ⁇ Irciniastatin B pancreas BXPC-3 0.0038 0.00073 breast MCF-7 0.0032 0.0005
  • (+)-irciniastatin A was evaluated against the panel of 60 human cancer cell lines within the NCT Developmental Therapeutics in Vitro Screening Program (Table 1.2).
  • (+)-lrciniastatin A exhibits activities in the low nanomolar range for the MDA-MB-35 breast cancer, SK-MEL-28 and UACC-62 melanoma, and the HCT-1 16 colon cancer cell lines with an activity differential of greater than 10,000-fold as compared to other cell lines within their respective subsets.
  • (+)-Irciniastatin A was also evaluated in the NCI Developmental Therapeutics Program hollow fiber assay using several solid tumor cell lines resulting in an overall score of 34 (compounds considered active score 20 or higher), based on scores of 28 against intraperatineal fibers and 6 against subcutaneous fibers.
  • R 2 is a C
  • R N is an amine protecting group
  • R 3 is at least one C 1 . 6 alky], substituted alkyl, halogen, -OH, -OR 1 , or carbonyl: wherein R 1 is a hydroxy! protecting group
  • R 4 is at least one C 1 . 6 alkyl, substituted alkyi, halogen, -OH, or OR; wherein R is a phenolic protecting group; and wherein R is a protecting group that is orthogonal to R 1 ; and converting the compound of formula TI to the irciniastatin.
  • R ]0 is Ci- 6 alkyl group substituted with at least one ORi 2 or carbonyl, each Ri i is independently Q.
  • ⁇ alkyl, and Ru and Rn are orthogonal protecting groups, as well as methods of their preparation and use in the preparation of irciniastatins.
  • the present invention is directed to methods of preparing irciniastatins.
  • irciniastatins As used herein,
  • the "'irciniastatin” refers to the general class of compounds, including analogs and homologs. characterized by linked substituted tetrahydropyran and dihydroisocoumarin moieties with pendant hydroxyl amido side chain, generally in a spatial orientation consistent with either (+)- irciniastatin A or (-)-irciniastatin B, and with a multiplicity of chiral centers throughout. Unless otherwise indicated, any reference to the terms "an irciniastatin'' or "the irciniastatin " ' or portion 0 thereof are intended to refer to this general class of compounds, including any analog or homolog.
  • amido-linked sidechain is intended to describe a C M alkyl chain, optionally substituted with a C M alkyl.
  • R 2 is a Q. 6 alkyl group; RN is an amine protecting group; R 3 is at least one Ci -6 alkyl. substituted alkyl, halogen, -OH. -OR 1 , or carbonyl; wherein R 1 is a hydroxyl protecting group; and R 4 is at least one Ci_6 alkyl, substituted alkyl. halogen, -OH, or OR; wherein R is a phenolic protecting group; and wherein R is a protecting group that is orthogonal to R 1 .
  • the compound of formula II is then converted to the irciniastatin.
  • the irciniastatin is irciniastatin A.
  • the irciniastatin is irciniastatin B.
  • alkyl refers to straight-chain and branch hydrocarbon groups such as, for example, methyl, ethyl, propyl, isopropyl, butyl, isobutyl, sec-butyl, ter-butyl. pentyl, and hexyl.
  • . 6 alkyP' refers to alkyl groups having from 1 to 6 carbon atoms.
  • substituted alkyl refers to an alkyl group including one or more functional groups such as alkyl. halogen, hydroxyl, amino, and cyano.
  • protecting group are those moieties introduced into a molecule by chemical modification of a functional group in order to obtain chemoselectivity in a subsequent chemical reaction.
  • Protecting groups are known in the art, and those skilled in the art would readily be able to select and use appropriate protecting groups through routine experimentation. For example, see T. W. Greene and P.G.M. Wuts, Protective Groups in Organic Synthesis, 2006.
  • amine protecting group refers to a protecting group for an amine.
  • Amine protecting groups are known in the art and include, for example, carbamates. Preferred carbamate groups are those containing hindered primary, secondary, or tertiary alkoxy groups.
  • R N is 9-fluorenylmethyl carbamate (Fmoc), 2,2,2- trichloroethyl carbamate, 2-trimethylsilylethylcarbamate (Teoc), t-butyl carbamate (Boc), allyl carbamate (Alloc), benzylcarbamate (Cbz), m-nitrophenyl carbamate, or p-methoxyphenyl carbamate.
  • the amine protecting group is (trimethylsilyl)ethocycarbonyl.
  • hydroxyl protecting group refers to a protecting group for a hydroxyl. Hydroxyl protecting groups are known in the art and include, for example, trialkylsilyl. In preferred embodiments, Ri is t-butyldimethylsilyl.
  • phenolic protecting group refers to a protecting group for a phenol.
  • Phenolic protecting groups are known in the art and include, for example, benzyl and trialkylsilylethoxymethyl.
  • R is benzyl.
  • R is (2-trimethylsilyl)ethoxymethyl.
  • halogen refers to F, Cl, or Br.
  • orthogonal when used to describe hydroxyl and/or phenolic protecting groups of the invention, refers to a strategy allowing the protection and deprotection of multiple -OH groups one at the time each with a dedicated set of reaction conditions without affecting the other.
  • compounds such as siloxy methyl halides, silyl alkoxymethyl halides (e.g., 2-(trimethylsilyl)-ethoxymethyl chloride), substituted phenoxy methyl halides, or alkoxy halides form the corresponding protecting group ethers, which can be reversed under varying hydrolysis conditions.
  • may refer to the same or different such protecting groups.
  • the compound of formula I is converted to the compound of formula II by subjecting the compound of formula I to conditions sufficient to effect a Curtius rearrangement.
  • a Curtius rearrangement is a chemical reaction that involves the rearrangement of an acyl azide, for example, the compound of formula 1, to an isocyanate. The isocyanate can then be trapped by a variety of nucleophiles.
  • the conditions sufficient to produce the compound of formula II comprise heating the compound of formula I in an organic solvent, for example. toluene, benzene, or xylene, for a time sufficient to generate an isocyante of formula III
  • the isocyanate of formula III can be treated with the alcohol either in situ or after purification.
  • the alcohol is 9-fluorenylmethanol, 2,2,2-trichloroethanol. 2-trimethylsilylethanol, t-butanol, allyl alcohol, benzyl alcohol, m-nitrophenyl alcohol, or p-methoxyphenyl alcohol.
  • the alcohol is trimethysilylethanol.
  • the compound of formula TII is N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N
  • the compound of formula I is N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl
  • the compound of formula I is N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl
  • a compound of formula T can be prepared by reacting a compound of formula VI:
  • each R 2 is independently Ci ⁇ alkyl.
  • the compound of formula VII can be 5 converted to the irciniastatin using techniques and methods known in the art.
  • the compound of formula VI is N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl
  • Ri is methyl or ethyl.
  • the compound of formula V is wherein R 2 is preferably methyl or ethyl.
  • the compound of formula VIl is N-(2-aminoethyl)-2-aminoethyl
  • an irciniastatin is provided via a synthetic scheme which includes the preparing the compound of formula I. the attachment of the amido linked sidechain proceeds by using the moiety described in formula VIlI
  • R x may be any C M alkyl chain, optionally substituted with a Ci -4 alkyl, Cj -4 alkenyl, alcohol, orthogonally protected alcohol, Ci -4 alkoxide, or other substituent.
  • L can be any group such as pivaloyl, alkyl sulfonyl, aryl sulfonyl. or other moiety that make the OL group a labile, or ready, leaving group. This list is not intended to be exhaustive, and those skilled in the art will appreciate the other opportunities for this group.
  • the compound of formula VIII is N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl
  • the compound of formula IX is N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl
  • a compound of formula X can be prepared by deprotecting a compound of formula TX, under conditions sufficient to produce a compound of formula XlT; and oxidizing the compound of formula XIT under sufficient conditions to form a compound of formula X.
  • Those skilled in the art would 15 appreciate the choice of protecting groups that would allow the selective remove of Ri, while retaining the remaining protecting groups.
  • the compound of formula X is:
  • a tetrahydropyran compound of formula XIII are provided by the cyclization of a compound of formula XIV,
  • R H ⁇ is alkyl group substituted with at least one ORn or carbonyl group
  • Rn are independently C
  • Rn and R1 2 are orthogonal protecting groups.
  • One of the many advantages of this method is the ability to selectively introduce chirality to the carbon atoms in the compounds of formulae XIIT and XIV, for example by stereoselective epoxidations and reductions of achiral precursors to a compound of formula XIV.
  • One skilled in the art would know how to affect these stereoselective epoxidations and reductions.
  • the compound of formula XIV is 1 and the tetrahydropyran compound of formula XUl is
  • This embodiment is also not limited to the case where the free alcohol described in structure XFV is isolated prior to affecting the cyclization.
  • compounds of formula XIIl can also be prepared by the aldol reaction of ketones with an aldehyde compound of formula XV.
  • Aryl aldehyde 2.4 is a compound of formula V having three R 4 groups — two OR groups and a methyl group, wherein each R is benzyl.
  • a compound wherein R is (2-trimethylsilyl)ethoxymethyl can be prepared by treating homophthalate 2.6 with SEMCl.
  • the sidechain portion of an irciniastatin can be prepared, for example, according to Scheme 9.
  • irciniastatin for example, irciniastatin A
  • Conversion to an irciniastatin can be accomplished 5 according to the sequence set forth in Scheme 10.
  • Infrared spectra were obtained using a Jascl FT/IR-480 plus spectrometer. Optical rotations were obtained using either a Jasco D1P-370 polarimeter or a Jasco P2000 polarimeter. Proton magnetic resonance spectra and carbon magnetic resonance spectra were obtained on either a Bruker AMX 500 MHz or a Bruker Avance III 500 MHz spectrometer. Chemical shifts are reported relative to chloroform ( ⁇ 7.26) or methanol ( ⁇ 4.78) for 1 H ⁇ MR spectra and chloroform ( ⁇ 77.23), methanol ( ⁇ 49.3), or benzene ( ⁇ 128.0) for 13 C spectra. High-resolution mass spectra were measured at the University of Pennsylvania or at the University of Delaware.
  • TBS alcohol (+)-2.17 A solution of pivalate ester (+)-2.16 (0.121 g, 0.495 mmol) in CH 2 CI 2 (5 mL) was cooled to -78 0 C and 2,6-lutidine (0.1 15 mL, 2.0 equiv.) was added followed by TBSOTf (0.136 mL, 1.2 equiv.). After 1 h, the reaction was diluted with ether (5 mL) and washed with sat. CuSO 4 and brine (5 mL each). The organic layer was dried over MgSO 4 and concentrated. Flash chromatography (5% EtOAc/hexanes) provided (+)-2.17 (0.169 g, 95% yield) as a colorless oil.
  • (+)-2.18 A solution of (+)-2.17 in CH 2 CI 2 was cooled to -78 0 C and DIBAL-H was added dropwise over 5 min. The reaction was stirred for 5 min and then quenched with slow addition of MeOH (0.5 mL). The reaction was warmed to rt and sat. Rochelle's salt (5 mL) was added. The solution was stirred for 2 h then extracted with Et 2 O (3 x 5 mL). The combined organic layers were then dried over MgSU 4 and concentrated. Flash chromatography (10% EtOAc/hexanes) provided (+)-2.18 (0.123 g, 95% yield) as a colorless oil.
  • Aryl Acid 2.22 A solution of diester 2.21 (0.518 g, 1.19 mmol) in CH 2 Cl 2 (6 mL) and MeOH (6 mL) was cooled to 0 °C and solid KOH (1.34 g, 20 equiv.) was added. Once all the KOH had dissolved, the cold bath was removed and the reaction stirred at rt. After 3 h, the reaction was cooled back to O 0 C and acidified to pH 2 with 3 N HCl. The reaction was then extracted with EtOAc (5 x 10 mL). The combined organic layers were dried over MgSO ⁇ and concentrated to provide diester 2.22 (0.463 g, 93% yield) which, was taken forward without purification.
  • Aryl Alcohol 2.23 A solution of acid 2.22 (0.38 g, 0.90 mmol) in THF (9 mL) was cooled to 0 0 C and BH 3 .SMe 2 (1.8 mL, I M solution in THF, 2.0 equiv.) was added dropwise. After 15 min, the cold bath was removed and the reaction stirred at rt for 5 h. The reaction was quenched slowly with MeOH (1 mL) and extracted with CH 2 CI 2 (4 x 15 mL). The combined organic layers were then dried over MgSOa and concentrated. Flash chromatography (25% EtOAc/hexanes) provided alcohol 2.23 (0.31 g, 85% yield) as a white foam.
  • Aryl Aldehyde 2.4. Alcohol 2.23 (0.261 g, 0.643 mmol) was dissolved in CH 2 CI 2 (8 niL) and DMSO (6.5 mL) and cooled to 0 0 C. Next, Et 3 N (0.90 mL, 10 equiv.) was added followed by SO 3 .pyridine (0.41 g, 4 equiv.). After 30 min at 0 0 C. the cold bath was removed and the reaction stirred at rt. After 2 h, the reaction was diluted with sat. NaHCO 3 (5 mL) and extracted with EtOAc (3 x 15 mL). The combined organic layers were washed with 1 M NaHSO-) (10 mL), sat.
  • THF 600 mL
  • propyne 100 g, 4 equiv.
  • a solution of «-BuLi 570 mL, 2.2 M in hexanes, 2 equiv.
  • the flask and syringe were then flushed with TTTF (0.3 mL) into the reaction.
  • the reaction flask was then placed in a 50 0 C oil bath. After 1 h, the reaction was cooled to 0 0 C and N-iodosuccinimide (0.265 g, 2.2 equiv) was added. After 10 min, the reaction was quenched with sat. ⁇ aHC0 3 (10 mL) and then filtered through a 1 cm plug of silica gel. The silica gel was rinsed with EtOAc and the layers separated. The aqueous layer was then extracted with EtOAc (3 x 10 mL) and the combined organic layers were dried over MgSO 4 and concentrated.
  • Epoxide (+)-2.28. Diene (-)-2.7 (2.94 g, 10.2 mmol) was dissolved in CH 3 CN (460 mL).
  • Na 2 B 4 O 7 buffer (0.05 M, 1 15 mL) was added followed Bu 4 NHSO 4 (0.425 g) and ketone catalyst H-2.27 (1.32 g, 0.50 equiv.).
  • Oxone (8.77g, 1.4 equiv) was dissolved in Na 2 EDTA buffer (59 mL, 4 x 10 "4 M) and K 2 CO 3 (8.31 g, 5.9 equiv.) was dissolved in H 2 O (59 mL).
  • the two solutions were then added simultaneously over 3 h via a dual-syringe pump.
  • Epoxide (+)-2.35 To freshly activated 3 A molecular sieves (0.4 g) in CH 2 Cl 2 (4.6 ⁇ iL) was added (-)-DTPT (58 ⁇ L, 0.12 equiv.) The solution was cooled to -20 0 C and Ti(O-Z-Pr) 4 (68 ⁇ L, 0.1 equiv.) was added followed by /-BuOOH (1.26 mL, 5.5 M in decane, 3.0 equiv.) The reaction was stirred for 30 min and then (+)-S2.5 (1.32 g, 2.31 mmol) dissolved in CH 2 Cl 2 (2 ml) was added via cannula.
  • Ester (+)-2.36 Epoxy alcohol (+)-2.35 was dissolved in CH 3 CN (12 mL) and then TEMPO (15 mg, 0.08 equiv.) was added followed by pH 7 buffer (12 mL). Next, NaClO 2 (0.42 g, 2.5 equiv.) was added in one portion followed by dropwise addition of NaOCl (0.32 mL, 5 wt% solution, 0.2 equiv.). After 1.5 h, anhydrous Na 2 SO 3 (0.49 g, 3.2 equiv.) was added and the reaction stirred for 30 min, upon which, the solution turned from orange to colorless. The reaction was acidified to pH 4 with 10% aq.
  • (+)-2.37 A solution of (+)-2.36 (1.32 g, 2.14 mmol) in CH 2 Cl 2 (22 mL) and pH 7 buffer (5.4 mL) was cooled to 0 0 C and DDQ (0.542 g, 1.1 equiv) was added in three portions over 1 min. After 45 min, the reaction was diluted with CH 2 Cl 2 (20 mL) and filtered through Celite. The Celite was then washed with sat. NaHCO 3 (10 mL). The layers were separated and the aqueous layer extracted with CH 2 Cl 2 (3 x 20 mL). The combine organic layers were then dried with MgSO 4 and concentrated.
  • (+)-2.38 To a solution of (+)-2.37 (0.998 g. 2.02 mmol) in CH 2 CI 2 (40 niL) was added camphorsulfonic acid (94 mg, 0.2 equiv). After stirring for 5 h at rt, sat. NaHCO 3 (20 mL) was added and the reaction mixture stirred for 10 min. The layers were separated and the aqueous layer extracted with CH 2 CI 2 (4 x 15 mL). The combined organic layers were then dried over MgSO 4 and concentrated. Flash chromatography (5% EtOAc/hexanes) provided (+)-2.38 (0.91 7g, 92%) as a colorless oil.
  • (+)-S2.6 To a solution of (+)-2.40 (0.229 g, 0.450 mmol) in EtOAc (4.5 mL) was added 10% Pd/C (0.025 g). The reaction flask was purged with H 2 and then a balloon of H 2 was attached to the flask. After 5 h at rt. the reaction mixture was filtered through a pad of Celite and the Celite rinsed with CH 2 Cb (10 mL). The reaction was concentrated and then flash chromatography (10% EtOAc/hexanes) provided (+)-S2.6 (0.182 g, 97%) as a colorless oil.
  • Acid (-)-2.2 (0.1 12 g, 0.387 mmol) was dissolved in MeOH (2.0 mL) and CH 2 Cl 2 (2.0 mL) and cooled to 0 °C.
  • TMSCHN 2 (ca. 0.2 mL, 2.0 M in Et 2 O) was then added dropwise until all gas evolution had ceased and the solution turned light yellow. Argon was bubbled through the reaction for 10 min and then the reaction concentrated. Flash chromatography (5% EtOAc/hexanes) provided (-)-2.43 (88 mg, 75% yield) as a colorless oil.
  • ⁇ -Hydroxy ketone (+J-2.46 A solution of ketone (+)-2.5 (0.113 g, 0.271 mmol) in CH 2 Cl 2 (1.5 mL) was cooled to -78 0 C and CI 2 BPh (42 ⁇ L, 1.2 equiv.) was added. After stirring for 20 min, /-Pr 2 NEt (71 ⁇ L. 1.5 equiv.) was added dropwise. The reaction was stirred for I h at -78 0 C, warmed to 0 0 C over 10 min, then stirred 1 h at 0 0 C.
  • aldehyde 2.4 (0.131 g, 1.2 equiv.) was dissolved in CH 2 CU (1.0 mL) and added to the boron enolate dropwise over 10 min. After 4 h at -78 0 C, the reaction was quenched with a 1 : 1 mixture of MeOH/pH 7 buffer (6 mL). After warming to rt, the reaction was neutralized to pH 7 with pH 8 buffer and stirred for 1 h at rt. The layers were separated and the aqueous layer extracted with CH 2 Cl 2 (3 x 10 mL). The combined organic layers were then dried over MgSCM and concentrated.
  • (+)-2.49 A solution of (+)-2.47 (44.7 mg, 0.054 mmol) was dissolved in MeOH (3.4 mL) and cooled to 0 0 C followed by addition Of H 2 O (20 ⁇ L, 20 equiv.) and LiOH (26 mg, 20 equiv.). The cold bath was removed and the reaction allowed to warm to rt. After 40 h, the reaction was quenched by diluting with EtOAc (3 mL) and acidified to pH 2 with 1 M NaHS(V H 2 O (3 mL) was added and the reaction extracted with EtOAc (5 x 5 mL).
  • the unpurified acid was dissolved in 5 acetone (7.2 mL) and cooled to 0 0 C followed by addition Of Z-Pr 2 NEt (61 ⁇ L, 2.4 equiv.) and isobutylchloroformate (41 ⁇ L, 2.2 equiv.). After 1 h. NaN 3 (47 mg, 5 equiv.) was dissolved in H?O (0.9 mL) and added to the mixed anhydride. After 5 min, the reaction was diluted with H ⁇ O (5 mL) and extracted with EtOAc (3 x 5 mL). The combine organic layers were dried over MgSO 4 and concentrated.
  • acyl azide was then dissolve in toluene (7.2 mL), the flask sealed, and heated to 80 0 C. After 1 h, the flask was cooled slightly and 2-trimethylsilyl ethanol (0.41 mL, 20 equiv.) was added and the flask heated back to 80 0 C. After 3 h, the reaction was cooled to it and the solvent evaporated. Flash chromatography (5% EtOAc/hexanes) provided (+)-2.60 (53.5 mg, 61% yield, 2 steps) as a light yellow oil. [ ⁇ p n ° +22.6 (c 1.0, CHCl 3 ); IR (neat) 2955,
  • the unpurified mixed anhydride was azeotroped with benzene (2 x 3 mL), placed on the vacuum pump for 30 min, and then dissolved in THF (0.6 mL).
  • a solution of (+)-2.60 in THF (0.6 mL) was cooled to -78 0 C and LiHMDS (67 ⁇ L, 1.07 M in THF 1.1 equiv.) was added dropwise over 1 min.
  • the mixed anhydride solution was added dropwise over 5 min.
  • the reaction was warmed to --40 0 C over 1 h and stirred for 1.5 h. The reaction was quenched with sat.
  • Procedure B A solution of 2.69 (0.104 g, 0.202 mmol) in CH 2 CI 2 (2.0 mL) was cooled to -78 0 C and DlBAL-H (0.22 mL, 1 M solution in toluene, 1.1 equiv.) was added dropwise over 15 min. After 5 min, the reaction was quenched with MeOH. The reaction was allowed to warm to it before EtOAc (5 mL) and sat. Rochelle's salt (5 mL) were added. After 1 h, the organic layer transitioned from cloudy to clear. The layers were separated and the aqueous layer extracted with 3 x 20 mL EtOAc. The combined organic layers were dried over MgSO ⁇ and concentrated.
  • Trciniastatin A (+)-2.1 Compound (+)-2.75 (9.8 mg, 7.1 ⁇ mol) was dissolved in DMF (0.16 mL) and TASF (30 mg, 15 equiv.) was added. The reaction was heated to 50 0 C. After 48 h, the reaction was diluted with EtOAc and sat. NH 4 Cl (1 mL) was added followed by enough HjO (0.5 mL) to dissolve any solids. The reaction was extracted with EtOAc (4 x 2 mL). The combined organic layers were then dried over MgSO 4 and evaporated.
  • CD 3 OD S 176.3, 172.5, 164.7, 163.8, 144.0, 141.3, 1 15.4, 1 13.1 , 101.6, 101 .5, 82.8, 82.3, 82.1, 79.9, 74.2, 73.6, 73.4, 72.2, 57.8, 56.7, 43.4, 39.9, 38.8. 34.5, 30.6, 29.6. 23.8, 23.0, 14.1 , 10.9, 9.3; high resolution mass spectrum (ES+) m/z 632.3038 [(M+Naf : calcd for C 31 H 47 NOnNa: 632.3047].
  • (+)-Mosher Ester (+)-S3.2 A solution of (+)-3.11 (5.0 mg, 15.8 ⁇ mol) in CH 2 CI 2 (0.32 mL) was cooled to 0 0 C and (S)-Mosher's acid chloride (8 mg, 2 equiv.) was added, followed by DMAP (8 mg, 4 equiv.) and Et 3 N (4.4 ⁇ L, 2 equiv.). After 45 min, sat. NaHCO 3 (0.5 mL) was added and the reaction extracted with EtOAc (3 x 3 mL). The combined organic layers were dried over MgSO 4 and concentrated.
  • Epoxide (+)-3.14 To freshly activated 3 A molecular sieves (0.2 g) was added (-)-DIPT (1 5 ⁇ L. 0.24 equiv.) in CH 2 CI 2 (0.5 mL). The solution was cooled to -20 0 C and Ti(O-Z-Pr) 4 (18 ⁇ L, 0.2 equiv.) in CH 2 CI 2 (0.5mL) was added followed by /-BuOOH (0.176 mL, 5 M in decane, 3.0 equiv.) The reaction was stirred for 30 min and then (-)-S3.4 (0.1 18 g, 0.293 mmol) dissolved in CH 2 Cl 2 (1 ml) was added via syringe.
  • CDCI 3 ⁇ 172.9, 73.5, 73.4, 72.9, 72.8, 52.6, 35.2, 30.1 , 26.0, 23.6, 22.9, 18.3, -4.4, -4.7; high resolution mass spectrum (ES+) m/z 355.1907 [(M+Na)" ; calcd for C 16 H 32 O 5 SiNa: 355.1917].

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Methods for the preparation of irciniastatins, including (+)-irciniastatin A and (-)- irciniastatin B, as well as analogs thereof, are described.

Description

METHODS FOR THE PREPARATION OF IRCINIASTATIN AND ANALOGS THEREOF
GOVERNMENT SUPPORT
The research carried out in this application was supported, in part, by a grant from the National Institute of Health (National Cancer Institute) through grant CA-19033. Pursuant to 35 U. S. C. § 202, the government may have rights in any patent issuing from this application.
CROSS REFERENCE TO RELATED APPLICATIONS
This application claims the benefit of U.S. Provisional Application No. 61/090,086, filed August 19, 2008, and U.S. Provisional Application No. 61/096379, filed September 12, 2008, both of which are incorporated by reference in their entireties.
TECHNICAL FIELD
The present invention is directed to methods for the preparation of irciniastatins, as well as methods for the preparation of analogs thereof.
BACKGROUND
In 2004, the laboratories of Pettit and coworkers first published the isolation, structural elucidation, and biological activity of (+)-irciniastatin A and (-)-irciniastatin B.
Figure imgf000002_0001
(+)-lrciniastatin A (Psymberin) R1 = OH, R2 = H (-)-lrciniastatin B R1 = R2 = O
Pettit, G. R.; Xu, J. P.: Chapuis. J. C; Pettit, R. K.; Tackett, L. P.; Doubek, D. L.; Hooper, J. N. A.; Schmidt, J. M. Journal of Medicinal Chemistry 2004, 47, 1 149-1 152. Pettit and coworkers first collected samples containing irciniastatins A and B from the Indo-Pacific marine sponge Ircinia ramosa near Samporna, Borneo in 1991 . The dichloromethane-methanol extracts exhibited strong activity (GI50 - 10'2 μg/mL) against the P388 murine lymphocytic leukemia cancer cell line. Unfortunately, recollection on a larger scale to allow for isolation of the individual constituents was not permitted (political obstacles) and so the extracts were preserved for later use. As isolation techniques advanced over the past decade, irciniastatins A and B were isolated as an individual constituent (34.7 mg and 2.2 mg, respectively) from the initial dichloromethane-methanol extracts.
After isolating irciniastatins A and B, Pettit and coworkers tested the compound against six human cancer cell lines, the P388 murine lymphocytic leukemia cell line used to guide their fractionation/isolation efforts, and human umbilical vein endothelial cells (HUVEC) (Table 1.1 ). Id
Table 1.1. Growth Inhibition of Cancer Cell Lines (GI50, μg/ml) by Irciniastatin A and B Cancer Cell Line Irciniastatin Λ Irciniastatin B pancreas BXPC-3 0.0038 0.00073 breast MCF-7 0.0032 0.0005
CNS SF-268 0.0034 0.00066 lung NCI-H460 O.OOOl 0.0012 colon KM20L2 0.0027 0.0021 prostate DU-145 0.0024 0.0016 leukemia P388 0.00413 0.006 normal endothelial HUVI;C <0.0005 NI)
Additionally, (+)-irciniastatin A was evaluated against the panel of 60 human cancer cell lines within the NCT Developmental Therapeutics in Vitro Screening Program (Table 1.2).
Table 1.2. Differential Sensitivities (LC50) of Several NCI 60 Cell Lines to (+)-lrciniastatin A Cell Line L.C50 (M) Cell Line I.C50 (M) leukemia melanoma
CCRF-CEM >2.5 x 10-5 LOX IMVI >2.5 x 10-5
HL-60(TB) >2.5 x 10-5 MALME-3M <2.5 x 10-9
K-562 >2.5 x 10-5 SK-MEL-2 >2.5 x 10-5
MOLT-4 >2.5 x 10-5 SK-MEL-5 <2.5 x 10-9
RPMI-8226 >2.5 x 10-5 UΛCC-257 >2.5 x 10-5
SR >2.5 x 10-5 UACC-62 <2.5 x 10-9 breast cancer colon cancer
MCF7 >2.5 x 10-5 HCC-2998 3.6 x 10-7
HS 578T >2.5 x 10-5 HCT-1 16 <2.5 x 10-9
MDΛ-MB-435 <2.5 x 10-9 I IT29 >2.5 x 10-5
NCI/ΛDR-RES 1.9 x 10-5 SW-620 >2.5 x 10-5
T-47D 1.36 x 10-5
(+)-lrciniastatin A exhibits activities in the low nanomolar range for the MDA-MB-35 breast cancer, SK-MEL-28 and UACC-62 melanoma, and the HCT-1 16 colon cancer cell lines with an activity differential of greater than 10,000-fold as compared to other cell lines within their respective subsets. Burres, N. S.; Clement. J. J Cancer Res. 1989, 49. 2935-2940; Kobayashi. J. i.; Itagaki, F.; Shigemori, H.: Sasaki, T. Journal of Natural Products 1993. 56. 976-981 ; West, L. M; Northcote, P. T.: Hood, K. A.; Miller, J. H.; Page, M. I. Journal of Natural Products 2000, 63, 707-709; Hood, K. A.; West. L. M.; Northcote, P. T.; Berridge. M. V.; Miller. J. H. Apoptosis 2001, 6, 207-219; Paul, G. K.; Gunasekera. S. P.; Longley, R. E.; Pomponi, S. A. Journal of Natural Products 2002. 65. 59-61.
(+)-Irciniastatin A was also evaluated in the NCI Developmental Therapeutics Program hollow fiber assay using several solid tumor cell lines resulting in an overall score of 34 (compounds considered active score 20 or higher), based on scores of 28 against intraperatineal fibers and 6 against subcutaneous fibers. Robinson, S. J.; Tenney. K.: Yee. D. F.; Martinez. L.: Media, J. E.; Valeriote, F. A.; vanSoest, R. W. M.: Crews. P. Journal of Natural Products 2007. 70, 1002- 1009.
Their impressive biological profile makes the irciniastatins attractive targets for total synthesis. To date, there have been only two total syntheses of irciniastatin A. Jiang, X.; Garcia- Fortanet, J.; DeBrabander, J. K. Journal of the American Chemical Society 2005, 127, 1 1254- 1 1255; Huang, X.; Shao, N.; Palani, A.; Aslanian, R.; Buevich, A. Organic Letters 2007, 9, 2597-2600. The De Brabander synthesis of (+)-irciniastatin A was accomplished in a longest linear sequence of 21 steps from commercially available starting materials in an overall yield of 6.1%. The Schering-Plough synthesis of (+) irciniastatin A was accomplished in a longest linear sequence of 25 steps from commercially available starting materials in an overall yield of 2.5%.
As such, more efficient syntheses of the irciniastatins are needed.
SUMMARY
Methods for the preparation of irciniastatins are described. According to the invention. compounds of formula I
Figure imgf000004_0001
are subjected to reaction conditions sufficient to provide a compound of formula II
Figure imgf000005_0001
wherein R2 is a C|.f, alkyl group; RN is an amine protecting group; R3 is at least one C1.6 alky], substituted alkyl, halogen, -OH, -OR1, or carbonyl: wherein R1 is a hydroxy! protecting group; and R4 is at least one C1.6 alkyl, substituted alkyi, halogen, -OH, or OR; wherein R is a phenolic protecting group; and wherein R is a protecting group that is orthogonal to R1; and converting the compound of formula TI to the irciniastatin.
Also within the scope of the invention are compounds of formula XlII
Figure imgf000005_0002
I O wherein R]0 is Ci-6 alkyl group substituted with at least one ORi2 or carbonyl, each Ri i is independently Q.ό alkyl, and Ru and Rn are orthogonal protecting groups, as well as methods of their preparation and use in the preparation of irciniastatins.
DETAILED DESCRIPTION OF ILLUSTRATIVE EMBODIMENTS
The present invention is directed to methods of preparing irciniastatins. As used herein,
15 the "'irciniastatin" refers to the general class of compounds, including analogs and homologs. characterized by linked substituted tetrahydropyran and dihydroisocoumarin moieties with pendant hydroxyl amido side chain, generally in a spatial orientation consistent with either (+)- irciniastatin A or (-)-irciniastatin B, and with a multiplicity of chiral centers throughout. Unless otherwise indicated, any reference to the terms "an irciniastatin'' or "the irciniastatin"' or portion 0 thereof are intended to refer to this general class of compounds, including any analog or homolog. containing conjoined substituted tetrahydropyran and dihydroisocoumarin moieties and an amido linked sidechain. generally in a spatial orientation consistent with (+)-irciniastatin A and (-)-irciniastatin B, without regard to the specific substitueπts on any of these moieties, or without regard to the stereochemistry of any individual chiral carbon center. As set forth herein, for example, there is represented di-alkoxy substitution on the aromatic portion of the "dihydroisocoumarin moiety" and multiple alkyl and alkoxide substituents.on the '"tetrahydropyran moiety." One skilled in the art will appreciate that the synthetic regimes described herein are not limited to these substituents so that the use of the terms or representations of a 'dihydroisocoumarin moiety" or a "tetrahydropyran moiety" are intended to accommodate other substitutents beyond those actually shown, for example, each may be optionally substituted with one or more C|.6 alkyl, substituted alkyl, halogen, -OH, protected -OH, or carbonyl. Similarly, use of the term "amido-linked sidechain" is intended to describe a CM alkyl chain, optionally substituted with a CM alkyl. CM alkenyl, alcohol, orthogonally protected alcohol, or CM alkoxide.
According to the methods of the invention, a compound of formula 1
Figure imgf000006_0001
is subjected to reaction conditions sufficient to provide a compound of formula 11
Figure imgf000006_0002
wherein R2 is a Q.6 alkyl group; RN is an amine protecting group; R3 is at least one Ci-6 alkyl. substituted alkyl, halogen, -OH. -OR1, or carbonyl; wherein R1 is a hydroxyl protecting group; and R4 is at least one Ci_6 alkyl, substituted alkyl. halogen, -OH, or OR; wherein R is a phenolic protecting group; and wherein R is a protecting group that is orthogonal to R1. The compound of formula II is then converted to the irciniastatin. In preferred embodiments, the irciniastatin is irciniastatin A. In other embodiment, the irciniastatin is irciniastatin B. As used herein, "alkyl" refers to straight-chain and branch hydrocarbon groups such as, for example, methyl, ethyl, propyl, isopropyl, butyl, isobutyl, sec-butyl, ter-butyl. pentyl, and hexyl. "C|.6alkyP' refers to alkyl groups having from 1 to 6 carbon atoms.
As used herein, "substituted alkyl" refers to an alkyl group including one or more functional groups such as alkyl. halogen, hydroxyl, amino, and cyano.
As used herein, "protecting group" are those moieties introduced into a molecule by chemical modification of a functional group in order to obtain chemoselectivity in a subsequent chemical reaction. Protecting groups are known in the art, and those skilled in the art would readily be able to select and use appropriate protecting groups through routine experimentation. For example, see T. W. Greene and P.G.M. Wuts, Protective Groups in Organic Synthesis, 2006.
As used herein, "amine protecting group" refers to a protecting group for an amine. Amine protecting groups are known in the art and include, for example, carbamates. Preferred carbamate groups are those containing hindered primary, secondary, or tertiary alkoxy groups. In particularly preferred embodiments, RN is 9-fluorenylmethyl carbamate (Fmoc), 2,2,2- trichloroethyl carbamate, 2-trimethylsilylethylcarbamate (Teoc), t-butyl carbamate (Boc), allyl carbamate (Alloc), benzylcarbamate (Cbz), m-nitrophenyl carbamate, or p-methoxyphenyl carbamate.In preferred embodiments of the invention, the amine protecting group is (trimethylsilyl)ethocycarbonyl.
As used herein, "hydroxyl protecting group" refers to a protecting group for a hydroxyl. Hydroxyl protecting groups are known in the art and include, for example, trialkylsilyl. In preferred embodiments, Ri is t-butyldimethylsilyl.
As used herein, "phenolic protecting group" refers to a protecting group for a phenol. Phenolic protecting groups are known in the art and include, for example, benzyl and trialkylsilylethoxymethyl. In preferred embodiments, R is benzyl. In other embodiments, R is (2-trimethylsilyl)ethoxymethyl.
As used herein, halogen refers to F, Cl, or Br.
As used herein, "orthogonal," when used to describe hydroxyl and/or phenolic protecting groups of the invention, refers to a strategy allowing the protection and deprotection of multiple -OH groups one at the time each with a dedicated set of reaction conditions without affecting the other. Developed originally in carbohydrate syntheses, it is now well known by those skilled in the art that the reactions of alcohols with compounds such as siloxy methyl halides, silyl alkoxymethyl halides (e.g., 2-(trimethylsilyl)-ethoxymethyl chloride), substituted phenoxy methyl halides, or alkoxy halides form the corresponding protecting group ethers, which can be reversed under varying hydrolysis conditions. Herein, use of the designations R and R|. for example, may refer to the same or different such protecting groups.
In the methods of the invention, the compound of formula I is converted to the compound of formula II by subjecting the compound of formula I to conditions sufficient to effect a Curtius rearrangement. A Curtius rearrangement is a chemical reaction that involves the rearrangement of an acyl azide, for example, the compound of formula 1, to an isocyanate. The isocyanate can then be trapped by a variety of nucleophiles.
In preferred methods of the invention, the conditions sufficient to produce the compound of formula II comprise heating the compound of formula I in an organic solvent, for example. toluene, benzene, or xylene, for a time sufficient to generate an isocyante of formula III
Figure imgf000008_0001
and treating the isocyanate of formula III with an alcohol. The isocyanate of formula III can be treated with the alcohol either in situ or after purification. In certain embodiments, the alcohol is 9-fluorenylmethanol, 2,2,2-trichloroethanol. 2-trimethylsilylethanol, t-butanol, allyl alcohol, benzyl alcohol, m-nitrophenyl alcohol, or p-methoxyphenyl alcohol. In preferred embodiments, the alcohol is trimethysilylethanol.
Preferably, the compound of formula TII is
Figure imgf000008_0002
In preferred embodiments of the invention, the compound of formula I is
Figure imgf000009_0001
In other embodiments, the compound of formula I is
Figure imgf000009_0002
The compounds of formula I can be prepared using any methods known to those skilled in the art. In preferred embodiments, a compound of formula T can be prepared by reacting a compound of formula VI:
Figure imgf000009_0003
with a compound of formula V
Figure imgf000009_0004
under conditions sufficient to produce a compound of formula VIl
Figure imgf000010_0001
and more preferably, the compound of formula VII is
Figure imgf000010_0002
wherein each R2 is independently Ci^alkyl. The compound of formula VII can be 5 converted to the irciniastatin using techniques and methods known in the art.
In some embodiments, the compound of formula VI is
Figure imgf000010_0003
In still other embodiments, the compound of formula VI is
Figure imgf000010_0004
I O In preferred embodiments, Ri is methyl or ethyl.
In other embodiments, the compound of formula V is
Figure imgf000011_0001
wherein R2 is preferably methyl or ethyl.
In preferred embodiments, the compound of formula VIl is
Figure imgf000011_0002
In accordance with certain preferred embodiments of this invention, an irciniastatin is provided via a synthetic scheme which includes the preparing the compound of formula I. the attachment of the amido linked sidechain proceeds by using the moiety described in formula VIlI
Figure imgf000011_0003
wherein Rx may be any CM alkyl chain, optionally substituted with a Ci-4 alkyl, Cj-4 alkenyl, alcohol, orthogonally protected alcohol, Ci-4 alkoxide, or other substituent.
The moiety designated L can be any group such as pivaloyl, alkyl sulfonyl, aryl sulfonyl. or other moiety that make the OL group a labile, or ready, leaving group. This list is not intended to be exhaustive, and those skilled in the art will appreciate the other opportunities for this group.
In certain embodiments, the compound of formula VIII is
Figure imgf000011_0004
Reaction of the compound of formula VIIl with a compound of formula II, under conditions known to those skilled in the art - for example, de-protecting the amino group, allowing it to react with the labilized carboxyl moiety in formula VlII - yields a compound of formula IX.
Figure imgf000012_0001
In certain embodiments, the compound of formula IX is
Figure imgf000012_0002
Additional reactions can be applied to further modify the compound of formula IX, depending on specific interest. For example, selective removal of the orthogonal protecting R and Ri groups from
Figure imgf000012_0003
I O and asymmetric reduction of the C- 15 carbonyl yields (+)-irciniastatin A.
In accordance with certain preferred embodiments of this invention, a compound of formula X can be prepared by deprotecting a compound of formula TX, under conditions sufficient to produce a compound of formula XlT; and oxidizing the compound of formula XIT under sufficient conditions to form a compound of formula X. Those skilled in the art would 15 appreciate the choice of protecting groups that would allow the selective remove of Ri, while retaining the remaining protecting groups.
In one embodiment, then, the compound of formula X is:
Figure imgf000013_0002
In accordance with certain preferred embodiments of this invention, a tetrahydropyran compound of formula XIII are provided by the cyclization of a compound of formula XIV,
Figure imgf000013_0003
wherein RHι is
Figure imgf000013_0004
alkyl group substituted with at least one ORn or carbonyl group, Rn are independently C|.ή alkyl groups, and Rn and R12 are orthogonal protecting groups.
One of the many advantages of this method is the ability to selectively introduce chirality to the carbon atoms in the compounds of formulae XIIT and XIV, for example by stereoselective epoxidations and reductions of achiral precursors to a compound of formula XIV. One skilled in the art would know how to affect these stereoselective epoxidations and reductions. As but one example of many possibilities on this theme, the compound of formula XIV is 1
Figure imgf000013_0005
and the tetrahydropyran compound of formula XUl is
Figure imgf000014_0001
which contain the stereochemistries corresponding to those found in the irciniastatins.
This embodiment is also not limited to the case where the free alcohol described in structure XFV is isolated prior to affecting the cyclization. As but one example of many possibilities on this theme, compounds of formula XIIl can also be prepared by the aldol reaction of ketones with an aldehyde compound of formula XV.
O OR13 O
H^X>!Λ0R)i (χv)
For example, it is possible to produce the product where the compound of formula XlV is
Figure imgf000014_0002
by first reacting the compound of formula XV
Figure imgf000014_0003
with 2-butanone, followed by cyclization. Similarly, one skilled in the art would appreciate that this method can be employed using homologs and substituted homologs of 2-butanone.
15
The methods of the invention are particularly described in the synthetic schemes that follow. The sequences set forth herein are illustrative only, and are not intended to limit the scope of the invention. Those skilled in the art will appreciate that modifications to the followed synthetic schemes can be performed without detracting from the spirit of the invention. 0 Preferred methods for preparing compounds of formula V are set forth in Scheme 1. Aryl aldehyde 2.4 is a compound of formula V having three R4 groups — two OR groups and a methyl group, wherein each R is benzyl. A compound wherein R is (2-trimethylsilyl)ethoxymethyl can be prepared by treating homophthalate 2.6 with SEMCl. Scheme 1
Figure imgf000015_0001
61 %, 2 steps
Figure imgf000015_0002
Bis-benzyl Ether 2.21
Figure imgf000015_0003
Figure imgf000015_0004
Aryl Aldehyde 2 4
One exemplar)' synthesis of a compound of formula VI is set forth in Schemes 2-4. Schemes 2-4 depict a method of prepared a compound of formula VI that is tetrahydropyran 2.5 wherein R3 is three groups - two methyl groups and an ORi group wherein R= is a trialkylsilyl group, Le , t-butyldimethylsilyl.
Scheme 2
Figure imgf000016_0001
Homopropargyllic Acid (+) 2 11
A, Oxone, K2CO3 CH3CN, buffer
73%
Figure imgf000016_0002
Vinyl Iodide (-) 2 26 11 1 mixture of epoxides
78% Diene (-) 2 7
Figure imgf000016_0003
Scheme 3
Figure imgf000016_0004
1) Pd2(dba)3 CHCI3
Figure imgf000016_0005
Figure imgf000016_0006
TBS Ester (+) 2 34
DIBAL, CH2CI2 97%
Figure imgf000016_0007
Allylic Alcohol (+) S2 5 92% Epoxide (+) 2 35 Scheme 4
Figure imgf000017_0001
Epoxide (+) 2.35 70%, 2 steps Ester (+) 2.36
Figure imgf000017_0002
Me2SO4, NaH
THF * 87%
Figure imgf000017_0003
Tetrahydropyran (+) 2 5
Compounds of formula VI can also be prepared according to the methods set forth in Schemes 5 and 6.
Scheme 5
OH OH I) NaH, TBSCI, THF OTBS O
2) Paπkh-Doering [O] 85%, 2 steps
D VlOl 3.13 Aldehyde 3.7
Figure imgf000017_0004
TBSOTf, 2,6-tutιdιne CH2CI2 96%
Figure imgf000017_0005
Scheme 6
I) TEMPO1 NaCI2O1 NaOCI,
OTBS OTBS buffer, CH3CN 2) TMSCHN2, MeOH , CH2CI2 HF pyr, pyr
94%, 2 steps
Figure imgf000018_0001
THF, r.t.
Epoxide (+) 3.14 72%
Ester (+) 3.15
1 ) 2-butanone, (-)-DIPCI,
O OTBS O Et3N, Et2O ^ 86%, d.r. = 5:1
Figure imgf000018_0002
2) 20 mol% CSA, CH2CI2 ' 74% of desired isomer
Alcohol (+) 3.16 Aldehyde (+) 3.9
O2Me
Figure imgf000018_0003
Tetrahydropyran (+) 3.18
Tetrahydropyran (+) 3.5
With compounds of formulas V and VI in hand, the synthesis of the irciniastatin can proceed. An exemplary method of formula a compound of formula IT is set forth in Scheme 7. Aldol condensation of compounds 2.4 and 2.5 produced beta hydroxylketone 2.46. Reduction of the ketone, followed by hydrolysis of the methyl ester produced acid 2.48. After conversion to the corresponding azide using sodium azide. the Cuitius rearrangement is effected by heating the azide in toluene followed by treatment with TMSEtOH to form a compound of formula II.
I O Protection of the secondary hydroxyl of the compound of formula II was performed using TBSOTf to produce compound 2.49.
Scheme 7
Figure imgf000019_0001
Aryl Aldehyde 2 4 Tetrahydropyran (+) 2 5
Figure imgf000019_0002
(+) 2 46
Figure imgf000019_0003
Figure imgf000019_0004
2) TBSOTf, 2,6-lutιdιne 63%, 2 steps *"
Figure imgf000019_0005
An alternative sequence, wherein OR is OSEM, is set forth in Scheme 8.
Scheme 8
Figure imgf000020_0001
The sidechain portion of an irciniastatin can be prepared, for example, according to Scheme 9.
Scheme 9
Figure imgf000021_0002
Figure imgf000021_0001
Acetonide (+) 2.14
Figure imgf000021_0003
Conversion to an irciniastatin, for example, irciniastatin A, can be accomplished 5 according to the sequence set forth in Scheme 10.
Scheme I O
Figure imgf000021_0004
Figure imgf000021_0005
(+)-lrciniastatin A
EXPERIMENTAL SECTION
I O Reactions were carried out in flame-dried or oven dried glassware under an argon atmosphere unless noted otherwise. Anhydrous diethyl ether and tetrahydrofuran were obtained from a Pure Solve™ PS-400 or distilled from sodium/benzophenone under an argon atmosphere. Dichloromethane was obtained from the Pure Solve™ PS-400 or distilled over calcium hydride under an argon atmosphere. Triethylamine, 2,6-lutidine, diisopropylethylamine, pyridine, and
1 5 hexamethylphosphoramide were freshly distilled from calcium hydride under an argon atmosphere. All chemicals were purchased from Aldrich, Acros, TCI, or Strem. Alkyl lithium reagents were purchased from Aldrich or Acros and titirated using the N-benzylbenzamide protocol (J. Organomet. Chem., 1997, 542, 281.)- Reactions were magnetically stirred unless stated otherwise and monitored by thin layer chromatography (TLC) with 0.25 mm E. Merck pre-coated silica gel plates. Silica gel chromatography was performed utilizing ACS grade solvents and silica gel from either Silicycle or Sorbent Technologies.
Infrared spectra were obtained using a Jascl FT/IR-480 plus spectrometer. Optical rotations were obtained using either a Jasco D1P-370 polarimeter or a Jasco P2000 polarimeter. Proton magnetic resonance spectra and carbon magnetic resonance spectra were obtained on either a Bruker AMX 500 MHz or a Bruker Avance III 500 MHz spectrometer. Chemical shifts are reported relative to chloroform (δ 7.26) or methanol (δ 4.78) for 1H ΝMR spectra and chloroform (δ 77.23), methanol (δ 49.3), or benzene (δ 128.0) for 13C spectra. High-resolution mass spectra were measured at the University of Pennsylvania or at the University of Delaware.
Figure imgf000022_0001
Diol (+)-S2.1. A 2 Ν HCl solution (10 mL) was added to acetonide (+)-2.14 (0.836 g, 4.18 mmol) at rt. After 30 min, the reaction was quenched with sat. NaHCO3 until all gas evolution had ceased. The reaction was then extracted with EtOAc and the combined organic layers were dried over MgSO4 and concentrated. Flash chromatography (40% EtOAc/hexanes) provided (+)- S2.1 (0.650 g, 97% yield) as a colorless oil. [a]* +21.8 (c 1.5, CHCl3); IR (neat) 3416, 2932, 1646. 1456, 1092, 1050 Cm-1; 1H NMR (500 MHz, CDCl3) δ 4.79 (s, I H), 4.76 (s, I H), 3.72-3.58 (m. 3H), 3.47-3.42 (m, I H).. 3.37 (s, 3H), 3.33 (s, I H), 3.16 (s, I H), 2.24 (ddd, ./= 20.0, 14.4, 6.4 Hz. 2H), 1 .75 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 142.49, 1 13.2, 81 .7, 72.8, 63.3, 58.4, 38.9, 22.9; high resolution mass spectrum (CI+) m/z 161.1 177 [(M+H)~; calcd for C8H17O3: 161.1 178].
Figure imgf000022_0002
Pivalate Ester (+)-2.16. To a 0 0C of (+)-S2.1 (0.243 g, 1.52 mmol) in pyridine (4 mL) was added trimethylacetyl chloride (0.205 mL, 1.67 mmol). The reaction was allowed to warm to rt and after 1 h the reaction was cooled to 0 °C and H;O (5 mL) was added. The reaction was diluted with Et2O (5 mL) and washed successively with 5 mL each of sat. NaHCθ3, 1 N HCI, and brine. The organic layer was then dried over MgSθ4 and concentrated. Flash chromatography (10% EtOAc/hexanes) provided (+)-2.16 (0.325 g, 88% yield). [a]]? +23.9 (c 1.1. CHCI3); IR (neat) 3467. 2971 ,. 2935, 1 728, 1457, 1286, 1 163, 1 103 cm"1: 1H NMR (500 MHz, CDCl3) δ 4.84 (s, I H), 4.81 (s, I H), 4.23 (dd, J = 1 1.7, 3.5 Hz, I H), 4.16 (dd, J = 1 1.6, 6.8 Hz, I H), 3.92-3.82 (m, IH), 3.48-3.39 (m, IH), 3.40 (s, 3H), 2.39 (d, J= 4.8 Hz, I H), 2.29 (ddd, J = 19.4, 14.4, 6.2 Hz, 2H), 1.79 (s, 3H), 1.22 (s, 9H); 13C NMR (125 MHz, CDCl3) δ 179.0, 142.6, 1 13.3, 80.6, 71.4. 65.6, 58.4, 39.0, 38.4, 27.4, 23.0; high resolution mass spectrum (ES+) m/z 245.1743 [(M+Hf; calcd for Ci3H25O4: 245.1753].
Figure imgf000023_0001
TBS alcohol (+)-2.17. A solution of pivalate ester (+)-2.16 (0.121 g, 0.495 mmol) in CH2CI2 (5 mL) was cooled to -78 0C and 2,6-lutidine (0.1 15 mL, 2.0 equiv.) was added followed by TBSOTf (0.136 mL, 1.2 equiv.). After 1 h, the reaction was diluted with ether (5 mL) and washed with sat. CuSO4 and brine (5 mL each). The organic layer was dried over MgSO4 and concentrated. Flash chromatography (5% EtOAc/hexanes) provided (+)-2.17 (0.169 g, 95% yield) as a colorless oil. [α]]? +0.4 (c 5.3, CHCI3); IR (neat) 2957, 2931 , 2860, 1733, 1468, 1283, 1254, 1 157, 1 1 16 cm"1; 1H NMR (500 MHz, CDCI3) δ 4.79 (s, IH), 4.76 (d, J = 0.9 Hz, I H), 4.15 (dd, J = 1 1.5, 4.5 Hz, I H), 4.02 (dd, J= 1 1.5, 5.3 Hz, I H), 3.90-3.85 (m, I H), 3.37 (s, 3H), 3.39-3.33 (m, I H), 2.23 (dd, J= 14.5, 4.3 Hz, I H), 2.18 (dd, J = 14.4, 8.4 Hz, I H), 1.75 (s, 3H), 1.20 (s, 9H), 0.87 (s, 9H), 0.07 (s, 6H); '3C NMR (125 MHz, CDCl3) δ 178.5, 143.1 , 1 12.7, 81.6, 72.3, 65.8, 58.7, 39.3, 38.9, 27.5, 25.9, 23.0, 18.2, -4.5; high resolution mass spectrum (ES+) m/z 381.2420 [(M+Na)"; calcd for C19H38O4SiNa: 381.2437].
Figure imgf000023_0002
Alcohol (+)-2.18. A solution of (+)-2.17 in CH2CI2 was cooled to -78 0C and DIBAL-H was added dropwise over 5 min. The reaction was stirred for 5 min and then quenched with slow addition of MeOH (0.5 mL). The reaction was warmed to rt and sat. Rochelle's salt (5 mL) was added. The solution was stirred for 2 h then extracted with Et2O (3 x 5 mL). The combined organic layers were then dried over MgSU4 and concentrated. Flash chromatography (10% EtOAc/hexanes) provided (+)-2.18 (0.123 g, 95% yield) as a colorless oil. [α]2 D° +5.9 {c 0.7, CHCI3): IR (neat) 3450, 2931 , 2900, 2858, 1646, 1597, 1465, 1377, 1253, 1 101 cm'1; 1H NMR (500 MHz, CDCl3) δ 4.82 (s, IH), 4.80 (s, IH), 3.75-3.60 (m.. 3H), 3.43 (s, 3H); 3.45-3.39 (m, I H), 2.27 (dd, J = 14.4, 4.1 Hz, I H), 2.22-2.15 (m, 2H), 1.78 (s, 3H), 0.91 (s, 9H), 0.10 (s, 6H); 13C NMR (125 MHz, CDCI3) δ 143.1 , 1 12.9, 82.2, 74.6, 64.1 , 59.3, 40.4, 26.1. 23.0, 18.3, -1.3, - 4.4; high resolution mass spectrum (ES+) m/z 297.1863 [(M+Na)'; calcd for Ci4H3OO2SiNa: 297.1862].
Figure imgf000024_0001
Aldehyde (-)-S2.2. To a 0 0C solution of alcohol (+)-2.18 (0.123 g, 0.448 mmol) in DMSO (0.32 mL, 10 equiv.) and CH2Cl2 (4.5 mL) was added /-Pr2NEt (0.234 mL. 3.0 equiv.) followed by SO3.pyridine (0.213 g, 3.0 equiv.). After 10 min, the reaction was diluted with H2O (2 mL) and brine (2 mL). The layers were separated and the aqueous layer was extracted with CH2CI2 (3 x 10 mL). The combined organic layers were dried over MgSO4 and concentrated. Flash chromatography (5% EtOAc/hexanes) provided (-)-S2.2 (0.1 16 g, 95% yield) as a colorless oil. [α]2 D° -24.6 (c 1 .5, CHCI3); IR (neat) 2932, 2858, 1 734, 1465, 1370, 1255, 1 146, 1 1 1 1 , 1028 cm" '; 1H NMR (500 MHz, CDCl3) δ 9.59 (d, ./= 0.9 Hz, I H), 4.83 (s, 2H), 4.14 (dd, ./= 2.4, 0.9 Hz, 1 H), 3.60 (ddd, J = 7.0, 7.0, 2.6 Hz, 1 H), 3.39 (s, 3H), 2.28 (dddd, J = 13.9, 13.9, 13.9, 7.0 Hz, 2H), 1 .68 (s, 3H), 0.94 (s. 9H), 0.10 (s, 3H), 0.08 (s, 3H); 13C NMR (125 MHz, CDCI3) δ 203.6, 141.8, 1 14.5, 83.1 , 78.7, 58.1 , 38.7, 26.0, 22.8, 18.4, -^.6, -^.8; high resolution mass spectrum (ES+) m/z 295.1 705 [(M+Na)τ; calcd for C4H28O3SiNa: 295.1706].
Figure imgf000024_0002
Acid H-2.2. Aldehyde (-)-S2.2 (0.1 16 g, 0.425 mmol) was dissolved in /-BuOH (7 mL) and H2O (7 mL) and cooled to 0 0C. To this solution was added 2-methyl-2-butene (3 mL), NaH2PO4^H2O (0.662 g, 10 equiv.), and then NaClO2 (0.583 g, 10 equiv.). After 30 min, the reaction was poured onto sat. NH4CI (10 mL) and water was added to dissolve all solids that had precipitated. The reaction was extracted with EtOAc (5 x 10 mL) and then the combined organic layers were dried over MgSO4 and concentrated. Flash chromatography (25% EtOAc/hexanes) provided (-)-2.2 (0.1 12 g, 91 % yield) as a white, viscous foam. [α]: D° -5.8 (c 0.7. CHCI3); IR (neat) 2932. 2858, 1726, 1464, 1366, 1255, 1 157, 1 1 13 cm-1: 1H NMR (500 MHz, CDCI3) δ 4.83 (s, l H), 4.80 (s, I H), 4.41 (d, J= 1.9 Hz, IH), 3.67-3.63 (m, IH), 3.43 (s, 3H), 2.31 (dd, ./ = 14.4, 8 2 Hz, I H), 2.19 (dd, J= 14.3, 5.1 Hz, I H), 1.76 (s, 3H). 0.94 (s, 9H), 0.15 (s, 3H), 0.12 (s, 3H): 13C NMR (125 MHz. CDCI3) δ 173.3. 14! .9, 1 13.7. 82.0. 73.8, 58.5, 38.2, 25.9, 22.9, 18.3. -4 5, -5.3; high resolution mass spectrum (ES+) m/z 31 1.1665 [(M+Na)~; calcd for Ci4H28O4SiNa: 31 1.1655].
Figure imgf000025_0001
Bis-Benzy] Ether 2.21. Homophthalate 2.6 (0.308 g, 1.21 mmol) was dissolved in DMF (4.0 mL) at rt and K2CO3 (0.1 84 g, 1.1 equiv) was added followed by benzyl bromide (0.145 mL, 1.0 equiv.) and tetrabutylammonium iodide (0.045 g. 0.1 equiv.). The reaction was heated to 70 0C and after 4 h, no benzyl bromide was present by TLC analysis. The reaction was cooled to rt and additional K2CO3 (0.184 g, 1.1 equiv) and benzyl bromide (0.145 mL, 1.0 equiv.) were added. The reaction was heated back to 70 0C. After 18 h, the reaction was cooled to rt and sat. NaHCO3 (4 mL) was added and the reaction extracted with EtOAc (3 x 5 mL). The combined organic layers were washed with sat. NaHCO3, brine, and then dried over MgSO4 and concentrated. Flash chromatography (5% EtOAc/hexanes to 10% EtOAc/hexanes) provided diester 2.21 (0.518 g. 99% yield) as a white, amorphous solid. IR (neat) 3064, 3032, 2950, 2875, 1732, 1596, 1454, 1318, 1267, 1 153, 1091 cm"1; 1H NMR (500 MHz, CDCl3) 7.40-7.28 (m, 10H), 6.50 (s, I H), 5.04 (s, 2H). 5.02 (s, 2H), 3.85 (s, 3H), 3.71 (s, 2H), 3.69 (s, 3H), 2.16 (s, 3H); 13C NMR ( 125 MHz, CDCI3) δ 171.2, 168.7, 158.6, 155.3, 137.0. 136.9, 132.8, 128.8, 128.7, 128.5. 128.2, 128.0, 127.3, 127.1 , 1 19.8, 1 17.7, 98.2, 71.2, 70.6, 82.2. 36.2, 1 1.7; high resolution mass spectrum (ES+) m/z 457.1639 [(M+Na)+; calcd for C26H26O6Na: 457.1627].
Figure imgf000026_0001
Aryl Acid 2.22. A solution of diester 2.21 (0.518 g, 1.19 mmol) in CH2Cl2 (6 mL) and MeOH (6 mL) was cooled to 0 °C and solid KOH (1.34 g, 20 equiv.) was added. Once all the KOH had dissolved, the cold bath was removed and the reaction stirred at rt. After 3 h, the reaction was cooled back to O 0C and acidified to pH 2 with 3 N HCl. The reaction was then extracted with EtOAc (5 x 10 mL). The combined organic layers were dried over MgSO^ and concentrated to provide diester 2.22 (0.463 g, 93% yield) which, was taken forward without purification. IR (neat) 2950, 2925, 1710, 1595, 1454, 1322, 1267, 1 155, 1092 cπT1 ; 1H NMR (500 MHz, CDCI3) δ 7.38-7.32 (m, 10H), 6.51 (s, I H), 5.04 (s, 4H), 3.92 (s, 3H), 3.69 (s, 2H), 2.27 (s, 3H); 13C NMR (125 MHz, CDCI3) δ 171.8, 171.1 , 159.5, 156.2, 136.8, 136.6, 133.0, 128.9, 128.8, 128.3, 128.2, 127.3, 127.2. 120.5, 1 16.3, 98.3, 71 .4, 70.6, 53.1 , 37.9, 1 1.7: high resolution mass spectrum (ES+) m/z 419.1487 [(M-Hf; calcd for C25H23O6: 419.1495].
Figure imgf000026_0002
Aryl Alcohol 2.23. A solution of acid 2.22 (0.38 g, 0.90 mmol) in THF (9 mL) was cooled to 0 0C and BH3.SMe2 (1.8 mL, I M solution in THF, 2.0 equiv.) was added dropwise. After 15 min, the cold bath was removed and the reaction stirred at rt for 5 h. The reaction was quenched slowly with MeOH (1 mL) and extracted with CH2CI2 (4 x 15 mL). The combined organic layers were then dried over MgSOa and concentrated. Flash chromatography (25% EtOAc/hexanes) provided alcohol 2.23 (0.31 g, 85% yield) as a white foam. IR (neat) 3409, 2949, 2886, 1723. 1594, 1454, 1319, 1273, 1 154, 1091 cm"1; 1H NMR (500 MHz, CDCl3) δ 7.40-7.26 (m, 10H), 6.40 (sr IH). 5.04 (s, 2H), 5.02 (s, 2H), 3.88 (s, 3H), 3.83 (dd, J = 7.0, 7.0 Hz, 2H), 2.90 (dd. J = 7.0, 7.0 Hz, 2H), 2.57 (s. I H). 2.20 (s, 3H); 13C NMR ( 125 MHz, CDCI3) δ 1 70.4. 158.8, 154.9, 137.0, 136.9, 136.6. 128.8, 128.7, 128.2. 128.1. 127.3, 127.2. 1 18.8, 1 18.0, 97.3.. 71.1. 70.5, 62.6, 52.6, 34.4, 1 1.5; high resolution mass spectrum (ES+) m/z 429.1693 [(M+Na)4; calcd for C25H26O5Na: 429.1678].
Figure imgf000027_0001
Aryl Aldehyde 2.4. Alcohol 2.23 (0.261 g, 0.643 mmol) was dissolved in CH2CI2 (8 niL) and DMSO (6.5 mL) and cooled to 0 0C. Next, Et3N (0.90 mL, 10 equiv.) was added followed by SO3.pyridine (0.41 g, 4 equiv.). After 30 min at 0 0C. the cold bath was removed and the reaction stirred at rt. After 2 h, the reaction was diluted with sat. NaHCO3 (5 mL) and extracted with EtOAc (3 x 15 mL). The combined organic layers were washed with 1 M NaHSO-) (10 mL), sat. NaHCO3 (10 mL), and brine (10 mL) and then dried over MgSθ4 and concentrated. Flash chromatography (10% EtOAc/hexanes) provided aldehyde 2.4 (O. I 13 g, 88% yield) as a colorless oil. IR (neat) 3064, 3032, 2948, 1723, 1595, 1454, 1324, 1270, 1 158, 1089 cm"1: 1H NMR (500 MHz, CDCI3) δ 9.67 (dd, J= 1.5, 1.5 Hz, 1 H), 7.40-7.34 (m, 1 OH), 6.54 (s, 1 H), 5.07, (s, 2H), 5.04 (s, 2 H), 3.86 (s, 3H), 3.71 (d, J = 1.6 Hz, 2H), 2.13, (s, 3H); 13C NMR (125 MHz, CDCl3) δ 198.7, 168.7, 158.8, 155.5, 136.9, 136.7, 131.1 , 128.8, 128.7, 128.2, 128.1 , 127.3, 127.1. 1 19.8, 1 17.9, 98.3, 71.2, 70.6, 52.3, 46.0r 1 1.8; high resolution mass spectrum (ES+) ni/z 405.1701 [(M+HV ; calcd for C25H25O5: 405.1702].
Figure imgf000027_0002
Homopropargyllic alcohol (+)-2.11. To a -78 0C solution of THF (600 mL) was added propyne (100 g, 4 equiv.) via subsurface cannula to dissolve the gas in the THF. Next, a solution of «-BuLi (570 mL, 2.2 M in hexanes, 2 equiv.) was cooled to -78 0C and added to the propyne solution over 1 h via cannula. After stirring for 1.5 h at — 78 0C (S)-l ,2-epoxybutane [(-)-2.24] (45 g, 0.625 mol) was added via cannula over 25 min followed by addition of BF3«OEt2 over 45 min via cannula. After stirring for 1.5 h at —78 °C, the reaction was quenched with sat. NaHCO3 until all gas evolution ceased (ca. 3 h). The layers were separated and the aqueous layer extracted with EtiO (3 x 500 mL). The combined organic layers were dried over MgSO4 and concentrated in a 0 0C bath (to minimize loss of product due to slight volatility) to provide (+)- 2.11 (55.6 g, 79%) as a colorless oil. [α]∞ +1 1.0 (c 1.3, CHCI3); IR (neat) 3382, 2964, 2922, 1461 , 1435, 1335, 1245, 1 1 12, 1063, 1020 cm'1; 1H NMR (500 MHz, CDCl3) δ 3.69-3.55 (m, I H), 2.37 (ddddd, J = 16.4, 4.9, 2.5, 2.5, 2.5 Hz, 1 H); 2.24 (ddddd, J = 16.4. 7.2, 2.5, 2.5, 2.5 Hz, I H), 1.95 (d, J = 4.8 Hz, I H), 1.80 (dd, ./ = 2.5, 2.5 Hz, 3H), 1.64-1.48 (m, 2H), 0.94 (dd, J = 7.5, 7.5 Hz, 3H); 13C NMR (125 MHz, CDCI3) δ 78.3, 75.5, 71.7, 29.2, 27.3, 10.1 , 3.6; low resolution mass spectrum (ES+) m/z 112.10 [(M+)+; calcd for C7Hi2O: 1 12.0888].
Figure imgf000028_0001
AIkyne (-)-2.25. To a solution of (+)-2.11 (1 8.5 g, 0.165 mol) in CH2Cl2 (184 mL) and cyclohexane (368 mL) at rt was added benzyl-2,2,2-trichloiOacetimidate (50.0 g, 1.2 equiv) followed by dropwise addition of TfOH (0.73 mL, 0.05 equiv.) The solution turned cloudy and light brown as the reaction progressed. After 6 h, hexane (600 mL) was added and the solution stirred 30 min to precipitate solids and then the suspension was filtered. The filtrate was washed with sat. NaHCO3 (200 mL), which was then back extracted with CH2Cl2 (3 x 100 mL). The combined organic layers were then dried over MgSO4 and concentrated. The concentrate was diluted with 10% EtOAc/hexanes (200 mL) to facilitate further precipitation of solids and then filtered. The filtrate was then concentrated and purified by flash chromatography (0.5% EtOAc/hexanes to 1 % EtOAc/hexanes) to provide (-)-2.25 (30.4 g, 91 % yield) as a light yellow oil. [αft° -27.6 (c- 1.4, CHCl3); IR (neat) 2964, 2919, 2873, 1496, 1454, 1348, 1207, 1 108, 1071 , 1028 cm"1; 1H NMR (500 MHz, CDCI3) δ 7.44-7.22 (m, 5H), 4.60 (dd, J = 58.0, 1 1 .8 Hz. 2H). 3.45 (dddd, J= 6.7, 6.7, 5.1. 5.1 Hz, I H), 2.45 (ddddd, J= 16.5, 5.1 , 2.5, 2.5, 2.5 Hz, IH), 2.41- 2.32 (m, 2H), 1.81 (dd, J = 2.5, 2.5 Hz, 3H). 1 .77-1.60 (m, 2H), 0.97 (dd, J = 7.4, 7.4 Hz, 3H); 13C NMR (125 MHz, CDCI3) δ 138.9, 128.5, 127.9. 127.7, 79.1 , 77.2, 76.1 , 71 .4, 26.8, 23.8, 9.8, 3.7; high resolution mass spectrum (ES+) m/z 202.1354 [(M)'; calcd for Ci4Hi9O: 202.1358].
Figure imgf000028_0002
Vinyl iodide (— )-2.26. To a flask protected from light was added bis(cyclopentadienyl) zirconium(IV) chloride (0.313 g, 2.0 equiv.) and THF (1 mL). The solution was cooled to 0 0C and DIBAL-H (1.07 mL, 1 M in hexanes, 2.0 equiv.) was added dropwise. After 30 min at 0 0C, alkyne (-)-2.25 (0.108g. 0.534 mmol) was dissolved in THF (0.3 mL) and added to the in situ generated Schwartz reagent. The flask and syringe were then flushed with TTTF (0.3 mL) into the reaction. The reaction flask was then placed in a 50 0C oil bath. After 1 h, the reaction was cooled to 0 0C and N-iodosuccinimide (0.265 g, 2.2 equiv) was added. After 10 min, the reaction was quenched with sat. ΝaHC03 (10 mL) and then filtered through a 1 cm plug of silica gel. The silica gel was rinsed with EtOAc and the layers separated. The aqueous layer was then extracted with EtOAc (3 x 10 mL) and the combined organic layers were dried over MgSO4 and concentrated. Flash chromatography (10% EtOAc/hexanes) provided (-)-2.26 (135 mg, 77% yield. >20: 1 selectivity) as a colorless oil. [α]2 D° -4.4 (c 1.0, CHCl3); TR (neat) 3030, 2963, 2931 , 2872, 1454, 1351 , 1092, 1065, 1028 cm"1; 1H NMR (500 MHz, CDCl3) δ 7.42-7.27 (m, 5H), 6.24 (dd, J= 7.5, 6.8 Hz, I H), 4.54 (s, 2H). 3.37 (dddd, J = 5.9, 5.9, 5.9, 5.9 Hz, I H), 2.39 (s, 3H), 2.36-2.17 (m, 2H), 1 .62-1.52 (m, 2H), 0.95 (dd, ./= 7.4, 7.4 Hz. 3H).; 13C NMR (125 MHz, CDCI3) δ 138.9, 137.7, 128.6, 127.9, 127.7, 95.3, 79.3, 71 .4. 34.8, 27.9. 26.8, 9.9.; high resolution mass spectrum (ES+) m/z 353.0386 [(M+Na)H ; calcd for Ci4Hi9IONa: 353.0378].
Figure imgf000029_0001
Diene (-)-2.7. Vinyl iodide (-)- 2.26 (6.02 g, 18.2 mmol) was dissolved in anhydrous DMF (70 mL) in a sealable tube. Methyl acrylate (2.35 g, 1.5 equiv.) was added followed by Pd(OAc)2 (0.81 7 g, 0.20 equiv.), NaHCO3 (3.06 g, 2.0 equiv.), and Bu4NI (6.73 g, 1.0 equiv.). The tube was flushed with argon, sealed, and heated to 100 0C over 1 h. After 7 h at 100 0C, the reaction was cooled to 0 0C and sat. NH4CI (100 mL) added. The reaction was then filtered and extracted with EtOAc (3 x 100 mL). The combined organic layers were washed with H2O, sat. NaHCO3, and brine (100 mL each). The organic layer was then dried over MgSO4 and concentrated. Flash chromatography (3% EtOAc/hexanes to 5% EtOAc/hexanes to 8% EtOAc/hexanes) provided diene (-)-2.7 (4.1 1 g, 78% yield) as a light yellow oil. [α]2 D° -1 1 .7 (c 1 .0, CHCI3); IR (neat) 3033, 2963, 2873, 1719, 1624, 1310, 1 194, 1 169, 1 123, 1097 cm"1; 1H NMR (500 MHz, CDCl3) δ 7.34-7.26 (m, 5H). 5.97 (dd, J = 8.0, 8.0 Hz, 1 H), 5.81 (d, J = 15.5 Hz, I H), 4.53 (s, 3H), 3.77 (s. 3H), 3.47 (ddd, ./= 12.0, 6.0, 6.0 Hz, I H), 2.51 -2.43 (m, 2H), 1.78 (s, 3H), 1.57-1.64 (m, 3H), 0.94 (dd, J = 7.5, 7.5 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 168.2, 149.9, 138.9, 138.4, 134.3, 128.6, 127.9, 127.8, 1 15.6, 79.8, 71.4. 51.7, 33.3, 27.0, 12.6, 9.9; high resolution mass spectrum (ES+) m/z 289.1823 [(M+Na)+; calcd for Ci5H25O3: 289.1804].
Figure imgf000030_0001
Epoxide (+)-2.28. Diene (-)-2.7 (2.94 g, 10.2 mmol) was dissolved in CH3CN (460 mL). Na2B4O7 buffer (0.05 M, 1 15 mL) was added followed Bu4NHSO4 (0.425 g) and ketone catalyst H-2.27 (1.32 g, 0.50 equiv.). Oxone (8.77g, 1.4 equiv) was dissolved in Na2EDTA buffer (59 mL, 4 x 10"4 M) and K2CO3 (8.31 g, 5.9 equiv.) was dissolved in H2O (59 mL). The two solutions were then added simultaneously over 3 h via a dual-syringe pump. After the addition was complete, water was added to dissolve any solids that had formed and the reaction extracted with EtOAc (3 x 300 mL). The combined organic layers were washed with brine (200 mL). dried over MgSO4, and concentrated. Flash chromatography (5% EtOAc/hexanes to 8% EtOAc/hexanes) provided (+)-2.28 (2.27 g, 73% yield, β:α = 14: 1 ) as a colorless oil. [α|D 20 +2.2 (c 1 .7. CHCI3): IR (neat) 2966, 2932. 2876, 1726, 1654, 1436, 131 1. 1 170, 1094 cm'1 ; 1 H NMR (500 MHz, CDCl3) δ 7.34-7.31 (m, 5H). 6.75 (d, J = 15.5 Hz, I H), 6.00 (d, ./ = 16.0 Hz, I H). 4.53 (dd, J= 46.5, 1 1.5 Hz, 2H), 3.75 (s, 3H), 3.59-3.55 (m, I H), 3.00 (dd, J= 6.5, 6.5 Hz. I H), 1.85 (ddd, J = 14.5, 8.0, 5.5 Hz, I H), 1.76 (ddd, J = 4.5, 6.5, 4.5 Hz. I H), 1. 68-1.60 (m, 2H), 1.41 (s, 3H), 0.95 (dd, J = 7.5, 7.5 Hz, 3H); '3C NMR (125 MHz, CDCl3) δ 166.8, 150.4. 138.8, 128.6, 128.0. 127.9, 121.3, 78.0, 71.6, 63.8, 58.9, 51.9. 33.2, 27.0, 15.7, 9.5: high resolution mass spectrum (ES+) m/z 3271578 [(M+Na)x; calcd for Ci8H24O4Na: 3271572].
Figure imgf000030_0002
Alcohol (+)-2.29. To a solution of compound (+)-2.28 (60 mg, 0.20 mmol) in CH2Cl2 (3 mL) was added H2O (21 μL, 6 equiv.) The reaction was cooled to -40 0C and Me3Al (0.98 mL, 10 equiv., 2 M in hexanes) was added. After 30 min, the reaction was warmed to 0 0C and the reaction quenched with slow addition Of H2O (1 mL) followed by addition of 1 N HCl (3 mL) to break up the emulsion. The reaction was extracted with CH2CI2 (3 x 10 mL) and the combined organic layers were dried over MgSO4 and concentrated. Flash chromatography (5% EtOAc/hexanes to 10% EtOAc/hexanes) provided (+)-2.29 (53 mg, 84% yield) as a colorless oil. [α]2 D° +31.7 (c 1.6. CHCI3); IR (neat) 3490, 2964, 2875, 1723, 1651 , 1435, 1314, 1201 , 1 173, 1060 cm-1; 1H NMR (500 MHz, CDCI3) 7.38-7.26 (m, 5H), 7.04 (d, J = 16.1 Hz, I H), 5.81 (d, ./ = 16.1 Hz, I H), 4.54 (dd, J = 40.1 , 1 1.6 Hz, 2H), 3.73 (s, 3H), 3.70 (d, J = 8.9, 1 H), 3.65-3.59 (m, I H), 2.75 (s, I H), 1.91 -1.66 (m, I H), 1.65-1.50 (m, 3H), 1.07 (s, 3H), 1.06 (s, 3H), 0.91 (dd, J = 7.5, 7.5 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 167.5, 155.9, 138.6, 128.7, 128.0, 128.0, 1 19.2, 78.9, 74.5, 71.6, 51 .7. 41.6, 34.2, 26.1 , 22.9, 22.9, 10.2; high resolution mass spectrum (ES+) m/z 343.1876 [(M+Na)+; calcd for Ci9H28O4Na: 343.1886].
Figure imgf000031_0001
PMB ether (+)-2.31. To a solution of (+)-2.29 (0.906 g, 2.83 mmol) in CH2Ch (9 niL) and cyclohexane (18 niL) at rt was added £>-methoxybenzyl-2,2,2-trichloroacetimidate (3.2 g, 4.0 equiv) followed by addition of TfOH (3 μL. 0.01 equiv.) The solution turned cloudy and light brown as the reaction progressed. After 30 min, hexane (20 mL) was added to precipitate solids and the suspension was filtered. The filtrate was washed with sat. NaHCO3 (25 mL), which was then back-extracted with CH2CN (3 x 25 mL). The combined organic layers were then dried over MgSO,) and concentrated. The concentrate was diluted with 10% EtOAc/hexanes (25 mL) to facilitate further precipitation of solids and then filtered. The filtrate was then concentrated and purified by flash chromatography (3% EtOAc/hexanes to 5% EtOAc/hexanes) to provide (+)-2.31 (0.910 g, 73% yield) as a light yellow oil. [a]2" +43.5 (c 1.6, CHCI3); IR (neat) 2962, 2875, 2360, 2340, 1722, 1613, 1513, 1248, 1 173, 1064 cm"1: 1H NMR (500 MHz, CDCI3) δ 7.44-7.28 (m, 5H), 7.21 (d, J = 8.5 Hz, 2H), 7.13 (d, J = 16.0 Hz. I H), 6.87 (d, J = 8.5 Hz, 2H), 5.83 (d, J = 16.0 Hz, I H), 4.49 (dd, J = 135.1 , 12.0 Hz, 2H), 4.41 (dd. J = 54.7, 10.5 Hz, 2H), 3.80 (s, 3H), 3.75 (s, 3H), 3.66-3.56 (m, I H), 3.50 (d, J = 9.7, I H), 1.72-1.58 (m, 3H), 1.56- 1.48 (m, I H), 1.12 (s, 3H), 1.12 (s, 3H), 0.93 (dd, J = 7.4, 7.4 Hz, 3H); 13C NMR (125 MHz, CDCI3) δ 167.5, 159.2, 156.5, 139.2, 131.2, 129.2, 128.5, 127.8, 127.6, 1 18.6, 1 13.9, 83.0, 76.9, 74.9, 70.0, 55.4, 51.6, 42.7. 36.5, 26.2, 23.4, 23.4, 9.1 ; high resolution mass spectrum (ES+) m/z 440.2568 [(M+)'; calcd for C27H36O5: 440.2563].
Figure imgf000032_0001
Allylic alcohol (+)-S2.3. A solution of (+)-2.31 ( 1.76 g, 4.0 mmol) in CH2CI2 (20 niL) was cooled to -78 0C and DTBAL-H (1.06 ml, 1.0 M in hexanes, 2.1 equiv.) was slowly added. After 5 min. the reaction was quenched with MeOH (5 mL) followed by addition of sat. Rochelle's salt (I O mL). The solution was stirred for 2.5 h and the layers were separated. The aqueous layer was extracted with CH2CN (3 x 20 mL), and the combined organic layers were dried over MgSO4 and then concentrated. Flash chromatography (25 % EtOAc/hexanes) provided (+)-S2.3 (1.56 g, 95%) as a colorless oil. [α]2 D° +65.0 (c 1.0, CHCl3); IR (neat) 3425, 2961 , 2931 , 2873, 1613, 1513, 1464, 1248, 1087, 1063, 1035 cm'1: 1H NMR (500 MHz, CDCI3) δ 7.41 -7.26 (m, 5H), 7.20 (d, J = 8.5 Hz, 2H), 6.85 (d.. J = 8.6 Hz, 2H), 5.77 (d, J = 15.8 Hz, 1 H), 5.60 (ddd, J = 15.8, 5.9. 5.9 Hz, I H), 4.47 (dd, J = 130.8, 1 1.6 Hz, 2H), 4.40 (dd, J = 57.5, 10.8 Hz. 2H), 4.10 (dd, J = 5.8, 5.8 Hz, 2H), 3.79 (s, 3H), 3.58 (ddd, ./= 6.5, 4.2, 2.3 Hz, 1 H). 3.40 (dd, J= 10.0, 1.5 Hz, I H), 1.74-1.53 (m, 3H), 1.48 (ddd, ./ = 14.5. 10.0, 2.2 Hz, I H), 1.07 (s, 3H), 1 .06 (s. 3H), 0.90 (dd, J = 7.5, 7.5 Hz. 3H); 13C NMR (125 MHz, CDCI3) δ 159.2, 140.6. 139.3, 131 .6. 129.2, 128.6. 127.9. 127.7. 126.5, 1 13.9, 83.6. 77.2. 74.9, 70.0, 64.4, 55.5, 41.7. 36.5, 26.3, 24.5, 23.8. 9.3; high resolution mass spectrum (ES+) m/z 435.2514 [(M+Na/; calcd for C26H36O4Na: 435.25121.
Figure imgf000032_0002
Epoxy alcohol (+)-2.32. To freshly activated 3 A molecular sieves (0.2 g) in CH2CI2 (2 mL) was added (+)-DlPT (31.8 μL, 0.12 equiv.). The solution was cooled to -20 0C and Ti(O-Z-Pr)4 (37.3 μL. 0.1 equiv.) was added followed by J-BuOOH (0.687 mL. 5.5 M in decane, 3.0 equiv.) The reaction was stirred for 30 min and then (+)-S2.3 (0.521 g, 1.26 mmol) dissolved in CH2CI2 (1 .5 ml) was added via syringe. The flask and syringe were rinsed with CH2Cl2 (2 x 0.8 mL) into the reaction flask. After 2 h, 10% aq. citric acid (10 mL) was added and the reaction wanned to rt. After 1 h at rt, the reaction was filtered through celite, and the celite washed with CH2CI2 (10 mL). The layers were separated and the aqueous layer extracted with CH2CI2 (3 x 5 mL). The combined organic layers were dried over MgSθ4 and concentrated. Flash chromatography (25% EtOAc/hexanes) provided (+)-2.32 (0.524 g, 97% yield, dr. > 20: 1 ) as a colorless oil. [a]% +56.9 (c 0.8, CHCl3); IR (neat) 3435, 2964. 2932, 2874, 1612, 1514, 1455, 1248, 1088, 1064, 1034 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.40-7.26 (m, 5H); 7.19 (d, J = 8.6 Hz, 2H), 6.85 (d, ./ = 8.6 Hz, 2H); 4.48 (dd, J = 138.6, 1 1.6 Hz, 2H), 4.42 (dd, J = 47.4, 1 1.0 Hz, 2H), 3.85-3.80 (m, I H), 3.79 (s, 3H), 3.63-3.52 (m, 2H), 3.52 (dd, J = 10.0, 1.4 Hz, I H), 3.05 (dd, J = 4.8, 2.6 Hz, I H), 2.94 (d, J = 2.4 Hz, I H), 1.82-1.50 (m, 4H), 0.93 (s. 3H), 0.93 (dd, J = 7.6.. 7.6 Hz, 3H), 0.87 (s, 3H); 13C NMR (125 MHz, CDCI3) δ 159.2, 139.2, 131.4, 128.9, 128.6, 128.0, 127.7, 1 13.9, 82.4, 77.0, 74.6, 70.0, 62.2, 61.4, 55.6, 55.5., 39.2, 36.2, 26.3, 20.4, 19.0, 9.2; high resolution mass spectrum (ES+) m/z 451.2444 [(M+Na)"; calcd for C26H36O5Na: 451.2460].
Figure imgf000033_0001
Aldehyde (+)-S2.4. To a 0 0C solution of (+)-2.32 (0.233 g, 0.545 mmol) in DMSO (6 inL) arid CH2CI2 (7 mL) was added Et3N (0.76 niL, 10 equiv.) followed by SO3.pyridine (0.347 g, 4 equiv.). After 1.5 h, NaHCO3 (4 mL) was added, the layers separated, and the aqueous layer was extracted 3 x 10 mL Et2O. The combined organic layers were then washed with I M NaHSO4, sat. NaHCO3, and brine (10 mL each). The organic layer was then dried over MgSO4 and concentrated. Flash chromatography (10% EtOAc/hexanes) provided (+)-S2.4 (1.43 g, 99% yield) as a colorless oil. [α]∞ +1 15.0 (c 1.2, CHCI3); IR (neat) 2964, 2931 , 2876, 1728, 1613, 1514, 1464, 1248, 1090, 1064, 1035 cm0; 1H NMR (500 MHz, CDCI3) δ 9.01 (d, J = 6.1 Hz, I H), 7.44-7.27 (m, 5H), 7.19 (d. J = 8.4 Hz, 2H), 6.86 (d. J = 8.5 Hz, 2H), 4.49 (dd, J = 143.1 , 1 1.6 Hz, 2H), 4.40 (dd, ./ = 26.3, 10.9 Hz, 2H). 3.80 (s, 3H), 3.64-3.58 (m, I H), 3.56 (d, J = 9.8 Hz, I H), 3.27 (dd, J = 6.1 , 1.8 Hz, I H), 3.21 (d, J = 1.8, I H), 1.83-1.49 (m, 4H), 0.95 (s. 3H), 0.93 (dd, J= 7.5, 7.5 Hz, 3H), 0.88 (s, 3H); 13C NMR (125 MHz, CDCI3) δ 199.1 , 159.4, 139.1. 131.1 , 129.2, 128.6, 127.9, 127.8, 1 14.0. 82.1, 76.9, 74.8, 70.0, 62.0, 56.9, 55.5, 39.6, 36.2, 26.2, 20.3, 19.1 , 9.1 ; high resolution mass spectrum (ES+) m/z 449.2305 [(M+Na)+; calcd for C26H34O5Na: 449.2304].
Figure imgf000033_0002
Ester (+)-2.8. A solution of (+)-S2.4 (0.445 g, 1.04 mmol) in CH2Cl2 (5 mL) was cooled to 00C and a solution of carbomethoxy triphenylphosphonium ylide (2.9) in CH2Cl2 (5 mL) was added over 1 min. The reaction was allowed to warm to rt and after 30 min, the solvent was evaporated. Flash chromatography (8% EtOAc/hexanes) provided (+)-2.8 (0.453 g.90% yield) as a light yellow oil. [α]∞ +48.7 (c 1.4, CHCl3); IR (neat) 2962, 2876, 1725, 1612, 1513, 1463, 1304, 1249, 1172, 1090, 1064 cm-'; 1HNMR (500 MHz, CDCl3) δ 7.41-7.26 (m, 5H), 7.17 (d, J = 8.5 Hz, 2H), 6.85 (d, J= 8.5 Hz52H), 6.66 (dd, J= 15.7, 7.0 Hz, IH)56.05 (d, J= 15.7 Hz, IH), 4.48 (dd, J= 139.9, 11.6 Hz.2H), 4.40 (dd, J= 28.5, 11.0 Hz, 2H), 3.80 (s, 3H), 3.74 (s, 3H), 3.63-3.56 (m, IH), 3.53 (d, J =9.2 Hz, IH), 3.35 (dd, J= 6.9, 1.7 Hz, IH), 2.88 (d, J= 1.9 Hz. IH).1.81-1.50(m, 4H), 0.94 (s.3H), 0.93 (dd, J= 7.4.7.4 Hz.3H), 0.86 (s, 3H); 13CNMR (125 MHz, CDCI3) δ 166.4, 159.3.145.6, 139.2, 131.3.129.0, 128.6, 128.6, 127.9, 127.7.123.2, 114.0, 82.1, 76.9, 74.6, 70.0, 67.0, 55.5, 53.8, 51.9. 39.9, 36.1, 26.3, 20.7. 18.6, 9.2; high resolution mass spectrum (ES+) m/z 505.2553 [(M+Na)'; calcd for C2QH38O6Na: 505.2566].
Figure imgf000034_0001
Alcohol (+)-2.33. To freshly distilled dioxane (2 mL) was added Pd2(dba)3.CHCl3 (46 mg, 0.05 equiv.) and K-Bu3P (13 μL, 0.06 equiv.)'. Next, a solution OfHCO2H (0.20 mL, 6.0 equiv.) and Et3N (0.25 mL, 2 equiv.) in dioxane (1 mL) was added. This mixture was stirred at rt for 10 min and then a solution of epoxide (+)-2.8 (0.452 g, 0.937 mmol) in dioxane (1.5 mL) was added via cannula. The flask and cannula were rinsed with dioxane (2 x 1 mL) into the reaction flask. After 4.5 h, the reaction mixture was filtered through a 1 cm plug of silica gel and the silica gel washed with CH2CI2 (20 mL). The filtrate was concentrated and subjected to flash chromatography (5% EtOAc/hexanes to 10% EtOAc/hexanes to 15% EtOAc/hexanes) to provide (+)-2.33 (0.421 g, 93% yield) as a colorless oil. [α]: D° +95.5 (c 0.7, CHCI3); IR (neat) 3464, 2963, 2875, 1722.1613.1514, 1249, 1173.1063, 1036 Cm-1; 1H NMR (500 MHz, CDCl3) δ 7.40-7.26 (m.5H), 7.13 (d. J =8.2 Hz, 2H), 7.08(ddd,J= 14.8, 7.2.7.2 Hz, IH).6.83 (d, J= 8.3 Hz, 2H). 5.90 (d, J= 15.6 Hz, IH), 4.49 (dd. J = 150.3, 11.9 Hz, 2H), 4.38 (dd, J= 61.0.10.8 Hz, 2H), 4.16 (s, IH), 3.79 (s, 3H), 3.71 (s, 3H), 3.59-3.56 (m, IH), 3.54 (d, J = 9.2 Hz, IH), 2.25 (m, 2H), 1.91-1.67 (m, 3H), 1.62 (ddd, J= 14.1, 7.1, 7.1 Hz, IH), 1.08 (s, 3H), 0.93 (dd, J= 7.4, 7.4 Hz, 3H), 0.83 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 167.1, 159.5, 148.0, 139.1, 130.4, 129.2, 128.6, 128.0, 127.8, 122.6, 114.1, 86.7, 77.1, 75.3, 75.0, 70.1, 55.5, 51.5,41.5, 35.8.35.1, 26.3, 23.3, 20.4, 9.2; high resolution mass spectrum (ES+) m/z 485.2888 [(M+H)+; calcd for C29H4IO6: 485.2903].
Figure imgf000035_0001
TBS ether (+)-2.34. To a 0 0C solution of (+)-2.33 (0.789 g, 1.63 mmol) in CH2CI2 (16.3 mL) was added 2,6-lutidine (0.38 mL, 2.0 equiv.) followed by dropwise addition of TBSOTf (0.45 mL, 1 .2 equiv.). After 20 min, sat. NaHCOs (10 mL) was added and the layers separated. The aqueous layer was extracted CH2CI2 (3 x 15 mL), and the combined organic layers were dried over MgSθ4 and concentrated. Flash chromatography (5% EtOAc/hexanes) provided (+)-2.34 (0.965 g, 99% yield) as a colorless oil. [α]: D° +42.1 (c 0.9, CHCI3); IR (neat) 2956, 2931 , 2881. 2855, 1725, 1513, 1463, 1249, 1 170, 1073 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.37-7.26 (m, 5IT), 7.20 (d, J = 8.5 Hz, 2H), 7.06 (ddd, J= 15.7, 8.3, 6.4 Hz, IH), 6.86 (d, J= 8.5 Hz, 2H). 5.76 (d, J = 15.7 Hz, I H), 4.48 (dd, J= 156.4, 1 1.4 Hz, 2H), 4.39 (dd, J = 72.5, 1 1.1 Hz, 2H), 3.80 (s, 3H). 3.73 (s. 3H), 3.65 (dd, J = 6.4, 4.0 Hz, 1 H). 3.60-3.55 (m. J= 9.9, 5.5 Hz, I H). 3.52 (dd, J = 6.5, 5.0 Hz, I H), 2.51 (ddd. J = 14.9, 4.2, 4.2 Hz. I H), 2.36 (ddd. J = 15.0, 7.5, 7.5 Hz. I H), 1.74-1.64 (m, I H), 1.65-1.58 (m, I H). 1.56 (dd, J = 5.9, 5.9 Hz, 2H). 0.95 (s, 3H), 0.92 (dd, J = 7.5, 7.5 Hz, 3H), 0.90 (s. 9H), 0.89 (s, 3H), 0.05 (s, 3H), 0.03 (s, 3H); 13C NMR (125 MHz. CDCI3) δ 167.1 , 159.2, 148.6, 139.2, 131.7. 129.0, 128.6, 127.8, 127.7. 122.2, 1 13.9, 81.3, 77.3, 76.6. 75.0. 70.3, 55.5, 51.5, 44.7, 36.2. 36.1, 26.3, 26.2, 21.0, 20.1 , 18.6. 9.2, -3.2. -3.8; high resolution mass spectrum (ES+) m/∑ 621.3605 [(M+Na)+; calcd for C35H54O6SiNa: 621.3588].
Figure imgf000035_0002
Allylic alcohol (+)-S2.5. A solution of (+)-2.34 (1.43 g, 2.38 mmol) in CH2CI2 (12 mL) was cooled to -78 0C and DIBAL-H (1.06 mL, 1.0 M in hexanes, 2.1 equiv.) was added slowly over 5 min. After 2 min, the reaction was quenched with methanol (1 mL) followed by addition of sat. Rochelle's salt (10 mL). The solution was stirred for 2 h and the layers were separated. The aqueous layer was extracted with CH2CI2 (3 x 25 mL), and the combined organic layers were dried over MgSO4 and then concentrated. Flash chromatography (5 % EtOAc/hexanes) provided (+)-S2.5 (1.32 g, 97%) as a colorless oil. [αJ2 D° +47.7 (c 0.7, CHCI3); IR (neat) 3444, 2958, 2930, 2880. 2855, 1613, 1514, 1463, 1249, 1070 cm"1; 1H NMR (500 MHz, CDCl3) δ 7.41 -7.27 (m, 5H), 7.21 (d, J = 8.5 Hz, 2H), 6.86 (d, J = 8.5 Hz, 2H), 5.74 (ddd, J = 15.2, 7.2 Hz, I H), 5.55 (ddd, J = 15.4, 5.8, 5.8 Hz, 1 H), 4.49 (dd, J = 142.1 , 1 1.1 Hz, 2H), 4.42 (dd, J = 84.5, 1 1.1 Hz, 2H).. 4.03-3.91 (m, 2H), 3.80 (s. 3H), 3.64-3.59 (m, I H), 3.58 (dd, J = 9.7, 1.3 Hz, I H), 3.55 (dd, J = 5.3, 5.3 Hz, I H). 2.41 (ddd, J = 14.5, 5.4 Hz, IH), 2.19 (ddd, J = 14.0, 6.7 Hz, I H). 1 .75-1.64 (m, I H), 1.64-1.49 (m, 3H), 1.47 (dd, J = 6.0, 6.0 Hz, I H), 0.98 (s, 3H), 0.92 (dd, J = 7.5, 7.5 Hz, 3H), 0.90 (s, 9H), 0.88 (s, 3H), 0.04 (s, 6H); 13C NMR (125 MHz, CDCl3) δ 159.2, 139.1 , 131.8. 131.4, 130.7, 129.0, 128.6, 128.1 , 127.7, 1 13.9, 80.9, 77.3, 75.0, 70.5, 63.8, 55.5, 45.0, 36.4. 36.0, 26.3, 26.3, 21.0, 19.9, 18.6, 9.2, -3.1 , -3.9; high resolution mass spectrum (ES+) m/z 593.3651 [(M+Na)+; calcd for C34H54O5SiNa: 593.3639].
Figure imgf000036_0001
Epoxide (+)-2.35. To freshly activated 3 A molecular sieves (0.4 g) in CH2Cl2 (4.6 πiL) was added (-)-DTPT (58 μL, 0.12 equiv.) The solution was cooled to -20 0C and Ti(O-Z-Pr)4 (68 μL, 0.1 equiv.) was added followed by /-BuOOH (1.26 mL, 5.5 M in decane, 3.0 equiv.) The reaction was stirred for 30 min and then (+)-S2.5 (1.32 g, 2.31 mmol) dissolved in CH2Cl2 (2 ml) was added via cannula. The flask and cannula were rinsed with CH2Cl2 (2 x 1.5 mL) into the reaction flask. After 4 h, 10% aq. citric acid (10 mL) was added and the reaction warmed to rt. After 2 h. the layers were separated and the aqueous layer extracted with CH2CI2 (3 x 25 mL). The combined organic layers were dried over MgSO4 and concentrated. Flash chromatography (10% EtOAc/hexanes to 15% EtOAc/hexanes) provided (+)-2.35 (1.24 g, 92% yield, dr > 20:1 ) as a colorless oil. [α]2 D° +72.4 (c 1.9, CHCl3); IR (neat) 3444, 2957, 2930, 2881 , 2856, 1613, 1514, 1463, 1249, 1071 CiV; 1H NMR (500 MHz, CDCl3) δ 7.39-7.27 (m, 5H), 7.22 (d. J = 8.5 Hz. 2H), 6.86 (d, J= 8.6 Hz, 2H), 4.46 (dd, J= 153.9, 1 1.4 Hz, 2H), 4.44 (dd, J= 66.0, 10.8 Hz, 2H), 3.80 (s, 3H), 3.78-3.71 (m, 2H), 3.62-3.51 (m, 2H), 3.49 (dd, J = 9.3, 2.0 Hz, I H). 3.10 (ddd. J = 6.8, 4.7, 2.1 Hz, I H), 2.70 (dd. J = 4.3, 2.6 Hz, IH), 1.80-1.64 (m, 3H), 1.64-1.50 (m, 3H), 0.98 (s. 3H), 0.92 (s, 12H), 0.92 (dd, J = 7.4, 7.4 Hz, 3H), 0.1 1 (s, 3H), 0.10 (s, 3H); 13C NMR (125 MHz, CDCI3) δ 159.2, 139.3, 131.7, 129.0, 128.5, 127.9, 127.6, 1 13.9, 81.4, 77.3, 75.1 , 75.0, 70.0, 61 .7, 59.9, 55.5, 53.7. 44.2, 35.9, 35.1 , 26.4, 26.2, 20.9, 20.0, 18.6, 9.2, -3.5, - 3.6; high resolution mass spectrum (ES+) m/z 609.3596 [(M+Na)+; calcd for C34H54O6SiNa: 609.3588].
Figure imgf000037_0001
Ester (+)-2.36. Epoxy alcohol (+)-2.35 was dissolved in CH3CN (12 mL) and then TEMPO (15 mg, 0.08 equiv.) was added followed by pH 7 buffer (12 mL). Next, NaClO2 (0.42 g, 2.5 equiv.) was added in one portion followed by dropwise addition of NaOCl (0.32 mL, 5 wt% solution, 0.2 equiv.). After 1.5 h, anhydrous Na2SO3 (0.49 g, 3.2 equiv.) was added and the reaction stirred for 30 min, upon which, the solution turned from orange to colorless. The reaction was acidified to pH 4 with 10% aq. citric acid solution and then extracted with EtOAc (3 x 25 mL). The combined organic layers were dried over MgSO4 and concentrated. The unpurified acid was then dissolved in Et2O (24 mL) and cooled to 0 0C. A solution Of CH2N2 in Et2O was then added dropwise until gas evolution ceased and the reaction turned light yellow. Argon was bubbled through the reaction mixture for 15 min to remove any excess CH2N2 and then the reaction was concentrated. Flash chromatography (10% EtOAc/hexanes) provided (+)-2.36 (0.557 g, 76% yield, 2 steps) as a colorless oil. [α]2 D° +86.8 (c 1.0, CHCI3); IR (neat) 2957, 2931 , 2882, 2857. 1754, 1513, 1458, 1249, 1065 cm"1; 1H NMR (500 MHz, CDCI3) δ 7.41 -7.27 (m. 5H), 7.21 (d, J = 8.6 Hz, 2H), 6.86 (d, J = 8.7 Hz, 2H), 4.45 (dd, J = 162.5, 11.5 Hz, 2H), 4.42 (dd, J = 69.0, 10.9 Hz, 2H), 3.80 (s, 3H), 3.75 (s, 3H), 3.75-3.70 (m, I H), 3.60-3.53 (m5 I H), 3.49-3.42 (m, I H), 3.31 (ddd, J = 6.5, 4.5, 1.8 Hz, I H), 3.04 (d, J = 1.8 Hz, IH), 1.80 (ddd, J = 14.5, 7.7, 4.5 Hz, I H), 1.71 -1.64 (m, 2H), 1.64- 1 .56 (m, IH), 1.54 (dd, J= 7.6. 4.5 Hz, 2H), 0.96 (s, 3H). 0.93- 0.90 (m. 15H), 0.12 (s, 3H), 0.09 (s, 3H); 13C NMR (125 MHz, CDCI3) δ 169.9, 159.2, 139.3, 131 .6, 129.0. 128.6, 127.8. 127.7, 1 13.9, 81.4, 77.1 , 75.1 , 74.9, 70.0, 56.6, 55.5, 54.7, 52.5, 44.2, 35.9, 34.8, 26.4, 26.1 , 21.0, 20.0, 1 8.6, 9.1 , -3.6, -3.6: high resolution mass spectrum (ES+) m/z 637.3521 [(M+Na)4 ; calcd for C35Hs4O7SiNa: 637.3537].
Figure imgf000037_0002
Alcohol (+)-2.37. A solution of (+)-2.36 (1.32 g, 2.14 mmol) in CH2Cl2 (22 mL) and pH 7 buffer (5.4 mL) was cooled to 0 0C and DDQ (0.542 g, 1.1 equiv) was added in three portions over 1 min. After 45 min, the reaction was diluted with CH2Cl2 (20 mL) and filtered through Celite. The Celite was then washed with sat. NaHCO3 (10 mL). The layers were separated and the aqueous layer extracted with CH2Cl2 (3 x 20 mL). The combine organic layers were then dried with MgSO4 and concentrated. Flash chromatography (5% EtOAc/hexanes until the anisaldehyde eluted then 10% EtOAc/hexanes) provided (+)-2.37 (0.998g, 94% yield) as a light yellow oil. [α]2 D° +54.3 (c 0.7, CHCI3); IR (neat) 3494, 2957, 2930, 2880, 2855, 1755, 1452.
1254, 1204, 1058 cm'1; 1H NMR (500 MHz, CDCI3) δ 7.42-7.23 (m. 5H), 4.58 (dd. J = 46.5,
1 1.6 Hz, 2H), 3.91 (dd, ./ = 8.8, 3.2 Hz, I H), 3.84 (s. I H). 3.82-3.76 (m. I H), 3.77 (s, 3H), 3.69 (ddd, J = 1 1.4, 5.9, 5.9 Hz, I H), 3.32 (ddd, J = 7.9, 3.3, 1.9 Hz, IH), 3.23 (d, J = 1.8 Hz. I H),
1.98 (ddd, J = 14.8, 8.2, 3.4 Hz, I H), 1.69-1.52 (m. 3H), 1.50-1.45 (m, 2H), 0.95 (s, 3H), 0.94-
0.91 (m, 12H), 0.72 (s, 3H), 0.16 (s. 3H), 0.15 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 169.6,
139.5, 128.5. 127.9, 127.6, 79.5. 78.2, 72.2, 71.4, 56.6 54.4, 52.7, 40.9, 36.1 , 35.2. 27.5, 26.3,
22.5, 20.0, 18.5, 9.9, -3.7, -4.1 ; high resolution mass spectrum (ES+) m/z 495.3125 [(M+H)*; calcd for C27H47O6Si: 495.3142].
Figure imgf000038_0001
Alcohol (+)-2.38. To a solution of (+)-2.37 (0.998 g. 2.02 mmol) in CH2CI2 (40 niL) was added camphorsulfonic acid (94 mg, 0.2 equiv). After stirring for 5 h at rt, sat. NaHCO3 (20 mL) was added and the reaction mixture stirred for 10 min. The layers were separated and the aqueous layer extracted with CH2CI2 (4 x 15 mL). The combined organic layers were then dried over MgSO4 and concentrated. Flash chromatography (5% EtOAc/hexanes) provided (+)-2.38 (0.91 7g, 92%) as a colorless oil. [α]2 D° +38.1 (c 1.6, CHCl3); IR (neat) 3461 , 2956. 2930, 2857, 1741 , 1471 , 1437, 1360, 1256, 1080 cm"1; 1H NMR (500 MHz, CDCl3) δ 7.44-7.17 (m, 5H), 4.54 (dd, J = 41.3, 1 1.5 Hz, 2H), 4.23 (dd, J = 5.8, 4.0 Hz, IH), 4.07 (dd, J = 9.9, 3.5 Hz, I H), 3.78 (s, 3H), 3.80-3.75 (m, IH), 3.63 (dd, J = 3.8, 3.8 Hz, I H), 3.56-3.48 (m, I H), 2.87 (d, J = 6.2 Hz, I H), 2.31 (dd, J = 13.0. 13.0 Hz. 1 H). 2.06 (ddd, J = 13.4. 10.0, 3.1 Hz, 1 H), 1 .71 - 1 .48 (m, 3H), 1.36 (ddd. J = 13.6, 3.9, 3.9 Hz. I H), 1.01 (s, 3H), 0.92 (dd, J = 7.5, 7.5 Hz, 3H), 0.90 (s, 9H). 0.86 (s, 3H). 0.05 (s. 3H), 0.03 (s, 3H); 13C NMR (125 MHz. CDCI3) δ 173.2, 139.5. 128.5, 128.4, 128.0, 127.5, 77.9, 73.8, 73.7, 71 .6, 67.6. 52.6, 37.3. 33.0, 30.1 , 27.2. 26.5, 26.0. 21.5. 18.2, 9.6, -4.4, -4.9; high resolution mass spectrum (ES+) m/z 517.2970 [(M+Naf: calcd for C27H46O6SiNa: 517.2962].
Figure imgf000039_0001
Methyl ether (+)-2.40. A solution of (+)-2.38 (0.236g, 0.478 mmol) in THF (5 mL) was cooled to 0 0C and NaH (29 mg, 60% in mineral oil, 1.5 equiv.) added in one portion. After 20 min, Me2SO4 (59 μL, 1.3 equiv.) was added dropwise and the reaction allowed to warm to rt. After 1.5 h, the reaction was quenched with sat. NaHCOs (5 mL). The layers were separated and the aqueous layer extracted with CH2CU (5 x 15 mL). The combined organic layers were then dried over MgSU4 and concentrated. Flash chromatography (3% EtOAc/hexanes to 5% EtOAc/hexanes) provided (+)-2.40 (0.229g, 94% yield) as a colorless oil. [α]∞ +20.0 (c 2.8, CHCl3); IR (neat) 2956, 2931 , 2857, 1751 , 1462, 1359, 1256, 1 195, 1 126, 1083, 1006 cm-l; 1H NMR (500 MHz, CDCl3) δ 7.44-7.14 (m, 5H), 4.54 (dd, J= 29.4, 1 1.4 Hz, 2H), 4.08 (ddd, J = 7.1 , 4.2, 4.2 Hz, I H), 3.89 (d, J= 6.4 Hz, I H), 3.74 (s, 3H). 3.70 (dd, J = 1 1.3, 1.5 Hz, I H).. 3.59 (dd, J= 6.5, 3.4 Hz, I H). 3.50-3.44 (m, I H), 3.39 (s, 3H), 2.08 (dd. J= 12.7. 12.7 Hz, I H), 1.98 (ddd, J= 13.7, 7.6, 3.5 Hz, 1H). 1.70-1 .48 (m. 4H), 1.00 (s. 3H), 0.92 (dd, J= 7.6, 7.6 Hz, 3H), 0.90 (s, 9H), 0.85 (s, 3H), 0.05 (s, 3H), 0.04 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 171.8, 139.8, 128.4, 127.8, 127.4, 83.2, 78.0, 77.9, 73.5, 71.6, 68.4, 58.8, 52.1, 37.9, 33.7, 30.7, 27.4, 26.0, 25.9, 19.2, 18.2, 9.6, -4.3, ^.9; high resolution mass spectrum (ES+) m/z 531.3139 [(M+Na)+; calcd for C28H48O6SiNa: 531.31 18].
Figure imgf000039_0002
Alcohol (+)-S2.6. To a solution of (+)-2.40 (0.229 g, 0.450 mmol) in EtOAc (4.5 mL) was added 10% Pd/C (0.025 g). The reaction flask was purged with H2 and then a balloon of H2 was attached to the flask. After 5 h at rt. the reaction mixture was filtered through a pad of Celite and the Celite rinsed with CH2Cb (10 mL). The reaction was concentrated and then flash chromatography (10% EtOAc/hexanes) provided (+)-S2.6 (0.182 g, 97%) as a colorless oil. [α]2 D Q +12.7 (c 3.6, CHCl3); IR (neat) 3557, 2955, 2930, 2857, 1730, 1463, 1285, 1254, 1 127, 1082 cm"1; 1H NMR (500 MHz, CDCI3) δ 4.08 (d, J = 9.0 Hz, I H), 4.04-4.00 (m, I H), 3.81 (s, 3H), 3.59-3.53 (m, 2H), 3.53-3.46 (m, I H), 3.41 (s, 3H), 2.92 (d, J= 4.1 Hz, I H), 1.93 (ddd, J = 13.8, 4.2, 2.8 Hz, I H), 1.74 (ddd, J = 13.8, 10.4, 5.7 Hz, I H), 1.60 (dd, J = 12.3, 12.3 Hz, I H), 1 .53-1.34 (in, 3H), 0.94 (dd, J = 7.4, 7.4 Hz, 3H), 0.89 (s, 12H), 0.83 (s, 3H), 0.05 (s, 3H), 0.04 (s. 3H); 13C NMR (125 MHz, CDCl3) δ 173.1 , 81.0, 76.1, 72.6, 72.2, 68.8, 58.8, 52.6, 39.0, 36.5, 30.4, 30.2, 26.0, 23.8, 18.2, 14.2, 10.6, -4.1, -4.8; high resolution mass spectrum (ES+) m/∑ 441.2642 [(M+Na)+; calcd for C2]H42O6SiNa: 441.2649].
Figure imgf000040_0001
Tctrahydropyran (+)-2.5. A solution of (+)-S2.6 (0.187g, 0.446 mmol) in CH2Cl3 (4.5 mL) was cooled to 0 0C and NaHCOj (56 mg, 1.5 equiv.) was added followed by Dess-Martin periodinane (0.568 g, 3 equiv.). After 1 h at 0 0C, H2O. sat. NaHCO3, and CH2Cl2 (5 mL each) were added. The solution was stirred until the organic layer went clear (ca. 30 min). The layers were separated and the aqueous layer extracted with CH2CI2 (3 x 10 mL). The combined organic layers were then dried over MgSO4 and concentrated. Flash chromatography (10% EtOAc/hexanes) provided (+)-2.5 (0.181 g, 97% yield) as a colorless oil. [α]2 D° +l 6.5 (c 1 .7, CHCI3); IR (neat) 2954, 2934, 2886, 2858. 1754, 1722. 17.1 12, 1462, 1361 , 1255, 1 1 19, 1073 cm-1; 1H NMR (500 MHz, CDCl3) δ 4.10 (dd, J= 10.6, 2.5 Hz, I H), 4.04 (ddd, J= 1 1.9, 4.5, 2.3 Hz. I H), 3.80 (d, J= 4.5 Hz, IH), 3.70 (s, 3H), 3.53 (dd, J = 2.7, 2.7 Hz I H), 3.40 (s, 3H), 2.60- 2.38 (m, 3H), 2.23 (dd, J= 14.5, 2.5 Hz, I H), 1 .96 (ddd, J= 14.1 , 12.0, 2.4 Hz, I H), 1 .40 (ddd, J = 13.8, 3.1 , 2.5 Hz, I H), 1.04 (dd. J = 7.3, 7.3 Hz, 3H), 0.90 (s, 9H), 0.89 (s, 3H), 0.80 (s, 3H), 0.03 (s, 3H), 0.01 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 210.4, 171.7, 82.5, 77.4, 73.1 , 69.8, 58.8, 52.2, 42.6, 38.1 , 37.2, 30.3, 26.0, 25.1, 18.2, 17.9, 7.8, -4.2, -4.8; high resolution mass spectrum (ES+) m/z 439.2491 [(M+Na)+; calcd for C21H40O6SiNa: 439.2492].
Figure imgf000040_0002
Ester (-)-2.43. Acid (-)-2.2 (0.1 12 g, 0.387 mmol) was dissolved in MeOH (2.0 mL) and CH2Cl2 (2.0 mL) and cooled to 0 °C. TMSCHN2 (ca. 0.2 mL, 2.0 M in Et2O) was then added dropwise until all gas evolution had ceased and the solution turned light yellow. Argon was bubbled through the reaction for 10 min and then the reaction concentrated. Flash chromatography (5% EtOAc/hexanes) provided (-)-2.43 (88 mg, 75% yield) as a colorless oil. [α]D :o -13.0 (c 1.0, CHCI3); IR (neat) 2955, 2930, 2898, 2858, 1760, 1732, 1463, 1254, 1157, 1115 cm"1; 1H NMR (500 MHz, CDCl3) δ 4.80 (d, J = 13.0 Hz, 2H), 4.30 (d, J = 4.0 Hz, IH), 3.73 (s; 3H), 3.61 (ddd,./= 6.5, 6.5, 4.0 Hz, IH); 3.39 (s, 3H), 2.27 (d, J= 6.0 Hz.2H), 1.76 (s, 3H), 0.91 (s, 9H), 0.06 (s, 6H);13C NMR (125 MHz, CDCI3) δ 172.8, 142.6, 113.0, 82.3.73.6, 58.4, 52.0, 39.0, 25.9, 23.0, 18.4, -4.9, -5.0; high resolution mass spectrum (ES+) m/z 325.1800 [(M+Na)'; calcd for Ci5H30O4SiNa: 325.1811].
Figure imgf000041_0001
β-Hydroxy ketone (+J-2.46. A solution of ketone (+)-2.5 (0.113 g, 0.271 mmol) in CH2Cl2 (1.5 mL) was cooled to -780C and CI2BPh (42 μL, 1.2 equiv.) was added. After stirring for 20 min, /-Pr2NEt (71 μL. 1.5 equiv.) was added dropwise. The reaction was stirred for I h at -780C, warmed to 00C over 10 min, then stirred 1 h at 00C. After cooling back to -780C, aldehyde 2.4 (0.131 g, 1.2 equiv.) was dissolved in CH2CU (1.0 mL) and added to the boron enolate dropwise over 10 min. After 4 h at -780C, the reaction was quenched with a 1 : 1 mixture of MeOH/pH 7 buffer (6 mL). After warming to rt, the reaction was neutralized to pH 7 with pH 8 buffer and stirred for 1 h at rt. The layers were separated and the aqueous layer extracted with CH2Cl2 (3 x 10 mL). The combined organic layers were then dried over MgSCM and concentrated. Flash chromatography (25% EtOAc/hexanes) provided (+)-2.46 (0.191 g, 86% yield, dr > 20:1) as a colorless oil. [α]2 D° +27.3 (c 2.0. CHCI3): IR (neat) 3439, 2952, 2930.2858, 1747. 1717, 1595, 1457, 1271, 1158, 1095.1074 cm"1; 1HNMR (500 MHz, CDCl3) δ 7.40-7.27 (m.10H), 6.45 (s, IH), 5.05-4.98 (m.4H).4.13-4.03 (m, 2H), 3.95 (d, J= 6.1 Hz, IH), 3.85 (s, 3H), 3.72 (s, 3H), 3.64 (dd, .7=7.8, 3.8 Hz. IH), 3.54 (d, J= 5.7 Hz, IH), 3.41 (s, 3H), 3.06 (dd, J= 16.3, 9.4 Hz, IH), 2.88 (dd, J= 14.2, 3.3 Hz, IH), 2.72-2.66 (m, IH), 2.62 (dd, J= 14.1.10.2 Hz, IH), 2.55 (dd,J= 16.4, 2.9Hz, IH), 2.21 (s, 3H), 1.96(ddd,J= 13.8, 5.8, 3.9 Hz, IH), 1.62-1.55 (m. IH), 1.21 (d, J= 7.1 Hz, 3H), 0.96 (s, 3H), 0.90 (s, 9H), 0.85 (s, 3H), 0.04 (s.3H).0.04 (s, 3H).; '3C NMR (125 MHz. CDCl3) δ 212.5, 171.6, 170.7, 158.9, 155.2, 137.2, 137.0, 136.9.128.9.128.8, 128.7, 128.2, 128.1, 127.3, 127.2, 127.1, 119.3, 117.8, 97.5, 82.3, 76.7, 73.1, 71.6, 71.2.70.5. 70.1.58.8, 53.2, 52.6.52.2, 42.4, 38.1, 35.8, 30.1, 26.0, 24.5, 18.2, 17.6, 11.8., 11.4,-4.3,-4.8; high resolution mass spectrum (ES+) m/z 843.4132 [(M+Na)"; calcd for C4e,H64θnSiNa: 843.41 16].
Figure imgf000042_0001
Diol (+)-2.47. A solution of ketone (+)-2.46 (0.066 g, 0.081 mmol) in THF (4.7 mL) was cooled to -30 0C and catecholborane (0.172 mL, 20 equiv.) was added dropwise. The reactions was warmed to 4 0C and stirred for 44 h and then quenched with sat. NaHCCb (2 mL). The reaction was extracted with EtOAc (3 x 5 mL) and the combined organic layers were then dried over MgSC>4 and concentrated. Flash chromatography (20% EtOAc/hexanes) provided (+)-2.47 (55 mg, 83% yield, dr = 13: 1) as a colorless oil. [α]£ +12.4 (c 1.7, CHCl3); IR (neat) 3482, 2953, 2890, 2858, 1737, 1593, 1455, 1275, 1 158, 1 124, 1073, 1008 cm'1; 1H NMR (500 MHz, CDCl3) δ 7.50-7.27 (m, 10H), 6.46 (s, I H), 5.06-4.98 (m, 4H), 4.16-4.10 (m. IH), 4.08-4.01 (m, I H), 3.98 (d, J = 7.9 Hz, I H), 3.90-3.84 (m, IH), 3.87 (s, 3H).. 3.81 -3.78 (m, I H), 3.79 (s, 3H), 3.68 (s, I H), 3.56-3.52 (m, 2H), 3.40 (s, 3H), 2.86 (d, J = 6.7 Hz, 2H), 2.25 (s. 3H), 1 .94 (ddd, J = 13.8, 3.9, 3.9 Hz, I H), 1.83 (ddd, .7 = 14.2, 10.2, 10.2 Hz, I H). 1.73-1.64 (m, I H). 1 .53 (ddd, J = 6.5, 6.5, 6.5 Hz, IH), 1.47 (d, J = 14.7 Hz. IH), 1.00 (d, J = 6.9 Hz, 3H), 0.91 (s, 9H), 0.89 (s. 3H), 0.86 (s, 3H), 0.05 (s, 3H), 0.05 (s, 3H).; 13C NMR (125 MHz, CDCI3) δ 171 .6, 1 70.3, 158.7, 154.9, 137.7, 137.1 , 128.8, 128.7, 128.2, 128.0, 127.3, 127.2, 1 19.5, 1 18.2.. 97.3, 8,1.9, 81 .2, 76.5, 75.8, 72.4, 71.7, 71.2, 70.5, 58.8, 52.5, 42.2, 39.2, 36.0, 33.7, 30.1 , 26.0, 24.2, 18.2, 15.4, 1 1.9, 6.1 , —4.1 , —4.8; high resolution mass spectrum (ES+) m/z 845.4264 [(M+Na)' ; calcd for C46H66OnSiNa: 845.4272].
Figure imgf000042_0002
Aminal (+)-2.49. A solution of (+)-2.47 (44.7 mg, 0.054 mmol) was dissolved in MeOH (3.4 mL) and cooled to 0 0C followed by addition Of H2O (20 μL, 20 equiv.) and LiOH (26 mg, 20 equiv.). The cold bath was removed and the reaction allowed to warm to rt. After 40 h, the reaction was quenched by diluting with EtOAc (3 mL) and acidified to pH 2 with 1 M NaHS(V H2O (3 mL) was added and the reaction extracted with EtOAc (5 x 5 mL). The combined organic layers were then dried over MgSO4 and concentrated to provide acid 2.48 (41 mg, 97% yield), which was used without further purification. A solution of the unpurified dihydroisocoumarin acid (32 mg. 0.041 mmol) in acetone (2.0 mL) was cooled to 0 0C and i- Pr2NEt (1 7 μL, 2.4 equiv ) was added followed by addition of isobiityl chloroformate ( 12 μL, 2.2 equiv.) After 45 min at 0 0C. NaNs ( 14 mg, 5.0 equiv.) was dissolved in H2O (0.3 mL) and added to the reaction over 2 min. After 20 min, cold H2O (2 mL) was added and the reaction extracted with cold EtOAc (3 x 3 mL). The combined organic layers were dried thoroughly over MgSO<i and concentrated. The residue was azeotroped with benzene (3 x 2 mL) and then placed on the vacuum pump for 30 min. The unpurified acyl azide was dissolved in toluene (2.0 mL). the reaction flask fitted with a reflux condenser, and then heated to 80 0C. After 45 min. 2- trimethylsilylethanol (0.1 18 mL, 20 equiv.) was added through the top of the reflux condenser. After 2 h. the reaction was cooled to rt and the solvent evaporated. Flash chromatography ( 10% EtOAc/hexanes to 20% EtOAc/hexanes) provided (+)-2.49 (27 mg. 74% yield) as a colorless oil. [α]£ +29.7 (c 1.0, CHCl3); IR (neat) 3325, 2953, 2896, 2858. 1717, 1592, 1459. 1248. 1 1 55. 1072 Cm-VH NMR (SOO MHz, CDCI3) 5 7.63-7.27 (m, 10H), 6.47 (s, I H). 5.38 (d, ./= 10.1 Hz, IH). 5.17 (dd, J = 33.6, 12.5 Hz, 2H), 5.03 (s, 2H), 4.90 (dd, J = 10.0, 2.5 Hz, I H), 4.33 (ddd, J = 1 1.7, 6.9, 2.3 Hz. I H), 4.26-4.10 (m, 3H), 3.98 (d, J = 9.3 Hz, IH), 3.67 (s, I H), 3.63 (d. J = 10.7 Hz, IH), 3 57 (dd, .7 = 4.9. 3.2 Hz, IH), 3.37 (s, 3H), 3.12 (dd. J = 16.4, 2.1 Hz. I H). 2.83 (dd, J= 16.4. 1 1.9 Hz, I H), 2.43-2.31 (m, 1 H), 2.15 (s, 3H), 1.94-1.78 (m, 2H). 1.45 (d, J = 1 5.0 Hz, I H), 1.13 (d, J= 6.9 Hz, 3H), 1.02-0.92 (m. 2H) 1.01 (s, 3H). 0.90 (s, 9H), 0.89 (s, 3H), 0 05 (s, 3H). 0.04 (s. 3H), 0.02 (s, 9H); 13C NMR (125 MHz, CDCI3) δ 163.6, 161.1. 160.3, 157.2. 142.2, 137.1. 136 6. 128.9. 128.7, 128.5, 128.3, 127.9, 127.3. 127.1 , 1 16.3, 108.2, 98.2, 83.7. 83.6, 79.2, 73.0, 72.8, 71.4, 70.4, 68.0. 63.7, 55.8. 43.5. 38.1 , 32.8. 31 .1 , 29.8, 26.1. 26.0, 18.2, 17.8. 1 1.4, 10.2, -1.3, -4.3, -4.8; high resolution mass spectrum (ES+) m/∑ 914.4707 [(M+Na)' ; calcd for C4QH73NO10Si2Na: 914.4671].
Figure imgf000044_0001
SiIyI ether (+)-2.3. A solution of (+)-2.49 (27 mg, 0.030 mmol) in CH2Cl2 (0.4 mL) was cooled to 0 0C and 2,6-lutidine (7 μL, 2.0 equiv.) added followed by dropwise addition of TBSOTf (14 μL, 2.0 equiv.). After 1 h, CH2Ch (1 mL) and sat. NaHCO3 (2 mL) were added and the reaction wanned to rt. The layers were separated and the aqueous layer extracted with CH2Cb (3 x 5 mL). Preparative TLC (25% EtOAc/hexanes, 500 micron plate) provided (+)-2.3 (22 mg, 73%) as a colorless oil. [α]: D ϋ +4.6 (c 0.3, CHCI3); IR (neat) 2953, 2927, 2857. 1719, 1592. 1462, 1382, 1250, 1 155, 1084 cm'1; 1H NMR (500 MHz, CDCI3) δ 7.57-7.26 (m, 10H), 6.50 (s, I H), 5.45 (d, J = 9.6 Hz, 1 H), 5.1 7 (dd, J = 33.2, 12.2 Hz, 2H), 5.10-5.02 (m, 2H), 4.82 (d, J = 8.0 Hz. 1 H). 4.26-4.08 (m, 3H), 4.00 (s, I H), 3.59 (dd, J = 3.9, 3.9 Hz, I H), 3.37 (s, 3H), 3.39-3.32 (m, I H), 3.1 1 (d, J = 16.3 Hz, IH), 2.65 (dd, J= 16.5,.12.1 Hz, IH), 2.28 (dd, J= 1 1.6, 1 1.6 Hz, I H), 2.15 (s, 3H), 2.05- 1.94 (m, I H), 1.87-1.75 (m, I H), 1.71 -1.57 (m, IH), 1.49 (ddd, J = 8.4, 3.8, 3.8 Hz, I H), 1.09 (d, J= 6.7 Hz, 3H), 0.98 (s, 3H), 0.91 (s, 9H), 0.90-0.83 (m, 2H) 0.87 (s, 3H), 0.80 (s, 9H), 0.10 (s, 3H), 0.07 (s, 3H), 0.06 (s, 3H), 0.00 (s, 9H), -0.01 (s, 3H); 13C NMR (125 MHz, CDCI3) δ 163.7, 161.1 , 160.4, 157.2, 141.8, 137.0, 136.6, 128.9, 128.7, 128.4, 127.9, 127.4, 127.1 , 1 16.0, 108.3, 98.1 , 84.4, 79.8, 77.6, 73.6, 71.3, 70.4, 68.8, 67.8, 63.6, 56.1. 39.9, 37.6. 32.8, 31.7, 29.9, 26.8, 26.2, 26.0, 18.4, 1 8.2, 17.8, 11.4, 9.0, -1.3, -3.3, -4.3, -4.7; high resolution mass spectrum (ES+) m/z 1028.5526 [(M+Na)+; calcd for C55H87NOi0Si3Na: 1028.5536].
Figure imgf000044_0002
Amide (-)-2.54. Acid (-)-2.2 (45 mg, 2 equiv.) was dissolved in CH2Cl2 (1 mL) and cooled to 0 0C. O.xalyl chloride (52 μL, 8.0 equiv.) and DMF (8 μL) were added. After 30 min at 0 °C, the cold bath was removed and the reaction stirred at rt for 1.75 h. The solvent was evaporated and the unpurified acid chloride placed on the vacuum pump for 20 min, then dissolved in THF (0.7 mL). Carbamate 2.53 (18 mg, 0.073 mmol) was dissolved in THF (0.7 mL), cooled to -78°C, and /7-BuLi (36 μL, 2.2 M in hexanes, 1.1 equiv.) added dropwise. After 20 min, the solution of acid chloride was added dropwise over 5 min. After I h at -780C. the reaction was warmed to 0 0C for 30 min then quenched with sat. NH4CI (2 mL). The reaction was extracted with CH2CI2 (3 x 3 mL) and then the combined organic layers were dried over MgSO4 and concentrated. Preparative thin layer chromatography (500 micron prep plate, 20% EtOAc/hexanes) provided (- 5 )-2.54 (9.2 mg, 23% yield). [α]D 20 -8.7 (c 1.0, CHCl3); IR (neat) 2954, 2930, 2898, 2855, 1732, 1389. 1252. 1 180, 1 151 cm'1; 1H NMR (500 MHz, CDCI3) δ 7.30-7.22 (m, 5H), 5.69 (d, J = 4.5 Hz, I H). 4.94 (ddd, J = 15.0. 15.0, 15.0 Hz, 2H), 4.74 (d, ./ = 17.5 Hz, 2H), 4.26 (ddddd, ./ = 1 1.0. 1 1 .0, 1 1.0, 8.5, 8.5 Hz. 2H), 3.49 (ddd, J= 9.5. 4.5, 2.5 Hz, I H), 3.28 (s, 3H). 3.27 (dd. J = 15.0. 9.5 Hz. I H), 2.13 (d. J = 14.5 Hz, I H), 1.69 (s, 3H). 1.02 (dd. J = 9.0, 9.0 Hz, 2H). 0.91 (s,0 9H), 0.07 (s, 3H), 0.05 (s, 12H) ; 13C NMR (125 MHz, CDCl3) δ 176.0, 154.7, 143.3, 137.8, 128.5, 128.3, 127.5, 1 12.3, 82.1 , 73.6, 66.0, 58.2, 47.8, 38.8, 28.2, 26.0, 23.1 , 18.5, 17.6, -1 .4, - 4.6, -4.8; high resolution mass spectrum (ES+) m/z 544.2894 [(M+Na)~; calcd for C27H47NO5Si2Na: 544.2891].
<.
Figure imgf000045_0001
Amide (+)-2.56. Method A. Acid (-)-2.57 (34 mg, 2 equiv.) was dissolved in CH2Cb (1 mL) and cooled to 0 0C. Oxalyl chloride (40 μL, 8.0 equiv) and DMF (8 μL) were added. After 30 min at 0 0C, the cold bath was removed and the reaction stirred at rt for 2 h. The solvent was evaporated and the unpurified acid chloride placed on the vacuum pump for 15 min, then0 dissolved in THF (0.5 mL). Carbamate 2.53 (13 mg, 0.073 mmol) was dissolved in THF (0.5 mL), cooled to -78°C, and H-BuLi (26 μL, 2.2 M in hexanes, 1.1 equiv.) added dropwise. After 20 min, the solution of acid chloride was added dropwise over 5 min. After 1 h at -78°C, the reaction was warmed to 0 0C for 30 min then quenched with sat. NH4CI (2 mL). The reaction was extracted with CH2Cl2 (3 x 3 mL) and then the combined organic layers were dried over5 MgSO4 and concentrated. Preparative thin layer chromatography (500 micron prep plate, 20% EtOAc/hexanes) provided (+)-2.56 (26 mg, 85% yield). Method B. Acid (-)-2.57 (30 mg, I equiv.) was dissolved in CH2Cl2 (1 mL) and cooled to 0 0C and /-Pr2NEt (19 μL, 1 .1 equiv.) was added followed by trimethylacetyl chloride (13 μL, 1.05 equiv.) After 45 min at 0 0C, sat. NH4CI (2 mL) was added followed by enough H2O to dissolve any solids. The layers were0 separated and the aqueous layer extracted with CH2CI2 (3 x 3 mL). The combined organic layers were then dried over MgSO.? and concentrated. The unpurified mixed anhydride was azeotroped with benzene (2 x 3 mL), placed on the vacuum pump for 30 min, and then dissolved in THF (0.5 mL). Carbamate 2.53 (25 mg. 0.10 mmol) was dissolved in THF (0.5 mL), cooled to -78°C. and «-BuLi (45 μL, 2.2 M in hexanes, 1.1 equiv.) added dropwise. After 20 min, the solution of acid chloride was added dropwise over 5 min. After 1 h at -78°C, the reaction was warmed to 0 0C for 30 min then quenched with sat. NH4CI (2 mL). The reaction was extracted with CH2Cb (3 x 3 mL) and then the combined organic layers were dried over MgSO4 and concentrated. Preparative thin layer chromatography (500 micron prep plate, 20% EtOAc/hexanes) provided (+)-2.56 (38 mg, 70% yield). [α]D 20 +16.8 (c 1.0, CHCI3); TR (neat) 2953, 2898, 1735, 1707, 1388, 1250, 1 1 89, 1 1 14.. 1064, 1036 cm"1: 1H NMR (500 MHz, CDCI3) δ 7.30-7.22 (m, 5H), 5.63 (d. J = 5.0 Hz, I H), 4.95 (dd, J = 90.5, 14.5 Hz, 2H) 4.75 (d, J= 16.5 Hz, 2H), 4.73 (dd, J = 28.5, 7.5 Hz, 2H), 4.26 (dd, ./ = 9.0, 9.0 Hz, 2H), 3.67-3.55 (m, 3H), 3.32 (s, 3H), 2.36 (dd, ./ = 14.5, 9.0 Hz, I H), 2.19 (d, ./= 13.0 Hz, I H), 1.71 (s, 3H), 1 .03-0.99 (m, 2H), 0.90-0.77 (m, 2H), 0.04 (s, 9H), 0.00 (s, 9H); 13C NMR (125 MHz, CDCl3) δ 174.9, 154.4, 143.0, 137.8. 128.5, 128.1 , 127.5, 1 12.6, 95.2, 80.6, 77.6, 66.1. 65.9, 58.2, 47.6, 39.0, 23.0, 18.3, 17.6, -1 .2, -1.4; high resolution mass spectrum (ES+) m/z 560.2856 [(M+Na)'; calcd for C27H47NOnSMNa: 560.2840].
Figure imgf000046_0001
SEM ether (-)-S2.7. A solution of (+)-2.16 (0.221 g, 0.905 mmol) in CH2CI2 (3 mL) was cooled to 0 0C and /-Pr2NEt (0.395 mL, 2.5 equiv.) was added, followed by dropwise addition of SEMCI (0.320 mL, 2.0 equiv.). The reaction was allowed to warm to rt and after 2 Ii , sat. NH4Cl was added. The reaction was extracted with CH2Cl2 (3 x 10 mL) and the combined organic layers were dried over MgSO4 and concentrated. Flash chromatography (5% EtOAc/hexanes) provided (-)-S2.7 (338 mg, 99% yield). [α]2 D° -6.3 (c 2.9. CHCI3); IR (neat) 3457, 2925, 1 728, 1480, 1283, 1249, 1 159, 1 107, 1031 cm'1; 1H NMR (500 MHz, CDCI3) δ 4.81 (s, I H), 4.78 (s, I H), 4.74 (dd, ./ = 14.7, 6.9 Hz, 2H), 4.29 (dd, J= 1 1.8, 3.9 Hz, I H), 4.1 1 (dd, J = 1 1 .8, 6.2 Hz, I H), 3.84-3.79 (m, I H), 3.68 (ddd, J = 10.1 , 6.3, 6.3 Hz, I H), 3.59 (ddd, J = 10.0, 6.5, 6.5 Hz, 1 H), 3.51 -3.46 (m, 1 H), 3.39 (s, 3H), 2.32-2.19 (m, 2H), 1.77 (s, 3H), 1.19 (s, 9H) 0.99-0.82 (m, 2H), 0.00 (s, 9H); 13C NMR (125 MHz, CDCl3) δ 178.4, 142.7, 1 13.0, 95.0, 80.3, 76.8, 65.6, 64.0, 58.6, 39.4. 39.0. 27.4, 23.0, 18.2, -1.2; high resolution mass spectrum (ES+) m/z 397.2372 [(M+Na)" ; calcd for C9H38O5SiNa: 397.2387].
Figure imgf000047_0001
Alcohol (+)-2.58. A solution of (-)-S2.7 (0.339g, 0.905 mmol) in CH2Cl2 (4.5 mL) was cooled to -78 °C and DlBAL-H (2.0 mL. I M in toluene. 2.2 equiv.) was added dropwise. After 5 min, the reaction was quenched with MeOH (0.5 mL). The reaction was allowed to warm to rt before EtOAc (5 mL) and sat. Rochelle's salt (5 mL) were added. After 1 h, the organic layer transitioned from cloudy to clear. The layers were separated and the aqueous layer extracted with EtOAc (3 x 10 mL). The combined organic layers were dried over MgSO4 and concentrated. Flash chromatography (10% EtOAc/hexanes) provided (+)-2.58 (0.249 g, 95% yield). [α]2 D° +31.7 (c 1.2, CHCI3); IR (neat) 3457, 2952, 2925, 2892. 1650, 1457, 1378. 1249, 1 102, 1054. 1025 cm'1; 1H NMR (500 MHz, CDCl3) δ 4.82 (s, I H), 4.78 (s. 1 H), 4.76 (dd, ./ = 58.6. 7.0 Hz, 2H), 3.79-3.68 (m. 3H), 3.65-3.56 (m, 2H). 3.49 (ddd, J = 7.6, 4.8. 4.8 Hz, I H), 3.41 (s, 3H), 3.21 (dd, J = 8.3, 4.2 Hz, I H), 2.31 (dd, J = 14.4, 7.6 Hz, I H), 2.21 (dd, J = 14.4, 5.3 Hz, I H), 1.77 (s. 3H), 0.99-0.92 (m. 2H), 0.02 (s, 9H): 13C NMR (125 MHz, CDCI3) δ 142.6, 1 13.2. 95.6, 82.6, 81.0, 66.0, 62.7, 58.6, 39.5, 23.0. 18.3. -1.3: high resolution mass spectrum (ES+) m/z 313.1821 [(M+Na)': calcd for C14H30O4SiNa: 313.181 1 ].
Figure imgf000047_0002
Aldehyde (-)-S2.8. A solution of (+)-2.58 (0.1 17 g, 0.404 mmol) in DMSO (0.29 mL, 10 equiv.) and CH2Cl2 (4 mL) was cooled to 0 0C and /-Pr2NEt (0.212 mL, 3 equiv.) was added followed by SO3«pyι idine (0.193 g, 3 equiv.) in one portion. After 5 min, brine (10 mL) and H2O (2 mL) were added and the reaction was warmed to rt. The layers were separated and the aqueous layer was extracted CH2Cl2 (3 x 10 mL). The combined organic layers were dried over MgSO4 and concentrated. Flash chromatography (5% EtOAc/hexanes) provided (-)-S2.8 (0.1 13 g, 97%) as a colorless oil. [α]2 D° -9.1 (c 0.9, CHCl3): IR (neat) 2952. 2892. 2825. 1732, 1450, 1376, 1249. 1 108, 1060, 1029 cm'1; 1H NMR (500 MHz, CDCl3) δ 9.66 (d, J= 1.4 Hz, I H), 4.85 (s. I H). 4.84 (s, I H), 4.80 (dd, J = 19.4, 6.9 Hz. 2H). 4.1 I (dd, J = 2.8, 1 .5 Hz, I H), 3.75-3.69 (m. 2H). 3.65 (ddd, J = 9.8, 9.8, 6.9 Hz, IH), 3.41 (s, 3H), 2.33 (dddd, J = 14.1 , 14.1 , 14.1. 6.9 Hz, 2H), 1 .72 (s, 3H), 0.92 (ddd. J = 10.1 , 6.6, 3.3 Hz, 2H), 0.02 (s, 9H); 13C NMR ( 1 25 MHz, CDCl3) δ 202.4, 141.7, 1 14.4, 96.3, 82.5, 81.8, 66.1 , 58.1, 38.9, 22.8, 18.2, 1.2; high resolution mass spectrum (ES+) m/z 31 1.1666 [(MH-Na)+: calcd for Ci4H28O4SiNa: 31 1.1655].
Figure imgf000048_0001
5 Acid H-2.57. Aldehyde (-)-S2.8 (0.203 g, 0.704 mmol) was dissolved in /-BuOH (7.5 mL) and H2O (7.5 mL). The solution was cooled to 0 °C followed by addition of 2-methyl-2-butene (6 mL), NaH2PO4.H2O (0.550 g, 5 equiv.), and NaClO2 (0.483 g, 80 wt%, 5 equiv.). After i 5 min, the reaction was poured onto sat. NH4CI ( I O mL) and extracted thoroughly with EtOAc. The combined organic layers were dried over MgSO4 and concentrated. Flash chromatography (25%
I O EtOAc/hexanes to 40% EtOAc/hexanes) provided (-)-2.57 (0.196 g, 92% yield) as a colorless oil. [α]]° -1 8.6 (c 1.1 , CHCl3); IR (neat) 2953, 2925, 1725, 1649, 1376, 1252, 1 1 10, 1060, 1030 cm-1; 1H NMR (500 MHz. CDCl3) δ 4.83 (s, I H), 4.81 (s, I H), 4.78 (s. 2H). 4.39 (d, J = 3.1 Hz, 1 H), 3.75 (ddd. J = 8.2, 5.2, 3.2 Hz. I H), 3.68 (dd, J = 8.5, 8.5 Hz. 2H), 3.43 (s, 3H), 2.39 (dd. J = 14.6, 8.0 Hz. I H), 2.28 (dd, J = 14.6, 5.2 Hz, I H). 1.76 (s, 3H), 0.96-0.87 (m, 2H). 0.01 (s.
15 9H); 13C NMR (125 MHz, CDCI3) δ 175.0, 141.9, 1 13.5, 95.1 , 81 .0, 76.2, 66.3, 58.3, 38.7, 22.9, 18.2, -1 .3; high resolution mass spectrum (ES+) m/z 327.1614 [(M+Na)"; calcd for Ci4H28O5SiNa: 327.1604].
Figure imgf000048_0002
0 Aminal (+)-2.60. To a solution of ester (+)-2.40 (77.2 mg, 0.152 mmol) in MeOH (3 mL) was added H2O (55 μL, 20 equiv.) followed by LiOH (73 mg, 20 equiv.). After stirring for 6 h at rt. the reaction was acidified to pH 3 with I M aq. NaHSO4. The reaction was extracted with EtOAc (5 x 10 mL) and the combined organic layers were then dried over MgSO4 and concentrated to afford acid 2.59 (71 mg, 95% yield). The unpurified acid was dissolved in 5 acetone (7.2 mL) and cooled to 0 0C followed by addition Of Z-Pr2NEt (61 μL, 2.4 equiv.) and isobutylchloroformate (41 μL, 2.2 equiv.). After 1 h. NaN3 (47 mg, 5 equiv.) was dissolved in H?O (0.9 mL) and added to the mixed anhydride. After 5 min, the reaction was diluted with H^O (5 mL) and extracted with EtOAc (3 x 5 mL). The combine organic layers were dried over MgSO4 and concentrated. The acyl azide was then dissolve in toluene (7.2 mL), the flask sealed, and heated to 80 0C. After 1 h, the flask was cooled slightly and 2-trimethylsilyl ethanol (0.41 mL, 20 equiv.) was added and the flask heated back to 80 0C. After 3 h, the reaction was cooled to it and the solvent evaporated. Flash chromatography (5% EtOAc/hexanes) provided (+)-2.60 (53.5 mg, 61% yield, 2 steps) as a light yellow oil. [αpn° +22.6 (c 1.0, CHCl3); IR (neat) 2955,
2930, 2850, 1 724, 1500, 1251 , 1 125, 1066 cm"1: 1H NMR (500 MHz, CDCI3) δ 7.40-7.21 (m. 5H), 5.42 (d. J = 8.9 Hz, I H). 4 86 (dd. J = 8.2, 2.9 Hz, I H), 4.59-4.43 (m. 2H). 4.22-4.06 (m, 2H), 3.82 (ddd, J = 8.4, 4.3, 4.3 Hz, IH), 3.61-3.56 (m, 2H), 3.55-3.49 (m, IH), 3.38 (s, 3H), 2.13 (dd, J = 12.6, 12.6 Hz, IH), 1.85 (ddd, J = 13.4. 8.2, 3.4 Hz, I H), 1.64-1.49 (m. 4H), 1.01 - 0.95 (m, 2H) 0.97 (s. 3H), 0.91 (s, 9H), 0.91 (dd, J= 7.2, 7.2 Hz, 3H), 0.85 (s, 3H). 0.05 (s, 3H), 0.05 (s, 3H), 0.02 (s, 9H): 13C NMR (125 MHz, CD3OD) δ 159.5, 140.6, 129.4. 129.3, 128.7, 84.4, 80.1. 78.5. 74.5, 72.9, 64.3, 56.0, 39.4, 35.3, 32.2, 28.5, 26.5. 25.6. 19.1 , 18.8, 1 7.6, 10.0. - 1 .4, -4.0, -4.7; high resolution mass spectrum (ES+) mJz 632.3806 [(M+Na)": calcd for C33HSgNO6Si2Na: 632.37791.
Figure imgf000049_0001
OBn
Protected amide (-)-2.62. Acid (-)-2.57 (47 mg. 2 equiv.) was dissolved in CH2Cl2 (4.8 mL) and cooled to 0 0C and /-Pr2NEt (29 μL, 1.1 cquiv.) was added followed by trimethylacetyl chloride (20 μL, 1.05 equiv.) After 45 min at 0 0C, sat. NH4Cl (3 mL) was added followed by enough H2O to dissolve any solids. The layers were separated and the aqueous layer extracted with CH2CI2 (2 x 5 mL). The combined organic layers were then dried over MgSO4 and concentrated. The unpurified mixed anhydride was azeotroped with benzene (2 x 3 mL), placed on the vacuum pump for 30 min, and then dissolved in THF (0.6 mL). A solution of (+)-2.60 in THF (0.6 mL) was cooled to -78 0C and LiHMDS (67 μL, 1.07 M in THF 1.1 equiv.) was added dropwise over 1 min. After stirring for 30 min at -78 °C, the mixed anhydride solution was added dropwise over 5 min. After 1.5 h at -78 0C, the reaction was warmed to --40 0C over 1 h and stirred for 1.5 h. The reaction was quenched with sat. NH4CI (2 mL), warmed to rt, and then diluted with CH2Ch (5 mL). The layers were separated and the aqueous layer extracted with CH2Cb (3 x I O mL). The combined organic layers were then dried over MgSO4 and concentrated. Flash chromatography (5% EtOAc/hexanes) provided (-)-2.62 (33.4 mg, 57% yield) along with recovered starting material (6.6 mg, 21 % yield). [α]2 D° -3.0 (c 0.5, CHCl3): IR (neat) 2954, 2931 , 2858, 1732, 1456, 1382, 1250, 1096, 1064 cπT1; 1H NMR (SOO MHz, CDCI3) δ 7.38-7.20 (m, 5H), 5.55 (d, J= 6.0 Hz, I H), 5.36 (d, J = 4.1 Hz, IH), 4.76 (s, 2H), 4.74 (s, 2H), 4.56-4.49 (m, 2H), 4.39 (d, J = 5.0 Hz, IH), 4.31-4.24 (m, 2H), 3.74-3.58 (m, 3H), 3.56 (dd, ./ = 7.6, 3.8 Hz, IH), 3.50 (d, J = 10.4 Hz, IH), 3.50-3.45 (m, I H), 3.34 (s, 3H), 3.32 (s, 3H), 2.33 (dd, J = 15.1, 9.4 Hz, IH), 2.24 (d, J= 14.4 Hz, IH), 1.87 (ddd, J= 13.5, 5.4, 4.1 Hz, I H), 1.80- 1.73 (m, I H). 1.72 (s, 3H). 1.64 (dd, ./ = 14.3, 9.2 Hz, I H), 1.61 -1.51 (m, 3H), 1 .12-1.03 (m, 2H), 0.93 (s. 3H), 0.91 (s, 9H), 0.93-0.87 (m, 5H), 0.84 (s, 3H), 0.06 (s, 3H), 0.05 (s, 3H), 0.04 (s. 9H). -0.01 (s, 9H); 13C NMR ( 125 MHz, CDCI3) δ 1 75.2, 154.7. 143.1. 139.9, 128.4, 127.7, 127.3, 1 12.4, 95.1 , 81.0, 78.0, 77.3, 77.1. 73.4, 71.0, 69.5, 66.1 , 66.0, 58.0, 57.2, 38.5, 38.2, 34.3, 32.1 , 27.1 , 26.1, 26.0, 25.3, 23.2, 18.3, 18.2, 17.8, 17.7, 9.2, -1.2, -1.4, -4.1, -4.8; high resolution mass spectrum (ES+) m/z 918.5375 [(M+Na)~; calcd for C46H85NOu1Si3Na: 918.5379].
Figure imgf000050_0001
Amide (+)-2.63. A solution Of MgBr2 (0.131 g, 20 equiv.) in MeNO2 (77 μL, 40 equiv.) and Et2O (0.36 mL) was added to neat (-)-2.62 (32.1 mg, 0.036 mmol). The flask was flushed with argon and sealed to prevent solvent evaporation. After 7 h, the reaction was quenched with H2O ( I mL) and extracted with Et2O (3 x 3 mL). The combined organic layers were then dried over MgSO4 and concentrated. Flash chromatography (20% EtOAc/hexanes to 40% EtOAc/hexanes to 60% EtOAc/hexanes) provided (+)-2.63 ( 1 5.3 mg. 69% yield) as a colorless oil. [α]: D n +12.6 (c- 0.5, CHCl3); IR (neat) 3398, 2391 , 2864, 1667, 151 1 , 1460, 1362, 1254, 1090 cm"1 ; 1 H NMR (500 MHz, CDCl3) δ 7.40-7.27 (m, 5H), 5.17 (dd, J= 9.1 , 6.6 Hz, IH), 4.80 (s, 1 H), 4.76 (s, 1 H), 4.41 (dd, J= 30.3, 10.8 Hz, 2H), 3.96 (s, IH), 3.82 (dd, J= 1 1.2, 5.5 Hz, I H), 3.76-3.69 (m, I H), 3.62 (ddd,./= 8.1, 3.7, 3.7 Hz, 2H), 3.50 (s, IH), 3.52-3.42 (m, IH), 3.39 (s, 3H), 3.30 (s, 3H), 2.31 (dd,J= 14.6,9.4Hz, IH), 2.12 (dd, J = 14.6.3.0Hz, IH), 1.90 (dd, J = 12.2, 12.2Hz, IH), 1.83 (ddd, J= 13.6, 5.3, 4.2 Hz.. IH), 1.73 (s, 3H), 1.72-1.62 (m, 3H), 1.55-1.43 (m, IH), 0.95 (dd, J= 7.4, 7.4 Hz, 3H), 0.95 (s, 3H), 0.91 (s, 9H), 0.86 (s, 3H), 0.07 (s, 3H), 0.07 (s, 3H); 13C NMR (125 MHz, C6D6) δ 172.9, 142.0, 140.1, 128.9, 128.6, 127.9, 113.5, 81.8, 81.1, 81.1, 77.8, 77.1 , 73.9, 72.6, 70.5, 69.9, 57.4, 56.8, 38.6, 38.0, 33.6, 32.0, 27.4, 26.3, 25.4, 23.3, 18.5, 10.3. - 4.1, —4.6; high resolution mass spectrum (ES+) m/z 644.3951 [(M+Na) ; calcd for C34H59NO7SiNa: 644.3959].
Figure imgf000051_0001
Aminal (-)-2.64. To a solution of (+)-2.63 (8 mg.0.013 mmol) in DMF (0.12 mL) was added
TASF (36 mg, 10 equiv.) in one portion. The reaction was heated to 600C and after 8 h, sat. NaHCO^ (0.5 mL) and H2O (0.5 mL) were added. The reaction was extracted with EtOAc (5 x 1 mL). The combined organic layers were then dried over MgSO4 and concentrated. Flash chromatography (40% EtOAc/hexanes to 60% EtOAc/hexanes) provided (-)-2.64 (6.4 mg.98% yield) as an amorphous white solid. [α]2 D°-14.l (c 0.5, CHCl3); IR (neat) 3397, 2963, 2932. 2873, 1666, 1513, 1452, 1378, 1096, 1073 cm"1; 1H NMR (500 MHz, CDCl3) δ 7.38-7.24 (m, 5H), 5.25 (dd, J= 9.1, 7.6 Hz, IH), 4.79 (s, IH), 4.75 (s, IH), 4.37 (dd, J= 37.3, 10.6 Hz, 2H), 3.87-3.80 (m, 2H), 3.79-3.73 (m, IH), 3.72-3.70 (m, 2H), 3.58 (ddd, J = 9.4, 3.3, 3.3 Hz, IH), 3.38 (s, 3H), 3.40-3.36 (m, IH), 3.26 (s, 3H), 2.30 (dd, J= 14.6, 9.4Hz, IH), 2.10 (dd, J= 14.6. 3.1 Hz, IH), 1.95 (ddd, J= 13.5, 3.9, 3.9 Hz, IH), 1.79 (ddd, J= 13.6, 10.1, 5.6 Hz, IH), 1.76- 1.73 (m, IH), 1.72 (s, 3H), 1.71-1.64 (m, 2H), 1.54-1.45 (m, 2H), 0.98 (s, 3H), 0.97 (dd,J= 7.4, 7.4 Hz, 3H), 0.89 (s, 3H); 13C NMR (125 MHz, CDCI3) δ 173.3, 142.5, 138.4, 128.8, 128.6, 128.0, 113.0, 80.8.79.8, 76.8, 75.6, 72.4, 72.1, 71.4, 67.3, 57.6, 57.1, 38.4, 37.4, 32.5, 30.7, 26.6, 23.8, 22.9, 14.4, 10.4; high resolution mass spectrum (ES+) m/z 530.3106 [(M+Na)1; calcd for C28H45NO7Na: 530.3094].
Figure imgf000052_0001
N-acyl Aminal (+)-2.65. To a solution of (-)-2.64 (3.4 mg, 6.7 μmol) in THF (0.2 mL) cooled to -78 0C was added Lithium di-tert-butylbi phenyl (LiDBB) until the solution maintained a dark blue color. The reaction was stirred for 1.5 h and then quenched with sat. NaHCCb (1 rnL) and extracted with EtOAc (5 x 1 mL). The combined organic layers were then dried over MgSO4 and concentrated. Flash chromatography (60% EtOAc/hexanes) provided (+)-2.65 (2.7 mg, 97% yield) as a white, amorphous solid. [α]2 D° +12.4 (c 0.3, CHCl3); IR (neat) 3389, 2925, 1660, 1519, 1455, 1377.. 1 1 16, 1071 cm"1; 1H NMR (500 MHz, CDCI3) δ 7.08 (d, J= 9.6 Hz, I H), 5.40 (dd, J = 9.4, 9.4 Hz, I H), 4.85 (s, I H), 4.82 (s, I H), 4.41 (dd, J= 2.9, 2.9 Hz, I H), 3.81 -3.72 (m, 2H), 3.65 (ddd, J = 1 1.0, 4.9, 4.9 Hz, I H), 3.59-3.51 (m, I H), 3.45 (s, 3H), 3.48-3.42 (m,- 1 H), 3.39 (s, 3H), 3.04 (d, J= 6.0 Hz, I H), 2.36 (dd, J= 14.5, 9.1 Hz, I H), 2.20 (dd, J= 14.6, 3.8 Hz. I H), 2.06 (ddd, J = 13.3, 4.4, 1.1 Hz, IH), 1.85-1.79 (m, IH), 1.78 (s, 3H), 1.49-1.38 (m, 4H), 0.94 (s, 3H), 0.93 (dd, J = 7.4 Hz, 3H), 0.86 (s, 3H); 13C NMR (125 MHz, CDCI3) δ 1 73.7, 142.2, 1 13.4, 80.6, 78.9, 75.5, 73.8, 72.3, 72.2, 69.6, 57.9, 56.7, 38.7, 37.5, 36.6.. 30.4, 30.0, 29.6, 22.9, 12.7, 10.7; high resolution mass spectrum (ES+) m/∑ 440.2623 [(M+Naf; calcd for C2IH39NO7Na: 440.2625].
Figure imgf000052_0002
Ester H-2.66. Acid (-)-2.57 (98 mg, 0.318 mmol) was dissolved in MeOH ( 1.6 mL) and CH2CI: (1.6 mL) and cooled to 0 0C. TMSCHN: (ca. X.XX mL, X.X M in Et:O) was then added dropwise until all gas evolution had ceased and the solution turned light yellow. Argon was bubbled through the reaction for 10 min and then the reaction concentrated. Flash chromatography (5% EtOAc/hexanes) provided (-)-2.66 (92 mg, 90% yield) as a colorless oil. [α]D 2° - 28.4 (c 1 , CHCl3); rR (neat) 2952, 2898, 1754, 1437, 1250, 1 198, 1 1 13, 1062, 1038 cm" '; 1H NMR (500 MHz, CDCl3) δ 4.80 (d, J= 18.0 Hz, 2H), 4.73 (d, J= 1.5 Hz, 2H). 4.31 (d. J = 4.0 Hz, I H), 3.74 (s, 3H), 3.68-3.61 (m, 3H), 3.39 (s, 3H), 2.35 (dd, J= 14.5, 8.0 Hz, I H), 2.27 (dd, J= 14.5, 5.0 Hz, I H), 1.75 (s, 3H), 0.89 (dd, J= 10.0, 7.5 Hz, 2H), 0.00 (s, 9H); 13C NMR (125 MHz, CDCI3) δ 171.6, 142.3, 1 13.2, 94.8, 80.9, 76.2, 66.0, 58.3, 52.1 , 38.9, 23.0, 18.2, - 1.3; high resolution mass spectrum (ES+) m/z 341.1760 [(M+Na)+: calcd for Ci5H30O5SiNa: 341.1760].
Figure imgf000053_0001
Bis-SEM Ether 2.69. A solution of homophthalate 2.6 (0.305 g, 1.20 mmol) in THF (6 itiL) was cooled to 0 0C and NaH (0.106 g, 60 wt%, 2.2 equiv.) was added. After 5 min, SEMCl (0.53 mL, 2.5 equiv.) was added dropwise. The reaction was allowed to warm to it, and after 30 min the reaction was quenched with slow addition of MeOH (0.5 mL). Sat. NaHCO3 (5 mL)was added and the reaction was extracted with CH2CI2 (3 x 10 mL). The combined organic layers were then dried over MgSO4 and concentrated. Flash chromatography (10% EtOAc/hexanes) provided 2.69 (0.61 1 g, 99% yield) as a colorless oil. IR (neat) 2952, 2898, 1736. 1597, 1314, 1266, 1250, 1 158, 1067 cm"1; 1H NMR (500 MHz, CDCI3) δ 6.94 (s, I H), 5.22 (s, 2H). 5.1 7 (s, 2H), 3.85 (s, 3H), 3.77-3.69 (m, 4H), 3.67 (s, 5H), 2.12 (s, 3H), 0.98-0.91 (m, 4H), 0.00 (s, 9H), 0.00 (s, 9IT); 13C NMR (125 MHz, CDCI3) δ 171.1 , 168.6, 157.4, 153.8, 132.3, 120.7, 1 19.0, 101.9, 94.0, 93.4, 66.5, 66.5, 52.2, 52.2, 36.3, 18.3, 18.2, 1 1.7, -1.2; high resolution mass spectrum (ES+) m/z 537.2303 [(M+Na)+; calcd for C24H42O8Si2Na: 537.2316].
Figure imgf000053_0002
Aryl Acid S2.9. Diester 2.69 (0.421 g, 0.818 mmol) was dissolved in CH2CI2 (4 mL) and MeOH (4 mL) then cooled to 0 0C. Solid KOH (0.918 g, 20 equiv.) was added and the reaction warmed to rt. After stirring for 3 h at rt, the reaction was acidified to pH 3 with a 1 M NaHSO4 solution. The reaction was extracted with EtOAc (3 x 10 mL) and the combined organic layers were dried over MgSO4 and concentrated. Flash chromatography (25% EtOAc. hexanes to 40% EtOAc/hexanes) provided acid S2.9 (0.408 g, 99% yield) as a white foam. TR (neat) 2952. 2898, 1729, 1597, 1477, 1268, 1250, 1 158, 1065 cm"'; 1H NMR (500 MHz, CDCl3) δ 6.96 (s, I H), 5.23 (s, 2H), 5.18 (s, 2H), 3.90 (s, 3H), 3.74 (dd, J= 8.5, 8.5 Hz, 4H), 3.67 (s, 2H), 2.17 (s, 3H), 0.95 (dd, J= 8.5, 8.5 Hz, 4H), 0.00 (s, 18H); 13C NMR (125 MHz, CDCl3) δ 173.9, 170.1 , 158.0, 154.3, 132.1 , 121.2, 1 1 8.0, 102.0, 93.9, 93.3, 66.6, 66.6, 52.8, 37.3, 18.3, 18.2, 1 1.7, -1.2; high resolution mass spectrum (ES+) m/z 523.2160 [(M+Na)+; calcd for C23H40O8Si2Na: 523.2159].
Figure imgf000054_0001
Aryl Alcohol S2.10. Acid S2.9 (0.225 g, 0.45 mmol) was dissolved in THF (4.5 mL) and cooled to 0 0C. To this solution was added BH3.SMe2 (0.1 12 mL, 1 M solution in THF, 2.5 equiv.) dropwise over 2 min. The ice bath was removed and the reaction stirred at rt. After 2 h, the reaction was quenched with MeOH (1 mL) and diluted with brine (4 mL) and water (4 mL). The reaction was extracted with CH2CI2 (3 x 10 mL) and the combined organic layers were then dried over MgSO4 and concentrated. Flash chromatography (10% EtOAc/hexanes) provided alcohol S2.10 (0.1 18 g, 86% yield) as a colorless oil. IR (neat) 2952, 2897, 1725, 1 594, 1272, 1248, 1 1 1 1 , 1072, 1054 cm'1; 1H NMR (500 MHz, CDCl3) δ 6.89 (s, I H), 5.22 (s, 2H), 5.1 7 (s, 2H), 3.89 (s, 3H), 3.80 (ddd, J = 6.5, 6.5, 6.5 Hz, 2H), 3.77-3.71 (m, 4H), 2.86 (dd, J = 6.7, 6.7 Hz, 2H), 2.34 (dd, J = 5.6. 5.6 Hz, IH), 2.15 (s, 3H), 0.99-0.87 (m, 4H), 0.01 (s, 9H), 0.00 (s, 9H); 13C NMR (125 MHz, CDCI3) δ 170.2, 157.6, 153.4, 136.1 , 1 19.9, 1 19.4, 101.1 , 93.8. 93.4, 66.5, 66.5, 62.2, 52.6, 34.5, 1 8.3, 18.2, I 1.5, -1.2; high resolution mass spectrum (ES+) m/z 509.2361 [(M+Na)+; calcd for C23H42O7Si2Na: 509.23671.
Figure imgf000054_0002
Aldehyde 2.70. Procedure A: Alcohol S2.10 (0.129 g, 0.265 mmol) was dissolved in CH2CI2
(2.7 mL) and DMSO (0.21 mL, 10 equiv.) and cooled to 0 °C. Next, /-Pr2NEt (0.139 mL, 3 equiv.) was added followed by SO3^pyridine (0.127 g, 3 equiv.). After 30 min at 0 °C, the reaction was diluted with H2O (2 mL) and brine (5 mL) followed be extraction with CH2Cl2 (3 x 10 mL). The combined organic layers were then dried over MgSO4 and concentrated. Flash chromatography (10% EtOAc/hexanes) provided aldehyde 2.70 (0.1 13 g, 88% yield) as a light yellow oil. Procedure B: A solution of 2.69 (0.104 g, 0.202 mmol) in CH2CI2 (2.0 mL) was cooled to -78 0C and DlBAL-H (0.22 mL, 1 M solution in toluene, 1.1 equiv.) was added dropwise over 15 min. After 5 min, the reaction was quenched with MeOH. The reaction was allowed to warm to it before EtOAc (5 mL) and sat. Rochelle's salt (5 mL) were added. After 1 h, the organic layer transitioned from cloudy to clear. The layers were separated and the aqueous layer extracted with 3 x 20 mL EtOAc. The combined organic layers were dried over MgSO^ and concentrated. Flash chromatography (10% EtOAc/hexanes) provided 2.70 (0.64 g. 66% yield) as a light yellow oil. TR (neat) 2953, 2901 , 1726, 1595, 1477. 1272, 1251 , 1 157, 1 1 10, 1065 cm"1: 1H NMR (500 MHz, CDCI3) 9.62 (dd, ./ = 1.8. 1.8 Hz, I H), 6.97 (s, I H), 5.24 (s, 2H), 5.19 (s. 2H), 3.85 (s. 3H), 3.79-3.71 (m. 4H), 3.64 (d, ./ = 1.8 Hz. 2H), 2.08 (s. 3H), 0.99-0.91 (m, 4H), 0.00 (s. 9H), 0.00 (s, 9H); 13C NMR (125 MHz, CDCI3) δ 198.7, 168.7. 157.7, 154.0, 130.5, 120.8, 1 19.3, 102.1 , 93.9, 93.4, 66.6, 66.6, 52.3, 46.1 , 1 8.3, 18.2, 1 1 .9, -1.2; high resolution mass spectrum (ES+) m/z 507.2210 [(M+Na)"1 ; calcd for C23H40O7Si2Na: 507.221 1 ].
Figure imgf000055_0001
β-Hydroxy ketone (+)-2.71. A solution of ketone (+)-2.5 (0.140 g, 0.336 mmol) in CH2CI2 (3.4 mL) was cooled to -78 0C and Cl2BPh (52 μL, 1.2 equiv.) was added. After stirring for 20 min. /-Pr2NEt (88 μL, 1.5 equiv.) was added dropwise. The reaction was stirred for 1 h at -78 0C. warmed to 0 0C over 10 min, then stirred for 1 h at 0 0C. After cooling back to -78 0C. aldehyde 2.70 (0.237g. 1.45 equiv.) was dissolved in CH2Cl2 ( 1.5 mL) and added to the boron enolate dropwise over 15 min. After 1 h at -78 0C, the reaction was quenched with a 1 : 1 mixture of MeOH/pH 7 buffer (6 mL). After warming to 0 °C, the reaction was neutralized to pH 7 with pH 8 buffer and stirred for 1 Ii at 0 0C. The layers were separated and the aqueous layer extracted with CH2Cl2 (3 x 15 mL). The combined organic layers were then dried over MgSO4 and concentrated. Flash chromatography (15% EtOAc/hexanes) provided (+)-2.71 (0.273 g, 90% yield) as a single diastereomer. [α]2 D° +30.0 (c 0.9, CHCl3); IR (neat) 3467, 2952, 2896, 1731 , 1593, 1463, 1253, 1064 Cm^ 1H NMR (SOO MHz1 CDCl3) S o-SS (S, I H), 5.21 (s, 2H), 5.15 (d, J = 2.3 Hz, 2H). 4.09 (dd, J= 1 1.1 , 5.7 Hz, I H), 4.07-4.00 (m, 2H), 3.94 (d, J = 6.1 Hz. I H), 3.87 (s. 3H), 3.78-3.70 (m, 4H), 3.72 (s, 3H), 3.64 (dd, ./= 7.8, 3.8 Hz; I H), 3.43 (d../ = 5.6 Hz, I H), 3.40 (s, 3H), 3.06 (dd, J = 16.4, 9.4 Hz, IH), 2.84 (dd, J= 14.2, 3.2 Hz, I H), 2.75-2.63 (m, I H), 2.61 -2.50 (m, 2H), 2.16 (s, 3H), 1.95 (ddd, J = 13.8, 5.8, 3.9 Hz, I H), 1.57 (ddd, J = 13.3, 7.8. 4.9 Hz, I H), 1.19 (d, J= 7.1 Hz, 3H), 0.95 (s, 3H), 0.98-0.92 (m, 4H)., 0.90 (s, 9H), 0.84 (s, 3H), 0.04 (s. 6H), 0.01 (s, 9H), 0.00 (s, 9H); 13C NMR (125 MHz, CDCl3) δ 212.5. 171 .6. 170.7, 157.8, 153.7, 136.6, 120.3, 1 19.1 , 101.1 , 93.9, 93.3, 82.4, 76.7, 73.1 , 71.6, 70.1 , 66.5, 66.5, 58.8, 53.2, 52.7, 52.2, 42.5, 38.1 , 35.9, 30.1 , 26.0, 24.9, 18.3, 18.2, 17.6, 1 1.8, 1 1.4, -1 .2, -4.3, -4.8; high resolution mass spectrum (ES+) m/z 923.4782 [(M+Na)'; calcd for C44H8nOi3Si3Na: 923.4805].
Figure imgf000056_0001
Diol (+)-S2.11. A solution (+)-2.71 (0.1 16 g, 0.129 mmol) in THF (1.4 mL) and MeOH (0.46 niL) was cooled to -78 0C and Et2BOMe (0.167 mL, 1 M in THF, 1.3 equiv.) was added dropwise. After 25 min, NaBH4 (10 mg, 2.0 equiv.) was added and the reaction was strirrβd at - 78 0C. After 1 h, the reaction was warmed to 0 °C over 10 min and then stirred for 30 min. EtOAc (2 mL) was added followed by H2O (2 mL) and a 1 : 1 solution of MeOH/30% aq. H2O2 (5 mL). After 1 h, the reaction was extracted with EtOAc (3 x 10 mL) and the combined organic layers were treated with solid Na2S2O3 to destroy any remaining peroxide. The organic layer was then filtered and washed with sat. Na2S2O3, dried over MgSO4, and concentrated. Flash chromatography (15% EtOAc/hexanes to 25% EtOAc/hexanes) provided (+)-S2.11 (0.109 g, 95% yield, dr > 20: 1 ) as a colorless oil. [α]∞ +10.3 (c 1.0, CHCl3); IR (neat) 3500, 2953, 2896, 2857, 1734, 1593, 1253, 1 157, 1 1 15, 1065 cm'1; 1H NMR (500 MHz, CDCl3) δ 6.87 (s, I H), 5.21 (s, 2H), 5.16 (s, 2H), 4.16-4.10 (m. I H), 4.02 (dd, J= 7.5, 4.9 Hz. I H), 3.97 (d, J= 7.9 Hz, I H), 3.88 (s, 3H). 3.84 (dd, J = 12.9, 7.1 Hz, I H), 3.78 (s, 3H), 3.76-3.70 (m, 4H), 3.65 (s, I H), 3.56-3.50 (m, 2H), 3.39 (s, 3H), 2.85-2.80 (m, 2H), 2.20 (s, 3H), 1.93 (ddd, J = 13.8, 4.0, 4.0 Hz, I H), 1.83 (ddd, J = 14.2, 10.3, Hz, I H), 1.72- 1.63 (m, I H), 1 .51 (d, J= 7.0 Hz, I H), 1.45 (d. J = 14.7 Hz, I H). 0.98 (d, J = 6.9, 3H), 0.96-0.92 (m, 4H), 0.90 (s, 9H), 0.88 (s, 3H). 0.85 (s, 3H), 0.04 (s. 3H), 0.04 (s, 3H), 0.01 (s, 9H), 0.00 (s, 9H); 13C NMR (125 MHz, CDCI3) δ 171.3. 169.9, 157.2, 153.1, 136.9, 120.2, 1 19.2, 100.6, 93.6, 93.1, 81.7, 80.9, 76.2, 75.5, 72.1 , 71.4, 66.2, 66.2, 58.5, 52.2, 52.2, 41 .9, 38.9, 35.8, 33.4, 29.8, 25.7, 24.0, 1 8.0, 17.9, 1 5.1 , 1 1 .7, 5.8, - 1 .5, -4.4. -5.0; high resolution mass spectrum (ES+) ιn/z 925.5000 [(M+NaV ; calcd for C44H82Oi3Si3Na: 925.4961 ].
Figure imgf000057_0001
Acid (+)-2.72. A solution of (+)-S2.11 (20.6 mg, 0.023 mmol) was dissolved in MeOH (1.1 niL) and cooled to 0 0C. Next, H2O (8 μL, 20 equiv.) was added followed by LiOH (1 1 mg, 20 equiv.). The cold bath was removed and the reaction allowed to warm to rt. After 28 h, due to bis-acid formation, the reaction was quenched by diluting with EtOAc and acidified to pH 5 with 5% aq. AcOH. Brine (2 niL) was added and the reaction extracted with EtOAc (5 x 3 mL). The combined organic layers were then dried over MgSO4 and concentrated. Flash chromatography (0.1 % AcOH in 30% EtOAc/hexanes to 0.2% AcOH in 60% EtOAc/hexanes) provided (+)-2.72 ( 17 mg, 87% yield). [α]: D° +31.4 (c 1.1. CHCI3); IR (neat) 3467, 2953. 2898, 2858, 1720. 1592, 1250, 1 107, 1065 cm"1 ; 1H NMR (500 MHz. CDCI3) δ 6.95 (s, I H), 5.30 (dd, J = 20.0, 7.0 Hz. 2H), 5.27 (s, 2H), 4.33 (ddd, J = 12.1 , 5.8, 2.5 Hz, IH), 4.23 (dd, J = 10.9, 6.6 Hz, I H), 4.15 (d, J = 7.3 Hz, I H), 3.87-3.79 (m, 3H), 3.78-3.72 (m, 2H), 3.64-3.57 (m, 2H), 3.45 (s, 3H), 3.03 (dd, J = 16.5, 2.4 Hz, I H), 2.91 (dd, J= 16.4, 12.2 Hz, I H), 2.24-2.07 (m, I H), 2.12 (s, 3H), 2.01 (dd, J = 10.6, 7.0 Hz, I H), 1.97-1.92 (m, I H), 1.66 (ddd, J = 13.7, 6.8, 4.7 Hz, I H), 1.54 (d, J = 15.0 Hz, I H). 1.08 (d, J = 7.0 Hz, 3H), 0.97 (s. 3H), 0.99-0.94 (m, 4H), 0.91 (s, 9H), 0.88 (s, 3H), 0.06 (s, 6H), 0.01 (s, 9H), 0.00 (s. 9H); 13C NMR (125 MHz, CDCl3) δ 172.3, 164.1 , 160.1 , 1 59.2, 141.9, 1 17.45, 109.0, 102.1 , 94.4, 93.1. 82.2, 81.9, 79.0, 72.7, 71.9, 69.8, 66.8, 66.8, 58.7, 41.7, 38.7, 33.0, 30.6, 29.5, 26.0, 25.0, 18.3, 18.3, 18.2, 1 1.4, 9.7, 9.7, -1.2, -1.2, -4.2, -4.8: high resolution mass spectrum (ES+) m/z 879.4569 [(M+Na)'; calcd for C42H76OuSi3Na: 879.4543].
Figure imgf000058_0001
Aminal (+)-2.73. A solution of (+)-2.72 (54 mg, 0.063 mmol) in acetone (3.2 mL) was cooled to 00C and /-Pr2NEt (24 μL, 2.2 equiv.) was added followed by dropwise addition of isobutyl chloroformate (20 μL.2.4 equiv.) After 45 min at 00C, NaN3 (21 mg, 5 equiv.)was dissolved in H2O (0.4 mL) and added to the reaction over 2 min. After 20 min, cold H2O (2 mL) was added and the reaction extracted with cold EtOAc (3 x5 mL). The combined organic layers were dried thoroughly over MgS(Xj and concentrated. The residue was azeotroped with benzene (3 x5 mL) and placed on the vacuum pump for 30 min. The unpurified acyl azide was dissolved in toluene (3.2 mL), the reaction flask fitted with a reflux condenser, and then heated to 800C. After 45 min, 2-trimethylsilyl ethanol (0.181 mL, 20 equiv.) was added through the top of the reflux condenser. After 2 h, the reaction was cooled to rt and the solvent evaporated. Flash chromatography (10% EtOAc/hexanes to 25% EtOAc/hexanes) provided (+)-2.73 (45 mg, 74% yield) as a colorless oil. [α]£ +8.4 (c 0.5, CHCl3): IR (neat) 3501, 3315, 2953, 2901, 2857.1719, 1595, 1249, 1108, 1064 cm'1; 1H NMR (500 MHz, CDCl3) δ 6.94 (s, IH), 5.37 (d, J= 10.1 Hz, IH), 5.29 (dd, .7=23.9.6.8 Hz, 2H), 5.26 (s, 2H); 4.89 (dd, ./= 10.0, 2.6Hz. IH), 4.31 (ddd,J = 11.6, 6.9.2.4 Hz, IH), 4.24-4.08 (m, 2H), 3.97 (d, ./ = 9.4 Hz, IH), 3.88-3.72 (m, 4H).3.65 (s. IH), 3.62 (d. J = 10.4 Hz. IH).3.56 (dd, J= 4.9, 3.2 Hz. IH).3.36 (s, 3H), 3.10 (dd, J= 16.4, 2.1 Hz, lH);2.82(dd. J= 16.4.11.9Hz, IH), 2.45-2.28 (m, IH), 2.12 (s, 3H).1.91-1.80 (m, J = 12.5, 8.0 Hz, 2H), 1.53-1.37 (m, 2H), 1.11 (d, J = 6.9 Hz, 3H), 1.00 (s, 3H), 0.98-0.93 (m, 6H), 0.90 (s, 9H), 0.88 (s, 3H), 0.05 (s, 3H), 0.04 (s..3H), 0.02 (s, 9H), 0.00 (s, 9H), 0.00 (s, 9H): 13C NMR (125 MHz, CDCl3) δ 163.5, 159.9, 159.1, 157.2, 141.9, 117.4. 109.4, 102.2, 94.4, 93.1, 83.8, 83.6, 79.4, 77.4, 73.0, 72.7, 68.0, 66.8, 66.7, 63.7, 55.8, 43.4, 38.1, 32.9, 31.1, 29.7, 26.1, 26.0, 18.4, 18.3, 18.2, 17.8, 11.4, 10.2, -1.1, -1.2, -1.3, -4.3, -4.8; high resolution mass spectrum (ES+) m/∑ 994.5354 [(M+Na)+; calcd for C47H89NO12Si4Na: 994.5360].
Figure imgf000059_0001
Silyl ether (+)-2.74. A solution of (+)-2.73 (19.6 mg, 0.020 mmol) in CH2Cl2 (0.2 mL) was cooled to 00C and 2,6-lutidine (9.5 μL, 4.0 equiv.) was added followed by dropwise addition of TBSOTf(IO μL.2.1 equiv.). After 45 min, CH2CI2 (1 mL) and sat. NaHCO3 (2 mL) added and the reaction allowed to warm to rt. The layers were separated and the aqueous layer extracted with CH2Cl2 (3 x 5 mL). Preparative TLC (25% EtOAc/hexanes, 500 micron plate) provided (+)-2.74 (20 mg, 91%) as a colorless oil. [α]2 D° +36.0 (c 0.8, CHCl3); IR (neat) 2954, 2928.2896, 2857, 1725, 1594, 1472, 1250, 1108, 1063 cm1; 1H NMR (500 MHz, CDCI3) δ 6.93 (s, IH), 5.45 (d, J = 9.7 Hz, IH), 5.30 (dd, J = 22.0, 6.5 Hz, 2H), 5.27 (s, 2H), 4.82 (d, J = 9.6 Hz, IH), 4.23-4.07 (m, 3H), 4.00 (d, J= 8.7 Hz, IH), 3.88-3.78 (m, 2H), 3.75 (dd, J= 8.7, 7.9 Hz.2H), 3.58 (dd, J= 3.8, 3.8 Hz. IH), 3.37 (s, 3H), 3.34 (d, J= 11.6Hz. IH), 3.09 (d, J= 15.3 Hz, IH), 2.64 (dd, J= 16.4, 12.1 Hz, IH).2.32-2.22 (m, IH), 2.12 (s, 3H), 2.03-1.92 (m. IH). 1.87-1.77 (m, IH).1.62 (dd, J= 11.6, Il 6 Hz, IH), 1.48(ddd,J = 13.7, 8.2.8.2 Hz. IH), 1.07(d,./=67 Hz, 3H).0.97 (s.3H), 0.9-0.93 (m.6H), 0.91 (s, 9H), 0.86 (s, 3H), 0.80 (s, 9H), 0.09 (s, 3H)5 0.07 (s, 3H), 0.06 (s.3H), 0.01 (s, 3H), 0.00 (s, 9H), 0.00 (s, 18H); 13C NMR (125 MHz, CDCI?) δ 163.5, 159.8, 159.1, 157.2, 141.4, 117.2, 109.5, 102.3, 94.5,93.1, 84.4, 79.9,77.7, 77.2, 73.6, 68.9, 67.8, 66.8.66.7, 63.6.56.1, 39.9, 37.6, 32.9, 31.7, 29.9.26.8, 26.2, 26.0.18.4, 18.3, 18.3. 18.2, 17.8, 11.4, 9.1, -1.1, -1.2, -1.3, -3.3. -4.2, -A.I, -4.7; high resolution mass spectrum (ES+) m/z 1108.6233 [(M+Na)+; calcd for C53H102NOi2Si5Na: 1108.6225].
Figure imgf000059_0002
Amide (+)-2.75. A solution of acid (-)-2.57 (47 mg.4 equiv.) in CH2Cl2 (1.5 mL) was cooled to 00C and /-Pr2NEt (30 μL, 1.1 equiv.) was added followed by trimethylacetyl chloride (20 μL, 1.05 equiv.) After 30 min at 00C, sat. NH4CI (3 mL) was added followed by enough H2O to dissolve any solids. The layers were separated and the aqueous layer extracted with CH2CI2 (3 x 5 mL). The combined organic layers were then dried over MgSO4 and concentrated. The unpurifϊed mixed anhydride was azeotroped with benzene (3 x 3 mL), placed on the vacuum pump for 30 min, and then dissolved in THF (0.4 mL). A solution of (+)-2.74 (41.5 mg. 0.038 mmol) in THF (0.4 mL) was cooled to -78 0C and LiHMDS (0.152 mL, 0.5M in THF, 2.0 equiv.) was added dropwise over 1 min. The solution was stirred for 30 min at -78 0C and then the solution of mixed anhydride was added dropwise over 5 min. The reaction was stirred at -78 0C for 45 min, then warmed to —60 0C and stirred for 30 min. Sat. NH4CI (2 mL) was added and the reaction allowed to warm to rt. The reaction was extracted with CH2CI2 (4 x 5 mL). The combined organic layers were then dried over MgSO4 and evaporated. Preparative chromatography (20% EtOAc/hexanes, 1000 micron plate) provided (+)-2.75 (41.2 mg, 79% yield) as a colorless oil. [α]2 D° +40.2 (c 0.4, CHCl3); IR (neat) 2953, 2896, 2857, 1726, 1591 ,
1467, 1250, 1 1 10, 1063 cm"1; 1H NMR (500 MHz, CDCI3) δ 6.92 (s, I H), 5.66 (d, J = 4.6 Hz, I H). 5.34-5.25 (m, 4H), 5.1 7 (d, J = 4.9 Hz, I H), 4.77 (d, J = 1 1.5 Hz, 2H), 4.63 (dd, ./ = 23.1. 6.6 Hz, 2H), 4.33-4.27 (m. 2H). 4.20 (ddd, ./ = 12.1 , 8.4. 2.0 Hz, 1 H), 4.12 (ddd, ./ = 10.0, 2.9, 2.9 Hz. I H), 3.90-3.78 (m, 2H), 3.78-3.73 (m, 2H), 3.65-3.59 (m, I H). 3.59-3.49 (m, 3H), 3.34 (s, 3H), 3.28 (s, 3H), 3.14 (d, J= 9.6 Hz, IH), 3.10 (dd, J = 16.5, 2.0 Hz, I H), 2.93 (dd, J= 16.4, 12.6 Hz, 1 H), 2.30 (dd, J = 14.7, 9.0 Hz, I H), 2.22 (d, J = 12.7 Hz, I H), 2.19 (s, 3H), 2.07-1.96 (m, 2H), 1 .81 (dd, J = 14.0, 10.3 Hz, IH), 1.75 (s, 3H), 1.69 (ddd. J = 13.2, 10.8, 6.5 Hz, I H), 1.61 (ddd, J= 13.6, 9.5, 3.2 Hz, 2H), 1.10 (d, J= 6.6 Hz, 3H), 1.10-1.04 (m, 2H), 1.00-0.93 (m, 4H), 0.90 (s, 12H), 0.87-0.80 (m, 2H), 0.83 (s, 3H), 0.78 (s, 9H), 0.05 (s, 15H), 0.04 (s, 3H), 0.01 (s, 9H), 0.00 (s, 9H), -0.02 (s, 3H), -0.05 (s, 9H); 13C NMR (125 MHz, CDCI3) δ 174.9. 163.7, 159.8, 1 59.1 , 154.5, 142.9, 142.1. 1 17.5, 1 13.0, 109.5, 102.2, 95.3, 94.5, 93.1. 88.5, 81.3. 80.2, 75.7, 74.9, 73.0, 69.3, 66.8, 66.8, 66.3, 66.1 , 58.3. 56.8, 40.7, 39.2. 39.1 , 35.3, 30.5, 30.0, 28.7, 26.1, 26.0, 24.2, 23.1 , 18.3, 18.3, 18.3, 18.2, 17.8, 13.6, 1 1.4, 9.1, -1.2, -1.2, -1.3, -1.4, -3.1 , - 4.0, -4.5, -4.7.; high resolution mass spectrum (ES+) m/z 1394.7849 [(M+Na)f ; calcd for C67H129NOi6Si6Na: 1394.7825].
Figure imgf000061_0001
Trciniastatin A (+)-2.1. Compound (+)-2.75 (9.8 mg, 7.1 μmol) was dissolved in DMF (0.16 mL) and TASF (30 mg, 15 equiv.) was added. The reaction was heated to 50 0C. After 48 h, the reaction was diluted with EtOAc and sat. NH4Cl (1 mL) was added followed by enough HjO (0.5 mL) to dissolve any solids. The reaction was extracted with EtOAc (4 x 2 mL). The combined organic layers were then dried over MgSO4 and evaporated. Preparative TLC (70% EtOAc/hexanes, 500 micron plate provided (+)-2.1, irciniastatin A, (1.7 mg) along with a mono- protected compound (SEM group on one of the phenolic oxygens). The mono-protected compound was dissolved in Et2O (0.3 mL) and MeNO? (20 μL) was added followed by MgBr2 (13 mg, 20 equiv.). After stirring for 15 min at rt, the reaction was diluted with EtOAc (2 mL) and sat. NaHCθ3 (1 mL) was added. The reaction was extracted with EtOAc (5 x 1 mL) and the combined organic layers were then dried over MgSO4 and concentrated. Preparative TLC (60% EtOAc/hexanes, 500 micron plate) provided an additional 1.5 mg of the natural product to give a total of 3.2 mg (74% yield, 2 steps) of (+)-2.1 (irciniastatin A). [α]2 D° +21 .0 (c 0.1 , CHCI3): IR (neat) 3366, 2965, 2928, 2853, 1654, 1515, 1459, 1381, 1254, 1 173. 1 107, 1067 cm'1; 1 H NMR (500 MHz, CD3OD) δ 6.25 (s, IH), 5.38 (d, J = 8.2 Hz, I H), 4.74 (s, I H), 4.72 (s, I H), 4.49 (ddd. J = 12.2. 5.9, 3.1 Hz, IH), 4.35 (d. J = 2.6 Hz. I H), 3.97-3.92 (m, 2H). 3.67 (ddd, ./ = 9.3, 3.4, 2.7 Hz, 1 H), 3.59 (dd, ./ = 10.9, 4.5 Hz, 1 H), 3.50 (dd, J = 10.1 , 1.3 Hz, 1 H), 3.35 (s, 3H), 3.21 (s, 3H). 3.13 (dd, J= 16.7, 3.1 Hz, I H), 2.86 (dd, J= 16.7, 12.2 Hz, I H), 2.35 (dd, J= 14.6, 9.3 Hz, I H), 2.1 1 (dd, J = 14.1 , 3.6 Hz, 2H), 2.10 (s, 3H), 2.02 (ddd, J = 13.6, 4.3, 2.8 Hz. I H), 1.91 (ddddd, J = 6.9, 6.9, 6.9, 6.9, 2.7 Hz, I H). 1.77 (ddd, J = 13.7, 1 1.1 , 6.3 Hz. 2H), 1.72 (s, 3H), 1.68 (ddd, J = 14.5, 3.2, 1.9 Hz, 2H), 1.10 (d, J = 7.0, 3H), 0.97 (s, 3H), 0.90 (s. 3H); 13C NMR (125 MHz. CD3OD) S 176.3, 172.5, 164.7, 163.8, 144.0, 141.3, 1 15.4, 1 13.1 , 101.6, 101 .5, 82.8, 82.3, 82.1, 79.9, 74.2, 73.6, 73.4, 72.2, 57.8, 56.7, 43.4, 39.9, 38.8. 34.5, 30.6, 29.6. 23.8, 23.0, 14.1 , 10.9, 9.3; high resolution mass spectrum (ES+) m/z 632.3038 [(M+Naf : calcd for C31H47NOnNa: 632.3047].
Figure imgf000062_0001
Alcohol S3.1. To a 0 0C solution of diol 3.13 (0.50 g, 4.8 mmol) in THF (24 mL) was added 60% NaH (0.19 g, 1.0 equiv.) in three equal portions over 5 min. After 10 min, TBSCl (0.72 g, 1 equiv.) dissolved in THF (5 mL) was added dropwise. After 4 h, the reaction was quenched with MeOH (2 mL). Sat. NaHCO3 (15 mL) was added and the reaction extracted with CH2Cb (3 x 10 mL). The combined organic layers were then dried over MgSθ4 and concentrated. Flash chromatography (10% EtOAc/hexanes) provided S3.1 (0.93 g. 89% yield) as a colorless oil. IR (neat) 3389, 2955, 2929, 2858, 1472. 1254, 1096, 1047 cm"1; 1H NMR (500 MHz, CDCI3) δ 3.46 (s, 4H). 2.86 (dd, J = 5.5, 5.5 Hz, I H), 0.90 (s, 9H). 0.88 (s, 6H), 0.06 (s, 6H); 13C NMR (125 MHz, CDCI3) δ 73.0, 72.5, 36.6, 26.0. 21.7, 18.4, -5.4; high resolution mass spectrum (CI+) m/z 219.1794 L(M+H)+; calcd FOr Cn H27O2Si: 219.1780].
Figure imgf000062_0002
Aldehyde 3.7. To a 0 0C solution of S3.1 (1.51 g, 6.91 mmol) in DMSO (4.9 mL, 10 equiv.) and CH2Cl2 (35 mL) was added Et3N (2.89 mL, 3 equiv.) followed by SO3.pyridine (3.25 g, 3 equiv.). After 1 h, brine (20 mL) and H2O (5 mL) were added. The layers were separated and the aqueous layer was extracted with CH2Cl2 (3 x 20 mL). The combined organic layers were then dried over MgSO4 and concentrated. Flash chromatography (5% EtOAc/hexanes to 10% EtOAc/hexanes) provided 3.7 (1.43 g. 96% yield) as a light yellow oil. IR (neat) 2956, 2930. 2893, 2858. 1733, 1472, 1257. 1 104 cm"1; 1H NMR (500 MHz, CDCl3) δ 9.55 (s, I H). 3.58 (s, 2H), 1.03 (s. 6H), 0.85 (s. 9H), 0.02 (s, 6H); 13C NMR (125 MHz, CDCI3) δ 206.3, 68.6. 48.3, 26.0. 18.7, 1 8.4. -5.4; high resolution mass spectrum (CI+) m/z 215.1453 [(M-H)": calcd for CnH23O2Si: 21 5.1468].
Figure imgf000062_0003
Alcohol (+)-3.11. To a suspension of N-Ts-L-tryptophan (5.1 5 g. 1 .2 equiv.) in CH2CI2 ( 1 50 mL) was added Cl2BPh (1.87 mL, 1 .2 equiv.) dropwise. After 2 h at rt, the mixture was concentrated in vacuo, rc-butyronitrile (50 mL) added, and the solution cooled to -78 0C. A mixture of aldehyde 3.7 (2.6 g, 12.0 mmol), ketene acetal 3.12 (3.86 g, 1.5 equiv.), and isopropanol ( 1.38 mL. 1 .5 equiv) in «-butyronitrile (15 mL) was added over 2 h via syringe pump. After an additional 2 h at -78 0C, the solution was warmed to 0 0C over 30 min. followed by addition of sat. NaHCθ3 (20 mL) and brine (20 mL). The resulting solution was extracted with Et2θ (3 x 30 mL). The combined organic layers were then dried over MgSO4 and evaporated. Flash chromatography (5% EtOAc/hexanes to 10% EtOAc/hexanes to 15% EtOAc/hexanes) provided (+)-3.11 (2.49 g. 66% yield) as a single enantiomer, as determined by Mosher ester analysis. [α]2 D° +27.9 (c 0.6, CHCl3): IR (neat) 3486, 2953, 2929, 2858, 1726, 1657. 1471 , 1258, 1092 cm'1; 1H NMR (500 MHz. CDCl3) δ 7.10 (ddd, ./ = 15.6. 7.2, 7.2, Hz, I H). 5.91 (ddd, ./ = 15.7, 1.5, 1.5. Hz, IH), 3.75 (d, 7 = 3.2. IH), 3.71 (s, 3H), 3.63 (ddd, J = 10.0, 2.9, 2.9 Hz, I H). 3.49 (d, J = 2.0 Hz, 2H), 2.37 (dd. J = 14.5. 6.8 Hz. I H), 2.26 (dddd, J = 14.6, 10.0, 7.5, 1.4 Hz. I H), 0.91 (s. 3H), 0.89 (s. 9H), 0.85 (s, 3H), 0.07 (s, 6H); 13C NMR (125 MHz, CDCl3) δ 167.1. 147.9. 122.6, 78.3. 73.6, 51.6, 38.6, 35.5, 26.0, 22.6, 19.0, 18.3, -5.4, - 5.5; high resolution mass spectrum (ES+) m/z 317.2137 [(M+H)+; calcd for C]OH33O4Si: 317.2148].
Figure imgf000063_0001
(Λ)-Mosher Ester (+)-S3.2. A solution of (+)-3.11 (5.0 mg, 15.8 μmol) in CH2CI2 (0.32 mL) was cooled to 0 0C and (S)-Mosher's acid chloride (8 mg, 2 equiv.) was added, followed by DMAP (8 mg, 4 equiv.) and Et3N (4.4 μL, 2 equiv.). After 45 min, sat. NaHCO3 (0.5 mL) was added and the reaction extracted with EtOAc (3 x 3 mL). The combined organic layers were dried over MgSO4 and concentrated. Preparative thin layer chromatography (500 micron prep plate, 25% EtOAc/hexanes) provided (+)-S3.2 (8 mg, 94% yield). [α]2 D° +4.3 (c 0.5. CHCl3): IR (neat) 2953, 2929, 2857, 1728, 1660, 1471. 1254, 1 170, 1 104, 1012 crrT1; 1H NMR (500 MHz, CDCI3) δ 7.54-7.33 (m, 5H), 6.87 (ddd, J = 15.1 , 8.8, 6.0 Hz, I H). 5.78 (d, J = 1 5.6 Hz, I H), 5.33 (dd, J = 9.4, 3.2 Hz, IH), 3.70 (s, 3H), 3.45 (s, 3H), 3.31 (s, 2H), 2.68-2.59 (m. I H), 2.50- 2.39 (m. IH), 0.91 (s, 3H), 0.89 (s, 9H), 0.88 (s, 3H), 0.02 (s, 6H); 13C NMR (125 MHz, CDCl3) δ 166.5, 166.0, 145.1 , 131.9, 129.8, 128.6, 128.1 , 124.7, 123.8, 122.4, 79.0, 69.3, 55.4, 51.7, 39.8, 33.5, 26.0, 21.1 , 20.9, 18.4, -5.4, -5.5; high resolution mass spectrum (ES+) m/z 533.2556 [(M+HV ; calcd for C26H40F3O6Si: 533.2546].
Figure imgf000064_0001
(5)-Mosher Ester (-)-S3.3. A solution of (+)-3.11 (5.0 mg, 15.8 μmol) in CH2CI2 (0.32 mL) was cooled to 0 0C and (/?)-Mosher*s acid chloride (8 mg, 2 equiv.) was added, followed by DMAP (8 mg, 4 equiv.) and Et3N (4.4 μL, 2 equiv.). After 45 min, sat. NaHCO3 (0.5 mL) was added and the reaction extracted with EtOAc (3 x 3 mL). The combined organic layers were dried over MgSO4 and concentrated. Preparative thin layer chromatography (500 micron prep plate, 25% EtOAc/hexanes) provided (-)-S3.3 (7 mg, 94% yield). [α]∞ -4.2(c 0.5, CHCl3); IR (neat) 2953, 2933, 2857, 1747, 1729, 1660, 1471 , 1256, 1 184. 1 104, 1015 cm'1; 1H NMR (500 MHz, CDCl3) δ 7.54-7.35 (m, 5 H), 6.88 (ddd, ./ = 15.5, 8.7, 5.8 Hz, 1 H), 5.81 (ddd, J = 15.6, 1.6, 1.2 Hz. 1 H), 5.34 (dd, J = 9.3. 3.2 Hz, 1 H), 3.71 (s, 3 H), 3.51 (d, J = 1.0 Hz, 3 H), 3.29 (ddd. J = 9.9, 9.9, 9.9 Hz, 2 H), 2.66 (dddd, J = 15.4, 5.5, 3.2, 1.9 Hz, IH). 2.54-2.44 (m, I H), 0.89 (s. 9H), 0.88 (s, 3H), 0.85 (s, 3H), 0.01 (s, 6H).; 13C NMR (125 MHz, CDCI3) δ 166.5, 166.0, 145.2, 132.1 , 129.8, 128.5, 127.9, 124.8, 123.8, 122.5, 79.3, 69.2, 55.5, 51.7, 39.9, 33.5, 26.0, 21.1 , 20.8, 18.4, -5.4, -5.5; high resolution mass spectrum (ES+) m/z 533.2543 [(M+H)~; calcd for C26H40F3O6Si: 533.2546].
Figure imgf000064_0002
Bis-silyl ether (+)-3.13. To a 0 0C solution of (+)-3.11 (0.226 g, 0.714 mmol) in CH2Cl2 (7.1 mL) was added 2,6-lutidine (0.164 mL, 2.0 equiv.) followed by dropwise addition of TBSOTf
(0.246 mL, 1.5 equiv.). After 1 h, sat. NaHCO3 (5 mL) was added and the layers separated. The aqueous layer was extracted with CH2CI2 (3 x 10 mL), and the combined organic layers were dried over MgSO4 and concentrated. Flash chromatography (2% EtOAc/hexanes to 5%
EtOAc/hexanes) provided (+)-3.13 (0.269 g, 96% yield) as a colorless oil. [α]*' +3.6 (c 1 .0, CHCl3); IH (neat) 2955, 2930, 2886, 2857, 1730, 1657, 1472, 1257, 1090 cm"1; 1H NMR (500
MHz, CDCI3) δ 7.12-6.92 (m, 1 H), 5.81 (ddd, J = 15.7, 1.5, 1.5 Hz, 1 H), 3.74 (dd, J = 6.4, 4.4
Hz, I H), 3.72 (s, 3H), 3.30 (dd, J = 36.2, 9.6 Hz, 2H), 2.48 (dddd, J= 15.0, 6.4, 4.4, 1 .7 Hz, I H).
2.36-2.27 (m, I H), 0.89 (s, 9H), 0.83 (s, 3H), 0.79 (s, 3H), 0.04 (s, 3H), 0.02 (s, 3H), 0.01 (s, 6H); 13C NMR (125 MHz, CDCI3) δ 167.1 , 148.9, 122.0, 75.1 , 69.7, 51.6, 41.1 , 36.6, 26.2, 26.1 , 21.3, 20.9, 1 8.5, 18.4, -3.5. -4.1 , -5.2, -5.3; high resolution mass spectrum (ES+) m/z 431.2997 [(M+H)+; calcd for C22H47O4Si2: 431.3013].
Figure imgf000065_0001
Allylic alcohol (-)-S3.4. A solution of (+)-3.13 (0.217 g, 0.504 mmol) in CH2Cl2 (I O mL) was cooled to -78 °C and DlBAL-H (1.06 mL, 1.0 M in hexanes, 2.1 equiv.) was slowly added. After 5 min, the reaction was quenched with MeOH (0.5 mL) and allowed to warm to rt. Sat. Rochelle's salt (10 mL) and EtOAc (10 mL) were added and the solution stirred for 1 h. H2O (10 mL) was then added to dissolve the suspended solids and the layers were separated. The aqueous layer was extracted with EtOAc (3 x 10 mL), and the combined organic layers were dried over MgSO4 and concentrated. Flash chromatography (5 % EtOAc/hexanes to 10% EtOAc/hexanes) provided (-)-S3.4 (0.237 g, 99%) as a colorless oil. [α]2 D° -3.4 (c 1.0, CHCI3); IR (neat) 3327, 2955, 2929, 2892, 2857, 1715, 1472, 1254, 1091 , 1006 cm"1; 1H NMR (500 MHz. CDCl3) δ 5.82-5.57 (m, 2H), 4.09 (d, J = 5.7, 2H), 3.64 (dd, J = 6.3, 4.3 Hz, I H), 3.31 (dd, J= 28.1 , 9.5 Hz, 2H), 2.36 (ddd, J = 14.7, 4.8, 4.8 Hz, IH), 2.16 (ddd, J = 14.5, 7.1 , 7.1 Hz, I H), 0.89 (s, 21 H), 0.80 (s, 3H), 0.04 (s, 3H), 0.02 (s, 9H); 13C NMR (125 MHz, CDCl3) δ 132.3, 130.1 , 75.9. 69.9, 64.1 , 41.2, 36.5, 26.3, 26.2, 21.4, 20.8, 18.5, 1 8.4, -3.2, -4.1 , -5.2, -5.3: high resolution mass spectrum (ES+) m/z 403.3065 [(M+H)+; calcd for C2]H47O3Si2: 403.3063].
Figure imgf000065_0002
Epoxide (+)-3.14. To freshly activated 3 A molecular sieves (0.2 g) was added (-)-DIPT (1 5 μL. 0.24 equiv.) in CH2CI2 (0.5 mL). The solution was cooled to -20 0C and Ti(O-Z-Pr)4 (18 μL, 0.2 equiv.) in CH2CI2 (0.5mL) was added followed by /-BuOOH (0.176 mL, 5 M in decane, 3.0 equiv.) The reaction was stirred for 30 min and then (-)-S3.4 (0.1 18 g, 0.293 mmol) dissolved in CH2Cl2 (1 ml) was added via syringe. The flask and syringe were rinsed with CH2Cl2 (0.4 mL) into the reaction flask. After 4 h, 10% aq. citric acid (2 mL) was added and the reaction warmed to rt. After 1 h at rt, brine (3 mL) was added, the layers were separated, and the aqueous layer extracted with EtOAc (3 x 5 mL). The combined organic layers were dried over MgSO4 and concentrated. Flash chromatography (5% EtOAc/hexanes to 10% EtOAc/hexanes to 15% EtOAc/hexanes) provided (+)-3.14 (0.108 g, 88% yield) as a 13: 1 inseparable mixture of epoxides. [α]2 D° +24.3 (c 1.0. CHCI3); IR (neat) 3430, 2955, 2929, 2895, 2857, 1472. 1254, 1091 , 1009 cm"1; 1H NMR (500 MHz, CDCI3) δ 3.91 (ddd, J = 12.5, 5.4, 2.4 Hz, I H), 3.80 (dd, ./= 7.4. 3.8 Hz, I H), 3.60 (ddd, J= 12.5, 7.2, 4.4 Hz, I H), 3.31 (dd, J= 33.5, 9.6 Hz, 2H), 3.12 (ddd, J = 6.9, 4.5, 2.3 Hz, I H), 2.93 (ddd, J = 4.6, 2.4, 2.4 Hz, I H). 1.80 (dd. J = 7.1 , 5.8 Hz, I H), 1.79- 1.72 (m, I H), 1.65 (ddd, J = 14.6, 7.0. 3.8 Hz, I H), 0.90 (s. 9H), 0.89 (s, 9H). 0.83 (s, 3H), 0.79 (s, 3H), 0.09 (s, 3H), 0.08 (s, 3H). 0.01 (s, 6H); 13C NMR (125 MHz. CDCl3) δ 73.7. 69.7, 61 .9, 60.1 , 54.1 , 40.7, 35 5, 26.3, 26.1 , 21.5. 20.5, 18.6, 18.5, -3.8, -4.0, -5.2, -5.3; high resolution mass spectrum (ES+) m/z 441.2846 [(M+Na)+; calcd for C2]H46O4Si2Na: 441.2833]. '
Figure imgf000066_0001
Ester (+)-3.15. Alcohol (+)-3.14 (0.199 g, 0.474 mmol) in CH3CN (4.7 niL) was treated with TEMPO (6 mg, 0.08 equiv.) followed by addition of pH 7 buffer (4.7 mL). The reaction was then treated with NaCIO2, followed by dropwise addition of NaOCI (0.1 8 mL, 5% aq. solution). After 2 h, sodium sulfite (200 mg, 3.3 equiv.) was added and the reaction stirred for 30 min. where the solution turned from a light orange color to colorless. The reaction was acidified to pH 4 with 10% aq. citric acid and extracted with EtOAc (5 x 10 mL). The combined organic layers were dried over MgSO4 and concentrated. The unpurified acid was dissolved in CH2CN (2.4 mL) and MeOH (2.4 mL). The solution was cooled to 0 0C and TMS-diazomethanc (0.28 mL. 2 M in Et2O, 1.2 equiv.) was added dropwise until the solution remained yellow in color. Argon gas was bubbled through the reaction for 10 min and then the solvent evaporated. Flash chromatography (5% EtOAc/hexanes) provided (+)-3.15 (0.195 g, 91 % yield, 2 steps) as a colorless oil. [α]2 n° +15.8 (c 1.0. CHCl3); IR (neat) 2955, 2930, 2887, 2857, 1759, 1472. 1254, 1201 , 1089, 1006 cm"1: 1H NMR (500 MHz, CDCl3) δ 3.81 (dd, J = 7.4, 3.8 Hz, I H), 3.75 (s, 3H), 3.30 (ddd, J = 6.5, 4.5, 1.9 Hz, I H), 3.30 (dd, J = 30.1, 9.6 Hz, 2H), 3.22 (d, J = 1.9 Hz, I H), 1.80 (ddd, J = 14.6, 7.4, 4.5 Hz, I H), 1.67 (ddd, J = 14.7, 6.8, 3.8 Hz, I H). 0.90 (s, 9H). 0.88 (s. 9H). 0.83 (s, 3H), 0.78 (s, 3H). 0.10 (s, 3H), 0.08 (s, 3H). 0.01 (s, 6H); '3C NMR (125 MHz. CDCI3) δ 169.9, 73.6, 69.6, 56.9, 54 6. 52.5. 40.7, 35.5, 26.3, 26.1 , 21 .3. 20 7. 18.6. 18.5, -3.8, -4.0, -5.2. -5.3: high resolution mass spectrum (ES+) m/z 469.2778 [(M+Na)' : calcd for
C22H46O5Si2Na: 469.2782].
Figure imgf000067_0001
Alcohol (+)-3.16. To bis-silyl ether (+)-3.15 (72.0 mg, 0.159 mmol) was added a HF-pyridine/pyridine/THF solution (0.64 mL, 10 equiv. HF, stock solution made up of 0.5 mL HF-pyridine, t .0 mL pyridine, and 5.0 mL THF). After stirring 20 h at rt. sat. NaHCO3 (5 mL) was added slowly. Once all gas evolution had ceased, the reaction was extracted with CH2CI2 (3 x 5 mL). The combined organic layers were dried over MgSO4 and concentrated. Flash Chromatography (5% EtOAc/hexanes to 10% EtOAc/liexanes to 15% EtOAc/hexanes to 20% EtOAc/hexanes) provided (+)-3.16 as a single diastereomer (37.2 mg, 72% yield) as a colorless oil. [α]=° +46.8 (c 0.5, CHCI3); IR (neat) 3465, 2955. 2930, 2857, 1 744, 1446. 1290, 1253, 1205, 1089, 1051 , 1004 cm'1; 1H NMR (500 MHz, CDCI3) δ 3.80 (dd, J = 7.4, 3.8 Hz, 111), 3.77 (s, 3H), 3.59 (d, J = 10.9 Hz. I H), 3.36-3.27 (m, 2H). 3.26 (d, J = 1.7 Hz, I H), 2.37 (s, I H). 1.95 (ddd, J= 14.8, 7.4, 3.9 Hz, 1 H), 1.67 (ddd, J= 14.8, 7.3, 3.8 Hz, I H), 0.99 (s, 3H), 0.91 (s, 9H), 0.81 (s. 3H), 0.14 (s, 3H), 0.14 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 169.6, 76.7. 70.0, 56.6, 54.5, 52.7, 39.6, 35.6, 26.2, 23.0, 21.5, 18.4, -3.9, -4.0; high resolution mass spectrum (ES+) mlz 355.1908 [(M+Na)' : calcd for C)6H32O5SiNa: 355.1917].
Figure imgf000067_0002
Tetrahydropyran (— )-3.17. This compound was obtained in 14% yield as a byproduct during the reaction to provide alcohol (+)-3.16. [α]2 D° -26.8 (c 1.0, CHCl3); IR (neat) 3459. 2955. 2928. 2856, 1740, 1465. 1255, 1 144, 1088, 1065 cm"1; 1H NMR (500 MHz, CDCI3) 4.29 (dd. ./ = 5.1 , 2.9 Hz. I H), 4.02 (ddd, J = 12.0. 2.5, 2.5 Hz, I H), 3.78 (s, 3H), 3.65 (d, J = 10.9 Hz. I H). 3.56 (s. I H). 3.26 (d. J = 10.9 Hz, I H), 2.93 (d, J = 5.9 Hz, I H), 2.09 (ddd. J = 14.0, 12.3. 2.3 Hz, I H), 1.21 (ddd, J = 13.8, 2.7, 2.7 Hz, I H), 0.98 (s, 3H), 0.90 (s, 9H), 0.76 (s. 3H). 0.04 (s, 3H), 0.02 (s. 3H); 13C NMR (125 MHz. CDCI3) δ 172.9, 73.5, 73.4, 72.9, 72.8, 52.6, 35.2, 30.1 , 26.0, 23.6, 22.9, 18.3, -4.4, -4.7; high resolution mass spectrum (ES+) m/z 355.1907 [(M+Na)" ; calcd for C16H32O5SiNa: 355.1917].
Figure imgf000068_0001
Aldehyde (+)-3.9. To a solution of (+)-3.16 (0.025 g. 0.075 mmol) in CH2Cl2 (0.75 mL) and DMSO (0.75 mL) at 0 0C was added Et3N (0.105 mL, 10 equiv.) followed by SO3.pyridine (0.047 g, 4 equiv.) in one portion. After 2 h, sat. NaHCO3 (4 mL) was added and the layers separated. The aqueous layer was extracted with CH2Cl2 (3 x 5 mL) and the combined organic layers were dried over MgSO4 and concentrated. Flash chromatography (5% EtOAc/hexaπes to 10% EtOAc/hexanes to 20% EtOAc/hexanes) provided (+)-3.9 (23.5 mg, 95% yield) as a light yellow oil. [ct]∞ +22.9 (c 0.5, CHCl3); IR (neat) 2955, 2931 , 2857. 1754, 1448, 1291 , 1254, 1205, 1093 cm"1; 1H NMR (500 MHz, CDCl3) δ 9.56 (s, I H), 4.06 (dd, J= 7.9, 3.6 Hz. I H), 3.77 (s. 3H), 3.28 (ddd; J = 7.5, 3.8, 1.9 Hz. 1 H), 3.24 (d, J= 1.9 Hz, IH). 1.90 (ddd, ./ = 14.6, 7.9. 3.8 Hz, I H). 1.54 (ddd, J = 14.7, 7.5, 3.6 Hz, I H), 1.06 (s, 3H). 1.02 (s, 3H), 0.88 (s, 9H), 0.13 (s. 3H), 0.08 (s, 3H); 13C NMR (125 MHz, CDCI3) δ 205.8, 169.4. 73.7, 56.0, 54.4, 52.7, 51.3, 35.7, 26.1. 19.3. 18.4, 1 7.7, -3.9, -4.0; high resolution mass spectrum (ES+) m/∑ 353.1753 [(M+Na) ; calcd for C16H3OO5SiNa: 353.1761].
Figure imgf000068_0002
Tetrahydropyran (+)-3.18. To a solution of (-)-DΪPCl (0.035 g. 1.8 equiv.) in Et2O (0.4 mL) cooled to -78 0C was added Et3N (0.021 mL. 2.5 equiv.) followed by slow dropwise addition of 2-butanone (3.10) (0.010 mL, 1.8 equiv.). The solution immediately turned cloudy white. After stirring for 2 h at -78 0C, aldehyde (+)-3.9 (0.020 g, 0.061 mmol) was dissolved in Et2O (0.4 in L) and added dropwise to the boron enolate over 5 min via syringe. The flask and syringe were then rinsed with Et2O (0.4 mL) and the rinse added to the reaction over 2 min. After stirring at -78 0C for 5 h, the solution was warmed to -40 0C over 1 h and held at -40 0C. After 12 h, the reaction was warmed to 0 0C and a 1 : 1 :1 mixture of MeOH/pH 7 buffer/30% aq. H2O2 (1 mL) was added. After 1 h, sat. Na2S2O3 (4 mL) was added very slowly over 30 min to destroy any remaining peroxides. The reaction was then extracted with CH2CI2 (3 x 10 mL). The combined organic layers were dried over MgSO4 and concentrated. Flash chromatography ( 10% EtOAc/hexanes to 15% EtOAc/hexanes to 20% EtOAc/hexanes) provided the aldol product (0.020 g, 86% yield) as a 5: 1 mixture of diastereomers. The aldol products were dissolved in CH2CI: ( 1 mL) and CSA (2.3 mg, 0.2 equiv.) was added. After 2 h, sat. NaHCO3 (2 niL) added and the reaction stirred for 5 min. The layers were separated and the aqueous layer was extracted with CH2CI2 (3 x 5 mL). The combined organic layers were dried over MgSC>4 and concentrated. Flash chromatography (10% EtOAc/hexanes to 15% EtOAc/hexanes to 20% EtOAc/hexanes) provided (+)-3.18 ( 14.8 mg, 60% yield over 2 steps for the major diastereomer) and (-)-3.19 (2.9 mg, 12% yield over 2 steps for the minor diastereomer). Major diastereomer: [α]» +9.8 (c 0.5, CHCI3); IR (neat) 2954, 2930, 2861, 1741, 1714, 1461, 1388, 1366, 1258, 1074 cm'1; 1H NMR (500 MHz, CDCl3) δ 4.26 (dd, J = 6.3, 4.2 Hz, IH), 4.15 (ddd, J = 8.0, 3.8, 3.8 Hz, I H), 4.06 (dd, J= 10.0, 3.5 Hz, IH), 3.78 (s, 3H), 3.64 (dd, J = 5.0, 3.3 Hz, I H), 2.93 (d, J = 63 Hz, I H), 2.57 (dd, 7 = 15.6, 3.6 Hz, I H), 2.50-2.42 (m, 2H), 2.05 (ddd, J= 13.5, 9.3, 3.2 Hz, I H), 1.45-1.38 (m, I H), 1.40-1.36 (m, I H), 1.05 (dd, J = 7.3, 7.3 Hz, 3H), 1.00 (s, 3H), 0.92 (s, 9H), 0.85 (s, 3H), 0.05 (s, 3H), 0.04 (s, 3H); 13C NMR (125 MHz, CDCI3) δ 210.8. 173.3. 77.7, 73.5, 73.4, 68.8, 52.7, 42.4, 37.5, 36.9, 29.8, 26.0, 25.8, 20.7, 18.2, 7.9, -4.4, -4.8; high resolution mass spectrum (ES+) m/∑ 425.2330 [(M+Na)+; calcd for C2OH38O6SiNa: 425.2336]. Minor diastereomer: [α]2 D° -38.7 (c 0.8, CHCI3); IR (neat) 3480, 2955, 2930, 2885, 2857, 1741 , 1719, 1255, 1096, 1060, 1008 cm'1; 1H NMR (500 MHz, CDCI3) δ 4.24 (dd, J = 6.0, 3.3 Hz, I H), 4.17 (dd, J= 10.5, 2.3 Hz, I H), 4.08 (ddd. J = 12.2, 2.7, 2.7 Hz, I H), 3.75 (s, 3H), 3.55 (dd, J= 2.7. 2.7 Hz, I H), 2.79 (d, J= 6.1 Hz, I H), 2.59-2.40 (m, 3H), 2.25 (dd, J = 14.9, 2.4 Hz, I H), 2.04 (ddd, J= 14.2, 12.2, 2.4 Hz, I H), 1.22 (ddd, J= 13.4, 3.0. 3.0 Hz, I H), 1 .04 (dd, .7 = 7.3, 7.3 Hz, 3H), 0.91 (s, 9H), 0.87 (s, 3H), 0.81 (s, 3H). 0.04 (s, 3H), 0.01 (s, 3H); 13C NMR ( 125 MHz, CDCI3) δ 210.8, 172.9, 76.3, 74.9, 73.9, 73.4, 52.6, 42.8, 37.4, 37.2, 30.0, 26.0, 23.7, 19.7, 18.3, 7.8, -4.4, -4.7; high resolution mass spectrum (ES+) m/z 425.2336 [(M+Na)+; calcd for C20H38O6SiNa: 425.2336].
Figure imgf000069_0001
Tetrahydropyran (+)-3.5. To a 0 0C solution of (+)-3.l8 (14.8 mg, 0.036 mmol) in CH2Cl2
(0.1 8 mL) was added proton sponge (95 mg, 12.0 equiv.) followed by Me3BOF4 (54 mg, 1 0 equiv). The reaction was then stirred at it. After 4 h, 10% aq. citric acid (2 mL) added. The layers were separated and the aqueous layer extracted CH2Cl2 (3 x 5 mL). The combined organic layers were washed with 10% aq. citric acid (4 mL) and then brine (4 rnL). The organic layer was then dried over MgSθ4 and concentrated. Flash chromatography (10% EtOAc/hexanes) provided (+)-3.5 (14.2 mg, 92% yield) as a colorless oil. All spectral data matched that of the ketone fragment constructed during the first-generation approach, [α]2^ +16.5 (c 1.7, CHCl3); IR (neat) 2954, 2934, 2886, 2858., 1754, 1722, 1712, 1462, 1361 , 1255, 1 1 19, 1073 cm'1; 1H NMR (500 MHz, CDCl3) 4.08 (dd, J = 1 1 :3, 6.0 Hz, I H), 3.99 (dd, ./ = 9.6, 3.0 Hz, I H), 3.90 (d, J = 6.4 Hz, I H), 3.73 (s. 3H), 3.62 (dd, J = 7.5, 3.6 Hz, I H), 3.40 (s, 3H), 2.91 (dd, J = 15.2, 9.7 Hz, I H). 2.56-2.29 (m. 3H), 1 .93 (ddd. J = 13.8, 6.1 , 3.9 Hz, I H) 1 .60 (add, J= 12.7. 9.0, 5.3 Hz, I H), 1 .03 (dd, J = 7.3, 7.3 Hz. 3H). 0.96 (s. 3H), 0.90 (s, 9H), 0.83 (s, 3H). 0.04 (s. 6H); 13C NMR ( 125 MHz, CDCI3) δ 210.4, 171.7, 82.5, 77.4, 73.1 , 69.8, 58.8, 52.2, 42.6, 38.1 , 37.2, 30.3, 26.0, 25.1 , 18.2, 17.9, 7.8, -4.2, -4.8; high resolution mass spectrum (ES+) m/z 439.2491 [(M+Naf; calcd for C2IH40O6SiNa: 439.2492].
Figure imgf000070_0001
Tetrahyd ropy ran (-)-3.19. To a solution of (+)-DΪPCl (0.042 g, 1 .8 equiv.) in Et2O (0.5 mL) cooled to -78 0C was added Et3N (0.025 mL, 2.5 equiv.) followed by slow dropwise addition of 2-butanone (3.10) (0.017 mL, 2.6 equiv.). The solution immediately turned cloudy white. After stirring for 2 h at -78 0C, aldehyde (+)-3.9 (0.024 g, 0.073 mmol) was dissolved in Et2O (0.5 mL) and added dropwise to the boron enolate over 5 min via syringe. The flask and syringe were then rinsed with Et2O (0.3 mL) and the rinse added to the reaction over 2 min. After stirring at -78 0C for 6 h, the solution was warmed to —40 0C over 1 h and held at -40 0C. After 16 h, the reaction was warmed to 0 0C and a 1 : 1 : 1 mixture of MeOH/pH 7 buffer/30% aq. H2O2 (1.5 mL) was added. After 1 h, sat. Na2S2O3 (4 mL) was added very slowly over 30 min to destroy any remaining peroxides. The reaction was then extracted with CH2CI2 (4 x 5 mL). The combined organic layers were dried over MgSO4 and concentrated. Flash chromatography (10% EtOAc/hexanes to 15% EtOAc/hexanes to 20% EtOAc/hexanes) provided the aldol product as a 5: 1 mixture of diastereomers. The aldol products were dissolved in CH2CI2 (1 .5 mL) and CSA (3 mg, 0.2 equiv.) was added. After 2 h, sat. NaHCO3 (2 mL) added and the reaction stirred for 5 min. The layers were separated and the aqueous layer was extracted with CH2CI2 (3 x 5 mL). The combined organic layers were dried over MgSO4 and concentrated. Flash chromatography (10% EtOAc/hexanes to 15% EtOAc/hexanes to 20% EtOAc/hexanes) provided (-)-3.19 (23 mg, 79% yield over 2 steps). This compound was also previously synthesized as the minor diastereomer obtained during the formation of tetrahydropyran (+)-3.18. [α]j,° -38.7 (c 0.8, CHCI3); IR (neat) 3480, 2955. 2930, 2885, 2857, 1741 , 1719, 1255, 1096.. 1060, 1008 cm'1; 1H NMR (500 MHz, CDCl3) δ 4.24 (dd, ./ = 6.0, 3.3 Hz, 1 H), 4.17 (dd, ./ = 10.5, 2.3 Hz, 1 H), 4.08 (ddd, J = 12.2, 2.7, 2.7 Hz, I H), 3.75 (s, 3H), 3.55 (dd, J= 2.7, 2.7 Hz, I H), 2.79 (d, J= 6.1 Hz, I H), 2.59-2.40 (m, 3H), 2.25 (dd, J = 14.9, 2.4 Hz, IH), 2.04 (ddd, J = 14.2, 12.2, 2.4 Hz, I H), 1.22 (ddd. J = 13.4, 3.0, 3.0 Hz. I H), 1.04 (dd, J = 7.3, 7.3 Hz, 3H), 0.91 (s, 9H). 0.87 (s. 3H), 0.81 (s, 3H), 0.04 (s, 3H), 0.01 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 210.8, 172.9, 76.3, 74.9, 73.9, 73.4, 52.6, 42.8, 37.4, 37.2, 30.0, 26.0, 23.7, 19.7, 18.3, 7.8, -4.4, -4.7; high resolution mass spectrum (ES+) m/z 425.2336 [(M+Na)' ; calcd for C20H38O6SiNa: 425.2336].
Figure imgf000071_0001
2,6-c«-Tetrahydropyran (-)-3.20. A solution of (-)-3.19 (0.014 g, 0.035 mmol) in THF (0.7 mL) was cooled to 0 °C and NaH (2 mg. 60% in mineral oil, 1.5 equiv.) was added in one portion. After 20 min, Me^SO4 (5 μL, 1.3 equiv.) was added dropwise and the reaction allowed to warm to rt. After 1.5 h, the reaction was quenched with sat. NaHCO3 (2 mL). The layers were separated and the aqueous layer extracted with CH2CI2 (4 x 3 mL). The combined organic layers were then dried over MgSθ4 and concentrated. Flash chromatography (10% EtOAc/hexanes) provided (-)-3.20 (13 mg, 89% yield) as a colorless oil. [α]^ -63.6 (c 0.7. CHCl3); IR (neat) 2954, 2935, 2885, 2855, 1752, 1718, 1463, 1256, 1 193, 1093, 1058 cm 1 ; 1H NMR (500 MHz. CDCI3) δ 4.10 (dd, J = 10.6, 2.5 Hz. I H), 4.04 (ddd, J= 1 1.9, 4.5, 2.3 Hz, I H), 3.80 (d, J= 4.5 Hz, IH), 3.70 (s, 3H). 3.53 (dd, J = 2.7, 2.7 Hz I H), 3.40 (s, 3H), 2.60-2.38 (m, 3H). 2.23 (dd, J = 14.5, 2.5 Hz, I H), 1.96 (ddd, J= 14.1. 12.0, 2.4 Hz. I H), 1.40 (ddd, J = 13.8. 3.1 , 2.5 Hz, I H), 1 .04 (dd, J = 7.3, 7.3 Hz. 3H). 0.90 (s, 9H), 0.89 (s, 3H). 0.80 (s, 3H), 0.03 (s, 3H), 0.01 (s, 3H): 13C NMR ( 125 MHz, CDCl3) δ 21 1.1 , 171.3, 83.7, 76.7, 74.9, 73.4, 59.1 , 52.0, 43.0, 37.5, 37.0, 30.9, 26.1 , 23.8, 19.8, 18.3, 7.8, -4.3, -4.7; high resolution mass spectrum (ES+) m/z 439.2480 [(M+Na)+; calcd for C2]H40O6SiNa: 439.2492]. As those skilled in the art will appreciate, numerous modifications and variations of the present invention are possible in light of these teachings, and all such are contemplated hereby. In particular, it is understood that numerous modifications to both the overall synthetic schemes and to the eventual target molecules and intermediates will fall within the skill of the routineer. In particular, it is within the present invention to provide homologs and analogs of (+) irciniastatin A and (-) irciniastatin B, as well as the molecules themselves. It is therefore understood that within the scope of the appended claims, the invention may be practiced otherwise than as specifically described herein, and the scope of the invention is intended to encompass all such variations.

Claims

What is Claimed:
1. A method for preparing an irciniastatin comprising: subjecting a compound of formula I
Figure imgf000073_0001
to reaction conditions sufficient to provide a compound of formula II
Figure imgf000073_0002
wherein
R2 is a Ci_6 alkyl group;
RN is an amine protecting group;
R3 is at least one Cue alkyl, substituted alkyl, halogen, -OH, -OR1, or carbonyl; wherein R1 is a hydroxyl protecting group; and R4 is at least one
Figure imgf000073_0003
alkyl, substituted alkyl, halogen, -OH, or OR; wherein R is a phenolic protecting group; and wherein R is a protecting group that is orthogonal to R1; and converting the compound of formula II to the irciniastatin.
2. The method of claim 1 , wherein the reaction conditions sufficient to provide the compound of formula II comprise: heating the compound of formula I in an organic solvent for a time sufficient to generate an isocyante of formula III
Figure imgf000074_0001
and treating the isocyanate of formula III with an alcohol that is 9-fluorenylmethanol, 2,2,2- trichloroethanol, 2-trimethylsilylethanol, t-butanol, allyl alcohol, benzyl alcohol, m- nitrophenyl alcohol, or p-methoxyphenyl alcohol to produce the compound of formula II.
3. The method of claim 2, wherein the alcohol is trimethylsilylethanol.
4. The method of any of the preceding claims, wherein the solvent is toluene, benzene, or xylene.
5. The method of any of the preceding claims, wherein the compound of formula I is
Figure imgf000074_0002
6. The method of any of the preceding claims, wherein the compound of formula I is
Figure imgf000074_0003
7. The method of any of the preceding claims, wherein the compound of formula I is prepared by reacting a compound of formula VI:
Figure imgf000075_0001
with a compound of formula V
Figure imgf000075_0002
under conditions sufficient to produce a compound of formula VII
Figure imgf000075_0003
wherein each R2 is independently Chalky!; and converting the compound of formula VII into the compound of formula I.
8. The method of claim 7, wherein the compound of formula VI is
Figure imgf000075_0004
9. The method of claim 7, wherein the compound of formula VI is
Figure imgf000076_0001
10. The method of claim 8, wherein the compound of formula V is
Figure imgf000076_0002
11. The method of claim 8, wherein the compound of formula VII is
Figure imgf000076_0003
12. The method of any of the preceding claims, wherein R1 is a trialkylsilyl group.
13. The method of any of the preceding claims, wherein R1 is a t-butyldimethylsilyl group.
14. The method of any of the preceding claims, wherein R is 2-(trialkylsilyl) ethoxymethyl.
15. The method of any of the preceding claims, wherein R is 2-(trimethylsilyl) ethoxymethyl.
16. The method of any of the preceding claims, wherein R is benzyl.
17. The method of any of the preceding claims, wherein the irciniastatin is irciniastatin A.
18. The method of any of the preceding claims, wherein the irciniastatin is irciniastatin B.
19. A compound of formula XIII
Figure imgf000077_0001
wherein
R1O is Ci_6 alkyl group substituted with at least one OR12 or carbonyl, each R11 is independently Cue alkyl, and
Ro and R12 are orthogonal protecting groups.
20. The compound of claim 19, wherein the compound of formula XIII is
1
Figure imgf000077_0002
PCT/US2009/054305 2008-08-19 2009-08-19 Methods for the preparation of irciniastatin and analogs thereof Ceased WO2010022148A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US9008608P 2008-08-19 2008-08-19
US61/090,086 2008-08-19
US9637908P 2008-09-12 2008-09-12
US61/096,379 2008-09-12

Publications (1)

Publication Number Publication Date
WO2010022148A1 true WO2010022148A1 (en) 2010-02-25

Family

ID=41707441

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2009/054305 Ceased WO2010022148A1 (en) 2008-08-19 2009-08-19 Methods for the preparation of irciniastatin and analogs thereof

Country Status (1)

Country Link
WO (1) WO2010022148A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014113427A3 (en) * 2013-01-15 2014-08-28 The Trustees Of The University Of Pennsylvania Irciniastatin analogues
CN109956936A (en) * 2019-03-28 2019-07-02 北京大学深圳研究生院 Preparation method of Psymberin

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3729475A (en) * 1971-03-17 1973-04-24 Lilly Industries Ltd Phenyl alkyl amine derivatives
US20040122057A1 (en) * 2002-11-25 2004-06-24 Banner David William Novel mandelic acid derivatives
US20060057083A1 (en) * 2004-09-09 2006-03-16 Estelle Mathonneau Cosmetic composition comprising at least one diamantoid to improve the mechanical properties of some materials
WO2006056875A1 (en) * 2004-11-29 2006-06-01 Pharmacia & Upjohn Company Llc Thiazepine oxazolidinones as antibacterial agents
US20070015821A1 (en) * 2005-07-15 2007-01-18 Board Of Regents, University Of Texas System Synthesis and complete stereochemical assignment of psymberin/irciniastatin for use as antitumor compounds
US20070142380A1 (en) * 2003-01-22 2007-06-21 Boehringer Ingelheim International Gmbh Viral Polymerase Inhibitors

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3729475A (en) * 1971-03-17 1973-04-24 Lilly Industries Ltd Phenyl alkyl amine derivatives
US20040122057A1 (en) * 2002-11-25 2004-06-24 Banner David William Novel mandelic acid derivatives
US20070142380A1 (en) * 2003-01-22 2007-06-21 Boehringer Ingelheim International Gmbh Viral Polymerase Inhibitors
US20060057083A1 (en) * 2004-09-09 2006-03-16 Estelle Mathonneau Cosmetic composition comprising at least one diamantoid to improve the mechanical properties of some materials
WO2006056875A1 (en) * 2004-11-29 2006-06-01 Pharmacia & Upjohn Company Llc Thiazepine oxazolidinones as antibacterial agents
US20070015821A1 (en) * 2005-07-15 2007-01-18 Board Of Regents, University Of Texas System Synthesis and complete stereochemical assignment of psymberin/irciniastatin for use as antitumor compounds

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014113427A3 (en) * 2013-01-15 2014-08-28 The Trustees Of The University Of Pennsylvania Irciniastatin analogues
US9540355B2 (en) 2013-01-15 2017-01-10 The Trustees Of The University Of Pennsylvania Irciniastatin analogues
CN109956936A (en) * 2019-03-28 2019-07-02 北京大学深圳研究生院 Preparation method of Psymberin
CN109956936B (en) * 2019-03-28 2021-01-05 北京大学深圳研究生院 Preparation method of Psymberin

Similar Documents

Publication Publication Date Title
CN108948039B (en) Intermediates and methods for the synthesis of halichondrin B analogs
EP3638685A1 (en) Synthesis of 3&#39;-deoxyadenosine-5&#39;-0-[phenyl(benzyloxy-l-alaninyl)]phosphate (nuc-7738)
EP0761663B1 (en) Process for preparing optically active 3-hydroxy furan compounds
AU2021225706B2 (en) Intermediate useful for synthesis of SGLT inhibitor and method for preparing SGLT inhibitor using same
WO2010022148A1 (en) Methods for the preparation of irciniastatin and analogs thereof
Manchand et al. A novel synthesis of the monobactam antibiotic carumonam
AU2005264678A1 (en) Method for the preparation of D-erythro-2,2-difluoro-2-deoxy-1-oxoribose derivative
KR101880939B1 (en) Intermediate for Preparing Eribulin Mesylate and Process for Preapring the Same
EP3686208B1 (en) Intermediates for preparing halichondrin compounds and preparation method therefor
US5220003A (en) Process for the synthesis of 2&#39;,3&#39;-dideoxynucleosides
Wang et al. Synthesis of the trioxadispiroketal domain of spirastrellolide B
CA2416769C (en) Process for preparing discodermolide and analogues thereof
Ikota Synthesis of (-)-galantinic acid from D-ribonolactone
Watanabe et al. Synthesis of GLA-60 type pyran carboxylic acids with an alkyl chain instead of an ester chain as LPS-antagonists
JP6898323B2 (en) Method for preparing 6-azido-2,4-diacetamide-2,4,6-trideoxy-D-mannose
US6506910B1 (en) Process for preparing discodermolide and analogues thereof
AU2001293726A1 (en) Process for preparing discodermolide and analogues thereof
US20250276992A1 (en) Synthesis methods of acyl chain of qs-21 and derivative thereof
US5504206A (en) Formation of esperamicin precursors
RU2328492C2 (en) General synthesis of myriaporones
JP2832356B2 (en) Synthetic intermediates and production methods for hygromycins
HK1055962B (en) Process for preparing discodermolide and analogues thereof
WO2022094711A1 (en) Process for preparation of advanced intermediate for eribulin synthesys
Vi Synthetic Studies on the Validamycins. IV. Synthesis of DL-Valienamine and Related Branched-chain Unsaturated Aminocyclitols^
Wing-Chuen Studies on the Construction of 0-Heterocycles from Carbohydrates via 1, 3-Dipolar Cycloaddition

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09808765

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09808765

Country of ref document: EP

Kind code of ref document: A1